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Osteoarthritis (OA), also called degenerative joint disease, is one of the most frequently 
occurring disorders of the locomotor system. It is a disease of the whole joint in which all 
articular structures are affected, including articular cartilage loss, development of marginal 
outgrowths, osteophytes, and increased thickness of the bony envelope (subchondral 
sclerosis). Soft-tissue structures in and around the joint are also affected, including 
synovium, ligaments and bridging muscles. Patients with OA of the hip or knee have pain 
that typically worsens with weight bearing and activity and improves with rest, as well as 
morning stiffness and gelling of the involved joint after periods of inactivity (1). Especially 
when the hip or knee is involved, it accounts for more difﬁculty in walking, stair climbing, 
and other lower extremity tasks (2). On physical examination, there is often tenderness 
on palpation, bony enlargement, crepitus on motion, and/or limitation of joint motion (1). 
Because of the longevity of working careers and the substantial prevalence of OA in middle-
aged persons, OA causes a considerable burden in lost time at work and early retirement 
(3). OA is expected to be the fourth leading cause of disability by the year 2020 (4). Recent 
estimates suggest that total costs for arthritis, including OA, may exceed 2% of the gross 
domestic product (3). 
Based on the baseline results of the Rotterdam Study (5) and standardized to the Dutch 
society (6), the estimated number of persons with radiologic OA (ROA) of the hip in 2000 
was 257,400. This number of persons with OA of the hip is somewhat higher than the number 
known by the GPs (6). In a large follow-up study (EPOZ) of men and women aged between 
45 and 65 years, it was found that the nine-year incidence of ROA of the hip was 9% for men 
and 12% for women (7). Because the prevalence of OA will increase with the aging of the 
Western society, it is expected that the percentage of persons with OA will increase by 37.7% 
between 2000 and 2020 (6). Over the last two decades many epidemiological studies have 
investigated the different determinants of the occurrence of hip OA. OA of the hip is assumed 
to be a multifactorial disease involving both systemic factors, such as metabolic, hormonal, 
genetic, age and gender, and local biomechanical factors, such as mechanical workload, 
mechanical load of sport activity, obesitas and acetabular dysplasia. Dieppe introduced the 
model proposing that the joint becomes susceptible for OA by systemic factors and that 
local biomechanical factors play the ﬁnal role in determining site and severity of OA (8) (see 
Figure 1). This interplay between systemic and local factors was investigated among families 
in whom inherited OA occurs at an early age, and in each member of the susceptible 
families, different joints were affected, suggesting that local biomechanical factors had acted 
on a predisposed joint (9). To date, many more studies have investigated the epidemiology 
of knee OA than of hip OA. However, the inﬂuence of local biomechanical factors on the 
occurrence of hip OA has not been well explored. Furthermore, the independent inﬂuence 
of the different determinants on the occurrence of hip OA and also the interaction between 
different determinants is not clear. This is especially important because the identiﬁcation of 
modiﬁable determinants of hip OA may help to develop preventive strategies. Furthermore, 
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a pathogenetic approach may help elucidate the role of the different determinants in the 
occurrence of OA. Based on these arguments, we conclude that hip OA is a particularly 
important topic to investigate more thoroughly. 
Case deﬁnition 
A major problem in studying hip OA is the absence of consensus in deﬁning hip OA 
for epidemiological studies. In most epidemiological studies OA is assessed by means of 
radiologic evaluation, because radiographs are easily obtainable and relatively cheap for 
large epidemiological studies. The most commonly used radiological deﬁnition of hip OA 
– the Kellgren & Lawrence grade – is also the one that is most criticized. Therefore several 
other deﬁnitions of hip OA have been proposed during the last decades. One limitation 
of a radiological deﬁnition of hip OA is that the majority of the subjects with radiographic 
evidence of OA have no symptoms (17–33% of the persons with ROA have joint pain). 
Moreover, not all people with symptomatic OA have radiographic evidence of OA. Another 
limitation of radiographs is that signiﬁcant osteoarthritic changes must already have occurred 
in order to be visible on a radiograph. To overcome this, biochemical markers aiming to 
detect OA in an early stage have been developed. Such a biochemical marker might also be 
useful for identiﬁcation of patients at high risk for progression, and for a faster assessment 
of therapeutic response in OA. Moreover, all imaging techniques provide a historical view 
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Figure 1. Diagram showing the pathogenesis of osteoarthritis with putative risk factors adapted from Dieppe (8).
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of damage that has already occurred, rather than assessing the current rate of disease 
progression (10). 
Progression 
The identiﬁcation of patients at high risk for progression of hip OA is important for at least 
two reasons. Firstly, well-characterized ‘high risk’ groups may be useful in clinical trials and, 
secondly, assuming that disease-modifying OA drugs might become available in the future, 
to identify primary target groups in need of such therapy. Up till now the prognostic factors 
of progression of hip OA have been investigated in small studies, with a short follow-up 
time and in a hospital setting only. Hence, the conclusion that until now the main predictive 
factors showed to be radiological features (11) should be investigated in an open population 
and in a primary care setting. 
NSAIDs and progression 
There is no known cure for OA, and currently the main goals of medical management of 
patients with OA are symptomatic relief and preservation of function. 
In about 80% of the patients with symptomatic hip OA the clinician will prescribe a non-
steroidal anti-inﬂammatory drug (NSAID) (12). Efﬁcacy and side-effects of NSAIDs are well 
understood. However, it remains controversial as to what effects these agents have on the 
progression of OA. Several in-vitro studies of human cartilage and animal studies suggest 
that some NSAIDs inhibit the synthesis of glycosaminoglycans and other aspects of articular 
cartilage metabolism, while others are supposed to have a neutral effect on cartilage 
metabolism (13). Whether the rate of progression is also increased in patients receiving 
such NSAIDs remains an open question.
Aim of this thesis
The overall objective of the studies described in this thesis is to determine the prognostic 
factors of osteoarthritis of the hip in a large open population. Based on the model of Dieppe 
the prognostic factors were divided in systemic factors (e.g. age, gender, genetics, hormonal 
inﬂuence) and metabolic factors; and in local biomechanical factors such as mechanical load 
by work or sport activity, weight, and acetabular dysplasia. 
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Description of chapters
In chapter 2 we summarize and review articles addressing the quality, in terms of validity, 
reliability, applicability, of seven commonly used deﬁnitions of hip OA for epidemiological 
studies, primarily used as classiﬁcation criteria.
In chapter 3 we directly compare the reliability and validity of three frequently used 
radiological deﬁnitions of hip OA namely, Kellgren & Lawrence grade, Minimal Joint Space 
and Croft’s grade in a large open population aged 55 years and over. Additionally, we 
investigate whether the validity of the three deﬁnitions of hip OA is gender dependent.
In chapter 4 we investigate the association between urinary concentrations of C-telopeptide 
fragments of collagen type II (CTX-II) and the prevalence and progression of radiologic OA 
of the hip and knee in a large open population aged 55 years and over with a long-term 
follow-up. Additionally, we repeated the analyses in those subjects with pain at baseline 
(hip or knee).
In chapter 5 we investigate which determinants will best identify those persons who are at 
high risk for progression of hip OA in a large open population aged 55 years and over, with 
a long-term follow-up period. 
In chapter 6 we investigate the association between radiographic evidence of acetabular 
dysplasia in participants without ROA of the hip at baseline, and an incident hip ROA, 
in a large open population aged 55 years and over, with a long-term follow-up period. 
Additionally we investigate whether the association between acetabular dysplasia and 
incident hip ROA is modiﬁed by other determinants of hip OA.
In chapter 7 we investigate the associations between two groups of NSAIDs, those 
(indomethacin, naproxen and ibuprofen) that are supposed to have a deleterious effect on 
joint cartilage and those NSAIDs (such as diclofenac and piroxicam) that are supposed to 
have a neutral effect on cartilage metabolism, and progression of OA of the hip and knee 
in a large open population aged 55 years and over with a long-term follow-up period. 
Additionally, we investigated the associations between each of the NSAIDs and progression 
of OA of the hip and knee.
Finally, in chapter 8, the most important results of these studies, as well as their limitations 
and implications are discussed.
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Abstract
Objective: To summarise and review articles addressing quality (in terms of validity, 
reliability, applicability) of seven commonly used deﬁnitions of hip osteoarthritis (OA) for 
epidemiological studies, in order to use it primary as classiﬁcation criteria.
Methods: Relevant articles were identiﬁed based on a search in Medline and Embase. Articles 
with the aim to study the validity, reliability or applicability of the deﬁnitions of hip OA 
were selected. Two reviewers independently performed data extraction of the quality of the 
7 deﬁnitions of hip OA.
Results: Review of the literature reveals that particularly the validity of the various deﬁnitions 
of hip OA has barely been investigated. Minimal joint space (MJS) demonstrated the highest 
(intra- and inter-rater) reliability, and showed the highest association with hip pain and 
restricted internal rotation compared to the other deﬁnitions of hip OA. The reliability of the 
Kellgren & Lawrence grade and the index according to Lane is comparable to that of MJS, 
but the construct validity should be investigated more thoroughly. The Croft grade, appeared 
to be inferior to the MJS, the Kellgren & Lawrence grade and the index according to Lane, 
regarding reliability and validity. Despite a precise and extensive method of development, 
the ACR criteria showed poor reliability and poor cross-validity (agreement between 3 ACR 
criteria sets) in a primary care setting. 
Conclusions: Summarising the literature, it showed that the reliability of MJS, Kellgren & 
Lawrence and index according to Lane was comparable, but MJS had the highest relationship 
with hip pain in a male population. Considering how frequently the deﬁnitions of hip OA 
are used, it is surprising that the validity has been so poorly investigated, therefore we 
recommend that the validity be studied more thoroughly.
Ann Rheum Dis 2004;63(3):226–32.
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Introduction
Osteoarthritis (OA) is the most common joint disorder [1] and represent a considerable 
burden to society. Depending on the deﬁnition of hip OA used, the prevalence ranges from 
7 to 25% in persons aged 55 years and over [2]. The hip is particularly interesting because it 
is often the sole joint affected by OA, suggesting an important role of local biomechanical 
risk factors. In addition the hip is crucial to independent function [3]. 
A major problem in studying hip OA, is the absence of consensus in deﬁning hip OA for 
epidemiological and clinical studies [4]. Most epidemiological studies have used a single 
hallmark of hip OA (namely radiological changes) to deﬁne hip OA [5, 6]. 
To investigate (potential) risk factors, a valid and reliable deﬁnition of hip OA is required. 
Therefore we appraised the quality (in terms of validity, reliability and applicability) of 
seven deﬁnitions of hip OA commonly used for epidemiological studies: 
1. The radiological grading system of Kellgren & Lawrence [7];
2. Croft’s radiological grading system (a modiﬁcation of the Kellgren & Lawrence grading 
system) [8];
3. Minimal Joint Space (MJS) according to Croft et al. (a measurement of the narrowing of 
the joint space) [8];
4. Measurement of the joint space according to Resnick & Niwayama [9];
5. Three sets of criteria (1 clinical, and 2 combined sets of clinical and radiographic criteria) 
of the American College of Rheumatology (ACR) [10]; 
6. Clinical deﬁnition of hip OA: radiological OA combined with pain in the hip region [11, 
12];
7. Radiographic index grade according to Lane [13, 14].
The objective of the present study was to review the quality (reliability, validity, applicability) 
of these seven deﬁnitions of hip OA commonly used epidemiological studies, in order to use 
it primary as classiﬁcation criteria [15, 16].
Methods
The literature was searched for all relevant papers containing one of the seven deﬁnitions of 
hip OA. Studies, which fulﬁlled predeﬁned inclusion criteria were identiﬁed and subsequently 
assessed on aspects of reliability, validity, and applicability of the deﬁnition of hip OA used 
in each particular study.
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Identiﬁcation of the literature
To identify the studies a search was made in the following databases: Medline / Pubmed 
(1966 – March 2002), Cochrane Library and Embase (1990 – March, 2002). The speciﬁc 
keywords were: “osteoarthritis, hip” or “osteoarthritis” and “hip” and “clinical deﬁnition”, 
“radiological deﬁnition”, “case deﬁnition”, “radiographic grading”, “diagnosis”, “severity”, 
“index of severity”, “classiﬁcation criteria”, “radiographic change”, “minimal joint space”, 
“Kellgren”, “Kellgren and Lawrence”, “reliability”, “reproducibility of results”, “epidemiologic 
studies” or “feasibility studies”. The search was extended by screening the reference lists 
of all relevant articles identiﬁed. We repeated the search using the keywords of all selected 
articles. 
Criteria for studies considered for inclusion
A study was included in this review if it fulﬁlled all of the following criteria: 1) the study 
population contained persons with and persons without hip OA, 2) it was an original 
article or a systematic review, 3) at least one of the seven deﬁnitions of hip OA investigated 
here was used, 4a) the study described the design, or the reliability, or the validity, or the 
applicability of at least one of the above mentioned deﬁnitions, or 4b) the study investigated 
the risk factors (or determinants) of hip OA, and used at least two of the above mentioned 
deﬁnitions.
Critical assessment of OA deﬁnitions
Using the information from the criteria of Buchbinder et al. [15], Felson et al. [16] and 
Bierma-Zeinstra et al. [17], we compiled a list of criteria to evaluate the deﬁnitions of hip 
OA (Appendix 1). These criteria relate to the reliability, the validity and the applicability of 
the deﬁnition of hip OA: 
1. The reliability of the deﬁnition expressed in intra- and inter-rater reliability
2. The validity of the deﬁnition expressed in 
 Criterion validity
 – expert validity
 The expert validity evaluates the sensitivity and speciﬁcity of the classiﬁcation criteria 
with the use of a predeﬁned “gold standard” by expert’s opinion in a trans-sectional 
study design [15, 16].
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 – predictive validity
 The predictive validity evaluates the sensitivity and speciﬁcity of the classiﬁcation criteria 
with the use of a predeﬁned “gold standard” by an “obvious hip OA” (for example a total 
hip replacement) after a certain period of follow-up [15, 16].
 Construct validity. 
 The construct validity evaluates whether the deﬁnition correlates with the external 
variables it should correlate with [16, 17]. In case of radiological hip OA, the deﬁnition 
should correlate with known symptoms (hip pain, disability, limited ROM, morning 
stiffness < 1 hour) of hip OA, or with known risk factors of hip OA. If the deﬁnition is 
based on clinical signs, it should correlate with radiological signs of hip OA. 
3. The applicability of the deﬁnition of hip OA expressed in three issues, namely: 
 – the ability to discriminate between hip OA and no hip OA, 
 – the ability to categorise the severity of hip OA, 
 – the tools and skills needed to deﬁne persons with hip OA. 
4. A description of which method has been used to develop the deﬁnition of hip OA 
(content validity).
Two reviewers (MR and SMABZ) independently evaluated the deﬁnition of hip OA used in 
the included articles according to the above criteria. In case of disagreement, both reviewers 
tried to achieve consensus. If disagreement was not resolved, a third reviewer (BWK) was 
consulted to achieve a ﬁnal judgement. 
Data extraction
In the included studies, data on reliability (various measures of intra- and inter-rater reliability), 
construct validity (association measures) as well as information on the applicability of the 
seven deﬁnitions used for hip OA were collected by two reviewers independently of each 
other and summarised (descriptive analysis) according to each deﬁnition separately. 
Results
Identiﬁcation / selection of the literature
The initial searches resulted in 1,170 potentially relevant articles [18]. Of these, 12 articles 
fulﬁlled the predeﬁned inclusion criteria. After screening the reference lists of the 12 articles, 
another two articles were included. Finally, 14 publications were used to extract data 
regarding the reliability, validity, or applicability of the deﬁnitions for hip OA. 
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Description of included studies 
Of the 14 articles, 13 studied the reliability and 7 the validity of one (or more) of the 
deﬁnitions. Table 1 lists the characteristics of the studies. As can be seen, there is a large 
difference in the reported prevalence of hip OA, probably due to the large difference in 
the percentage of males and the different classiﬁcations of hip OA used. All studies used a 
relatively young population (mean age < 66 years). 
The 14 studies deﬁned hip OA according to one (or more) of the following seven deﬁnitions 
(Appendix 2): Kellgren & Lawrence grade = 5 studies, Croft grade = 6, MJS (according to 
Croft et al.) = 8, MJS (according to Resnick & Niwayama) = 1, the ACR criteria = 3, hip pain 
and joint space narrowing (JSN) = 1 study, and the index grade according to Lane = 2.
Results of the included studies 
Reliability
Of the 14 studies, 13 investigated the reliability of 5 of the 7 deﬁnitions of hip OA 
(Table 2). 
The four studies that investigated the reliability of the Kellgren & Lawrence grade reported 
an intra-rater reliability with Kappa statistics of 0.76 [19], Pearson Correlation Coefﬁcient 
of 0.66–0.89 [5], an inter-rater reliability with Kappa statistics of 0.60–0.75 [12, 19], and 
an Intraclass Correlation Coefﬁcient (ICC) of 0.63 [5]. In contrast to more recent studies, 
the original study of Kellgren & Lawrence showed a relatively lower inter-rater reliability 
(Correlation Coefﬁcient of 0.40) [7]. 
In ﬁve studies the overall grade of Croft (a modiﬁcation of the Kellgren & Lawrence grade) 
had an intra-rater reliability with Kappa statistics of 0.49–0.93 [5, 8, 20, 21] but a relatively 
lower inter-rater reliability with Kappa statistics of 0.37–0.79 [5, 8, 20]. The wide range of 
intra- and inter-rater reliability between the studies is mainly explained by the different cut-
off levels used.
In seven studies the MJS according to Croft et al. showed the highest intra- and inter-rater 
reliability compared to the other deﬁnitions of hip OA. The MJS according to Croft et al. 
showed an intra-rater reliability with Kappa statistics of 0.81–0.85 [5, 8, 21] and an ICC of 
0.83–0.94 [19, 20], an inter-rater reliability with Kappa statistics of 0.42–0.84 [5, 8, 22] and 
an ICC of 0.75–0.96 [19, 20]. Only the study by Hirsch et al. [5], described a relatively low 
inter-rater reliability with Kappa statistic of 0.42.
Only one study investigated the inter-rater reliability of the ACR classiﬁcation(s) [23] and 
reported a wide range for the clinical set with Kappa statistics of 0.0–0.65 and the combined 
clinical, radiological and lab signs set with Kappa statistics of 0.31–0.85.
Two studies investigated the reliability of the index according to Lane. These studies 
reported an intra-rater reliability with Kappa statistics of 0.83 (≥ grade 2) and an ICC of 
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Table 2: Reliability of the deﬁnitions of hip osteoarthritis
Intra-rater Inter-rater Cut-oﬀ
level
Statistic Size Prevalence
(%)
Reference
Kellgren &
Lawrence
(0–4)
0.75 ≥ 2 Kappa 
(dichotomous)
227 NA Bierma-Zeinstra
(1999) 
0.66 / 0.89 0.63 
(0.59-0.67)
- Intra: Pearson
Inter: ICC
775 3.6 Hirsch
(1998)
0.76 0.60 / 0.65 ≥ 2 Kappa 
(dichotomous)
147 9.2 Ingvarsson
(2000)
0.75 0.40 - Correlation 
coeﬃcient
85 NP Kellgren
(1957)
Croft
Grade
(0–5)
0.81 0.79 NP Kappa NA Birrell
(2001)
0.49
0.93
0.41
0.63
≥ 3
≥ 4
Kappa
(dichotomous)
50 24.3 (≥2)
11.0 (≥3)
Croft
(1990)
0.61 0.37 NP Kappa Hirsch
(1998)
081 NP Kappa 350 16.3 (≥1)
11.7 (≥2)
MacGregor
(2000)
0.61 0.37 ≥ 3 Kappa 40 NP Smith
(1995)
MJS
According
to 
Croft
0.81 / 0.84 NP Kappa 350 8a Antoniades
(2000)
0.83 0.75 - ICC 195 NA Birrell
(2001)
0.81
0.83
0.70
0.79
≤ 2.5 mm
≤ 1.5 mm
Kappa
(dichotomous)
50 14.4
2.0 
Croft
(1990)
0.85 0.42 NP Kappa Hirsch
(1998)
0.94 0.81 / 0.96 - ICC 147 10 Ingvarsson
(2000)
0.84 NP Kappa 350 10.9 MacGregor
(2000)
0.85 0.42 ≤ 2.5 mm Kappa 40 NP Smith
(1995)
ACR criteria
– Clinical 0 / 0.65 
(0.93/0.95 b)
Kappa
(dichotomous)
159 NP Bellamy
(1999)
– Clin/rad/lab 0.31 / 0.85 
(0.91/0.97 b)
Kappa
(dichotomous)
159 NP Bellamy
(1999)
Index according 
to Lane 
0.70/ 0.88
0.36
0.83
0.76 / 0.85
0.40 / 0.47
0.72 / 0.92
0-3
≥ 1
≥ 2
ICC
Kappa
Kappa
31 55.5 (right hip 
≥ 2)
36.1 (left hip 
≥ 2)
Lane
(1993)
0.87
0.71
0-4
≥ 2
ICC
Kappa
4090 7.1 (≥ 2)
4.7 (≥ 3)
Nevitt
(1995)
a < 2.5 mm used as cut-oﬀ level
b Kappa adjusted for prevalence and bias (24)
NP = not provided
NA = not applicable (population includes patients with hip pain who consulted the general practitioner) 
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0.70–0.88[13], an inter-rater reliability with Kappa statistics of 0.72–0.92 (≥ grade 2) and an 
ICC of 0.76–0.87 [13, 14].
Validity
None of the screened studies investigated the criterion (expert or predictive) validity of 
the seven deﬁnitions of hip OA. In the 14 studies the construct validity was evaluated by 
considering two questions: Does the radiological deﬁnition correlate with known symptoms 
of hip OA? and Does the deﬁnition correlate with other deﬁnitions of hip OA? Of the 14 
studies, 7 evaluated the construct validity of two of the deﬁnitions of hip OA (MJS and the 
overall grade of Croft) (Table 3). The association between the radiological deﬁnition and 
(known) symptoms of hip OA (hip pain, restricted ROM) was used as a measure of construct 
validity. The highest association was described between severe radiological hip OA and hip 
pain, and between severe radiological hip OA and a restricted internal rotation of the hip 
[8, 20]. In their study, Birrell et al. [20] investigated the association between restricted ROM 
and mild to moderate radiological hip OA deﬁned as grade ≥ 2 (Croft grade) and severe OA 
deﬁned as MJS ≤ 1.5 mm. Internal rotation appeared to be the most discriminating movement 
for severe hip OA (OR of 46.8 (95% CI: 5.2–420.0) versus 3.6 (95% CI: 1.6–8.0) for moderate 
OA). In 1990 Croft et al. investigated the association between hip pain and radiologic hip 
OA [8]. Severe hip OA deﬁned by MJS ≤ 1.5 mm, showed a stronger association with hip 
pain than deﬁned by the Croft grade (prevalence of 56.0% versus 47.5% of those with hip 
pain). The association with pain and MJS ≤ 2.5 or Croft grade ≥ 3 is comparable (prevalence 
of 28.3% versus 28.8% of those with hip pain). 
For the construct validity we also reported the correlation between the different deﬁnitions 
of hip OA. The relationship between the Kellgren & Lawrence deﬁnition and the three 
sets of ACR criteria is very low (Kappa of 0.03–0.16) [12]. There is a moderate agreement 
between the deﬁnition of Kellgren & Lawrence and “hip pain and JSN” (Kappa of 0.52) [12]. 
There was a high association between a severe hip OA deﬁned by MJS ≤ 1.5 mm and grade 
Table 3: Association of deﬁnitions with known symptoms of hip osteoarthritis 
MJS (Croft) Croft grade
≤ 2.5 mm ≤ 1.5 mm ≥ 2 ≥ 3 ≥ 4
Restriction ROM (OR)
– Flexion (≤ 94°) 2.6
(0.8-8.9)
1.5
(0.7-3.2)
– External rotation  (≤ 23°) 1.2
(0.3-3.9)
3.0
(1.4-6.2)
– Internal rotation (≤ 23°) 46.8
(5.2-420.0)
3.6
(1.6-8.0)
Prevalence of pain 28.3% 56.0% 28.8% 47.5%
References: 8, 20
OR = Odds Ratio (95% Conﬁdence Interval)
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≥ 4 (Croft grade) (OR of 153.5) [8]. None of the studies compared the association between 
two of more deﬁnitions with known risk factors. 
The method of development of the seven deﬁnitions of hip OA also differs considerably. 
The Kellgren & Lawrence grade and the index according to Lane were developed based 
on the opinion of the researchers. The overall grade of Croft and the MJS were based on a 
study population, and were developed based on pain within the study population. The ACR 
criteria sets were also based on a study population, and were developed using regression 
analysis (classiﬁcation tree) on the occurrence of hip OA deﬁned by an expert team. The 
methods of development of the remaining two deﬁnitions were not given. 
Applicability
The applicability of the deﬁnitions of hip OA in the present study was made operational 
as the ability to discriminate between hip OA and no hip OA, the ability to categorise the 
severity of hip OA, and the skills and tools needed to classify persons according to the 
respective deﬁnitions (Table 4). According to their own description, six deﬁnitions intend 
to discriminate between persons with and without hip OA, and all six are easy to apply for 
persons at MD level. The Kellgren & Lawrence grade, Croft grade, the MJS and the index 
grade according to Lane are also able to categorise the severity of hip OA.
All deﬁnitions include information from a radiograph (except the clinical set of the ACR 
criteria). The ACR also makes use of information of the clinical history and physical 
examination (restricted ROM).
Discussion
Reviewing the selected literature demonstrates that particularly the validity of the various 
deﬁnitions of hip OA has barely been investigated. The highest (intra- and inter-rater) 
reliability was reported for the MJS and the index according to Lane and the highest 
association with hip pain compared to the other deﬁnitions of hip OA for the MJS. 
Despite putting much effort into identifying all relevant articles, some relevant articles may 
have been missed because e.g. they used other keywords, had unclear abstracts, or were 
not indexed in Pubmed or Embase. Although the sensitivity of our search action might not 
be optimal [24], [25], we nevertheless believe that we included the most appropriate studies 
that evaluated aspects of the quality of deﬁnition of hip OA, and assume that the data 
presented here gives a clear insight in the currently available studies on this topic. Only 
14 of 1170 potentially relevant articles fulﬁlled the predeﬁned inclusion criteria. The most 
restrictive inclusion criterion was, that the study population contained persons with and 
persons without hip OA.
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The problems encountered when comparing the results of the included studies, were the 
differences in study populations (percentage of males), settings (open population, patients 
with hip pain who consulted their GP), different cut-off points for case deﬁnitions, and the 
different or not transparent statistics used in the studies. For example, the percentage of 
males in the different studies ranged from 0–100%; because gender is a known risk factor 
for hip OA this will obviously inﬂuence the prevalence of hip OA. The prevalence, in turn, 
will also affect the value of reliability [26]. One study [23] adjusted the Kappa (Cohen) they 
found for prevalence (Prevalence Adjusted Bias Adjusted Kappa / PABAK [26]); the adjusted 
Kappa was much higher than the crude Kappa. 
In the absence of a gold standard for a deﬁnition of hip OA, we were particularly careful 
when evaluating the validity. Two potential solutions to deﬁne a “gold standard”, by expert’s 
opinion or by an “obvious hip OA” (such as total hip replacement) after a certain period of 
follow-up were not used in the screened studies. Summarising the available information, 
it was clear that very few studies investigated the construct validity of the deﬁnitions used 
for hip OA. Of the 14 articles, not one focused on the relationship between risk factors and 
radiologic hip OA, leaving us to evaluate the studies that reported the association between 
symptoms and radiological hip OA. Croft et al. [8] investigated the association between hip 
pain and radiological hip OA (2 deﬁnitions of Croft); in their study population of 1315 men, 
only 759 completed the questionnaire (243 men died, 152 men were too ill according to the 
GP). The men excluded were probably older, more disabled and had more co-morbidity 
compared to the men included, which may have led to a selection bias; the results of that 
study should therefore be interpreted with caution. Croft et al. [8] also investigated the 
association between individual radiological features and hip pain; they concluded that MJS 
(≤ 1.5 mm) showed a stronger association with hip pain than osteophytes (56% versus 
34.4%). Surprisingly, no articles were found that investigated the association between the 
overall Kellgren & Lawrence grade and hip pain. The validity of 3 sets of criteria of the 
ACR was investigated in only one study [12], which concluded that the clinical ACR criteria 
showed no cross-validity (agreement between 3 ACR criteria sets) with the two other ACR 
criteria sets, tested in primary care. 
For reliability, the lack of comparability between the different studies is also an important 
confounder. Different standardisation of the X-rays between studies, or a possible difference 
in mean joint space between men and women, can inﬂuence the results of the reliability. 
Only one study [19] directly compared the reliability of the Kellgren & Lawrence grade with 
MJS (according to Croft); the MJS showed a better (intra- and inter-rater) reliability. Five 
studies [5, 8, 20, 21, 27] directly compared the overall grade of Croft and the MJS; all these 
studies showed a better reliability of the MJS. No studies compared the other deﬁnitions. 
Only three studies reported the time interval between repeated readings: Croft et al.: 3–5 
months [8], Kellgren 1 month [7] and Lane et al. 1 month [13]. The length of this interval will 
probably inﬂuence the reliability (a longer time interval between repeat readings will give 
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a lower intra-rater reliability) [4]. Overall, we assume that the MJS and the index according 
to Lane deﬁnition for hip OA have the highest reliability for epidemiological and clinical 
studies.
The most commonly used deﬁnition of hip OA, the Kellgren & Lawrence grade, is also 
the most criticised one. Previous criticisms on the Kellgren & Lawrence grade include: 
inconsistencies in the description of radiographic features of OA [28–30], the prominence 
awarded to the osteophytes at all joint sites [1, 30], and a poor inter-rater and between-
center reliability [1, 28–30]. According to the articles included in our review, the inter-rater 
reliability was poor only in the original study of Kellgren & Lawrence [7], but much better 
in 3 other much larger studies [5, 12, 19]. Notably, the same description of the Kellgren & 
Lawrence grade was used in all studies. Therefore in the present study we could not conﬁrm 
the criticism of inconsistent grades and poor reliability of the Kellgren & Lawrence grade. 
The main criticism of the Kellgren & Lawrence grade is the importance of the presence of 
osteophytes. Although it is well known that the association between osteophytes and hip 
pain is poor [8], not one of the 14 articles investigated the association between the overall 
Kellgren & Lawrence grade and hip pain. Overall, we assume that the Kellgren & Lawrence 
grade for hip OA is a useful deﬁnition for epidemiological studies. 
Summarising the properties of the deﬁnitions used for hip OA investigated in the present 
study, we conclude that: 
1. The MJS showed a good intra- and inter-rater reliability, a good association with hip pain 
and restricted internal rotation, and a good applicability; however, the quality (validity, 
reliability) of this deﬁnition should be investigated in an open population. 
2. The Kellgren & Lawrence grade has a reliability comparable to MJS, but the construct 
validity should be investigated more thoroughly. 
3. The Croft grade appeared to be inferior to the MJS and the Kellgren & Lawrence grade 
for both reliability and validity. 
4. The ACR criteria (despite their precise and extensive method of development) showed 
a poor reliability and a poor cross-validity in a primary care setting. Because these data 
are based on the results of only two studies, more research is needed on the ACR criteria 
(also in other settings).
5. The index according to Lane showed also a good intra- and inter-rater reliability, but 
no studies were included which investigated the construct validity of this index grading 
system.
Considering how frequently the deﬁnitions of hip OA are used, it is surprising that the 
validity has been so poorly investigated. Meanwhile, because of the lack of such validity 
studies, we recommend that only those deﬁnitions with the best construct validity and the 
best reliability be used in epidemiological studies. We also recommend that the validity, 
especially the expert or predictive validity, of the commonly used deﬁnitions be studied 
more thoroughly. 
Max Reijman BW.indd   32 10/5/2004   10:29:28 AM
Validity, reliability and applicability of seven deﬁ nitions of hip osteoarthritis
33
Acknowledgments
This study was supported by a grant from the Dutch Arthritis Association.
References
 1. Croft P, Cooper C, Coggon D. Case deﬁnition of hip osteoarthritis in epidemiologic studies. J 
Rheumatol 1994;21(4):591–2.
 2. Dougados M, et al. Radiological progression of hip osteoarthritis: deﬁnition, risk factors and 
correlations with clinical status. Ann Rheum Dis 1996;55: 356–62.
 3. Birrell F, Croft P, Cooper C, Hosie G, Mac Farlane G, Silman A. Radiographic change is common 
in new presenters in primary care with hip pain. Rheumatology 2000;39:772–5.
 4. Sun Y, Gunther KP, Brenner H. Reliability of radiographic grading of osteoarthritis of the hip and 
knee. Scan J Rheumatol 1997;26(3):155–65.
 5. Hirsch R, et al. Hip osteoarthritis prevalence estimates by three radiographic scoring systems. 
Arthritis Rheum 1998;41(2):361–8.
 6. Gunther KP, Sun Y. Reliability of radiographic assessment in hip and knee osteoarthritis. 
Osteoarthritis Cartilage 1999;7(2):239–46.
 7. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 
1957;16:494–502.
 8. Croft P, Cooper C, Wickham C, Coggon D. Deﬁning osteoarthritis of the hip for epidemiologic 
studies. Am J Epidemiol 1990;132(3):514–22.
 9. Resnick D, Niwayama G. Degenerative disease of extraspinal locations. Diagnosis of Bone and 
Joint Disorders. 2nd ed. Philadelphia: WB Saunders; 1988:1426–42.
 10. Altman RD. The American College of Rheumatology Criteria for the Classiﬁcation and reporting 
of osteoarthritis of the hip. Arthritis Rheum 1991;34(5):505–14.
 11. Odding E, Valkenburg HA, Algra D, VandenOuweland FA, Grobbee DE, Hofman A. Associations 
of radiological osteoarthritis of the hip and knee with locomotor disability in the Rotterdam 
Study. Ann Rheum Dis 1998;57(4):203–8.
 12. Bierma-Zeinstra SMA, Bohnen AM, Ginai AZ, Prins A, Verhaar JAN. Validity of American College 
of Rheumatology criteria for diagnosing hip osteoarthritis in primary care research. J Rheumatol 
1999;26(5):1129–33.
 13. Lane NE, Nevitt MC, Genant HK, Hochberg MC. Reliability of new indices of radiographic 
osteoarthritis of the hand and hip and lumbar disc degeneration. J Rheumatol 1993;20:1911–8.
 14. Nevitt MC, et al. Radiographic osteoarthritis of the hip and bone mineral density. Arthritis Rheum 
1995;38(7):907–16.
 15. Buchbinder R, Goel V, Bombardier C, Hogg-Johnson S. Classiﬁcation systems of soft tissue 
disorders of the neck and upper limb: do they satisfy methodological guidelines? J Clin Epidemiol 
1996;49(2):141–9.
 16. Felson DT, Anderson JJ. Methodological and statistical approaches to criteria development in 
rheumatic diseases. Baillieres Clin Rheumatol 1995;9(2):253–66.
 17. Bierma-Zeinstra SMA, Verhagen AP, Berger MY. Het ontwikkelen van classiﬁcatiesystemen bij 
aandoeningen van het bewegingsapparaat. Huisarts en wetenschap 2000;43(11):473–7.
 18. Haynes RB, Wilczynski N, McKibbon A, Walker CJ, Sinclair JC. Developing optimal search 
strategies for detecting clinically sound studies in MEDLINE. J Am Med Informatics Assoc 
1994;1(6):447–58.
 19. Ingvarsson T, Hagglund G, Lindberg H, Lohmander LS. Assessment of primary hip osteoarthritis: 
Comparison of radiographic methods using colon radiographs. Ann Rheum Dis 2000;59(8):650–
3.
 20. Birrell F, Croft P, Cooper C, Hosie G, MacFarlane G, Silman A. Predicting radiographic hip 
osteoarthritis from range of movement. Rheumatology 2001;40(5):506–12.
Max Reijman BW.indd   33 10/5/2004   10:29:28 AM
34
Chapter 2
 21. MacGregor AJ, Antoniades L, Matson M, Andrew T, Spector TD. The genetic contribution 
to radiographic hip osteoarthritis in women: Results of a classic twin study. Arthritis Rheum 
2000;43(11):2410–6.
 22. Antoniades L, MacGregor AJ, Matson M, Spector TD. A cotwin control study of the relationship 
between hip osteoarthritis and bone mineral density. Arthritis Rheum 2000;43(7):1450–5.
 23. Bellamy N, et al. Perceptual variation in categorizing individuals according to American College 
of Rheumatology classiﬁcation criteria for hand, knee, and hip osteoarthritis (OA): Observations 
based on an Australian Twin Registry study of OA. J Rheumatol 1999;26(12):2654–8.
 24. Dickersin K, Scherer R, Lefebre C. Systematic reviews: Identifying relevant studies for systematic 
reviews. BMJ 1994;309(12):1286–91.
 25. Dickersin K. Systematic reviews in epidemiology: why are we so far behind? Int J Epidemiol 
2002;31:6–12.
 26. Byrt T, Bishop J, Carlin JB. Bias, Prevalence and Kappa. J Clin Epidemiol 1993;46(5):423–9.
 27. Smith RW, Egger P, Coggon D, Cawley MID, Cooper C. Osteoarthritis of the hip joint and 
acetabular dysplasia in women. Ann Rheum Dis 1995;54:179–81.
 28. Hart DJ, Spector TD. The classiﬁcation and assessment of osteoarthritis. Baillieres Clin Rheumatol 
1995;9(2):407–33.
 29. Hart DJ, Spector TD. Radiographic criteria for epidemiologic studies of osteoarthritis. J Rheumatol 
1995; suppl 43(22):46–8.
 30. Spector TD, Cooper C. Radiographic assessment of osteoarthritis in population studies: whither 
Kellgren and Lawrence? Osteoarthritis Cartilage 1993;1:203–6.
Max Reijman BW.indd   34 10/5/2004   10:29:28 AM
Validity, reliability and applicability of seven deﬁ nitions of hip osteoarthritis
35
Appendix 1: Criteria used in the present study to evaluate the deﬁnitions of hip osteo-
arthritis used in the literature
Reliability
1. Does the deﬁnition provide consistent results when classifying the same conditions (e.g. 
split-half reliability)?
 Positive if the results are comparable when tested in the same setting, but in a new 
group (e.g. split-half reliability).
2. Is the intraobserver reliability described?
– Results individual variables/features: Kappa or ICC or Pearson Product Moment 
Correlation Coefﬁcient (range, CI)
– Results case deﬁnition hip OA: Kappa or ICC or Pearson Product Moment Correlation 
Coefﬁcient (range, CI)
– Are the results speciﬁed for experienced observer, specialisation?
3. Is the interobserver reliability described?
– Results individual variables/features: Kappa or ICC or Pearson Product Moment 
Correlation Coefﬁcient (range, CI)
– Results case deﬁnition hip OA: Kappa or ICC or Pearson Product Moment Correlation 
Coefﬁcient (range, CI)
– Are the results speciﬁed for experienced observer, specialisation?
Criterion validity
4. Did the study investigate the validity of the deﬁnition with a predeﬁned “gold standard” 
by expert’s opinion (expert validity), in a cross-sectional study design?
5. Did the study investigate the validity of the deﬁnition with a predeﬁned “gold standard” 
by an “obvious hip OA” (for example a THR) after a certain period of follow-up 
(predictive validity), in a longitudinal study design?
Construct validity
6. Does the deﬁnition discriminate between entities that are thought to be different in a 
way appropriate for the purpose?
– category is related to a different intervention, or
– category is related to a different prognosis, or
– category has a different underlying etiological process 
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7. Do the deﬁnition show adequate associations with known risk factors of hip OA? 
 Positive if the deﬁnition showed an equal (positive) or higher association than the other 
deﬁnition of hip OA.
 Risk factors of hip OA:
– Genetics
– Bone Mineral density
– Biomechanical workload
– Sport activities
– Acetabular dysplasia
8. Do the deﬁnition show adequate associations with other symptoms (or signs) of hip OA, 
than included in the deﬁnition?
 Symptoms of hip OA:
– hip pain 
– limited physical function of the lower limb 
– limited ROM of the hip joint
– morning stiffness
 For the radiological deﬁnitions 1–4 and 7:
 Positive if the deﬁnition performs a positive association with pain (of the hip) and/or 
limited physical function of the lower limb and/or limited ROM of the hip joint and/or 
morning stiffness
 For deﬁnitions 5 and 6:
 Positive if the deﬁnition performs a positive association with limited physical function of 
the lower limb and/or limited ROM of the hip joint and/or morning stiffness.
 For deﬁnition 5, the clinical deﬁnition of the ACR criteria of hip OA:
 Positive if the deﬁnition performs a positive association with radiological symptoms 
(joint space narrowing, osteophytes of femur head, cysts, subchondral sclerosis, and 
migration of the femur head) of hip OA.
Content validity
9. Is the method of development of the deﬁnition clearly speciﬁed?
 Which method is used?
– Informal: opinion of researcher 
– Informal: opinion of (international) “experts” 
– Formal: the classiﬁcation is based on a study population, and frequencies of symptoms 
are given
– Formal: construction of the groups (classiﬁcation) with help of clinical endpoints 
(effect of intervention or known progression)
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– Mathematical method: cluster analysis, factor analysis, split-half analysis, classiﬁcation 
tree (regression analysis)
– Other method, …
Applicability
10. Is the deﬁnition easy to perform (for persons at MD level) without special training?
 Positive if no special training for persons with MD level (speciﬁc skills needed) is 
required.
11. Which tests are necessary to perform the deﬁnition? 
– clinical history
– physical examination/measurements (ROM)
– radiographs
– lab/blood samples 
Appendix 2: Deﬁnitions of hip osteoarthritis used in the literature
1. Kellgren & Lawrence grading system (7)
Grade Description
0 No osteoarthritis
1 Doubtful Possible narrowing of joint space medially and possible osteophytes around femoral head; or 
osteophytes alone
2 Mild Deﬁnite narrowing of joint space inferiorly, deﬁnite osteophytes and slight sclerosis
3 Moderate Marked narrowing of joint space, deﬁnite osteophytes, some sclerosis and cyst formation and 
deformity of femoral head and acetabulum 
4 Severe Gross loss of joint space with sclerosis and cysts, marked deformity of femoral head and 
acetabulum and large osteophytes
 Hips classiﬁed as grade 2 or higher were deﬁned as having OA
2. Croft’s modiﬁcation of the Kellgren & Lawrence grading system (“Croft grade”) 
(8)
Grade Description
0 No change
1 Deﬁnite osteophytes only
2 Joint space narrowing (JSN) only (deﬁned as an MJS of ≤ 2.5 mm)
3 Presence of 2 of the following: JSN, osteophytosis, subchondral sclerosis (of ≥5 mm), and cyst formation
4 Presence of 3 of the following: JSN, osteophytosis, subchondral sclerosis (of ≥5 mm), and cyst formation
5 Same as grade 4, but with deformity of the femoral head or total hip replacement due to OA (veriﬁed by record view) 
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3. Croft’s measurement of the “minimal joint space” (lateral, superior, axial, 
medial) (8)
 Minimal joint space (MJS) is the shortest distance on the radiograph between the femoral 
head margin and the acetabular edge.
 Grade Description
0 MJS > 2.5 mm
1 MJS > 1.5 mm and ≤ 2.5 mm
2 MJS ≤ 1.5 mm
4. Resnick and Niwayama measurement of the joint space (superior, axial and 
medial) (9)
Grade Description
0 MJS > 3.5 mm
1 MJS ≤ 3.5 mm
5. ACR criteria (10)
ACR 1
Clinical criteria
(Classiﬁcation tree format)
ACR 2
Combined Clinical and Radiographic Criteria
(Traditional format)
ACR 3
Combined Clinical and Radiographic Criteria
(Classiﬁcation tree format)
Hip pain Hip pain Hip pain
+ Hip internal rotation < 15° and ESR ≤ 
45 mm/h (if ESR not available, hip ﬂexion 
≤ 115°)
OR
+ At least 2 of the following 3 features: + Radiographic femoral and/or acetabular 
osteophytes
OR
+ Hip internal rotation ≥ 15° and pain on 
internal rotation and morning stiﬀness of 
the hip ≤ 60 min and age > 50 years
– ESR < 20 mm/h
–  Radiographic femoral or acetabular 
osteophytes
–  Radiographic joint space narrowing 
(superior, axial and/or medial)
+ ESR ≤ 20 mm/h and radiographic axial 
joint space narrowing
 ESR: one-hour erythrocyte sedimentation rate.
6. Clinical osteoarthritis of the hip: positive radiological osteoarthritis combined 
with pain in the hip region (19)
 Hip pain with joint space narrowing (JSN):
 – Superior JSN < 3.5 mm and/or
 – Axial JSN <2.5 mm
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7. Radiographic index grade according to Lane
Grade Description
0 Normal (no ﬁndings of OA) 
1 Possible osteophytes (IRF grade 1) and / or narrowing (IRF grade 1), or isolated deﬁnite osteophytes or narrowing 
(IRF grade ≥ 2)
2 Deﬁnite osteophytes or narrowing (IRF grade ≥ 2) plus cysts or sclerosis
3 3 of the following: deﬁnite osteophytes or narrowing (IRF grade ≥ 2), cysts or sclerosis
4 Grade 3 (as above) plus femoral head deformity
 Number of IRF (Individual Radiographic Features) scores that correspond to 0 = normal, 1 = mild, 2 = moderate, 3 = severe. 
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Abstract
Objectives: To compare the reliability and validity in a large open population of three 
frequently used radiological deﬁnitions of hip osteoarthritis (OA) namely, Kellgren & 
Lawrence grade, Minimal Joint Space (MJS) and Croft’s grade. Additionally, to investigate 
whether the validity of the three deﬁnitions of hip OA is gender dependent.
Methods: From subjects of the Rotterdam study (elderly aged 55 years and over, N = 3,585 
participants) all X rays were evaluated. The inter-rater reliability was tested in a random set 
of 148 X-rays. The validity was expressed as the ability to identify patients who show clinical 
symptoms of hip OA (construct validity) and as the ability to predict Total Hip Replacement 
(THR) at follow-up (predictive validity). 
Results: The inter-rater reliability was similar for the Kellgren & Lawrence grade and MJS 
(Kappa statistics of 0.68 and 0.62, respectively) but somewhat lower for Croft’s grade (Kappa 
statistics of 0.51). The Kellgren & Lawrence grade and MJS demonstrated both the strongest 
associations with clinical symptoms of hip OA. 
Gender appears to be a signiﬁcant effect modiﬁer for Kellgren & Lawrence; women had 
a signiﬁcantly stronger association with symptoms than men, and also for MJS; however, 
this gender dependency was attributed to differences in height between women and men. 
The Kellgren & Lawrence grade showed the highest predictive value for THR at follow-up 
compared to the other deﬁnitions.
Conclusion: Based on these ﬁndings, Kellgren & Lawrence still appears to be a useful 
deﬁnition for hip OA for epidemiological studies focusing on the presence of hip OA.
Ann Rheum Dis 2004; in press
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Introduction
Osteoarthritis (OA) of the hip is of particular interest since it is often the sole joint affected 
by OA suggesting an important role of local biomechanical risk factors. In addition, the 
prevalence of hip OA is expected to increase with the aging of the Western society (1) and 
the hip is crucial to independent function (2).
A problem in studying hip OA is the absence of consensus in deﬁning hip OA for 
epidemiological research (3). To investigate occurrence and (potential) risk factors, a valid 
and reliable deﬁnition of hip OA is required. Most epidemiological studies have used a 
single hallmark of hip OA (namely radiological signs) to deﬁne hip OA (4, 5). 
In a previous systematic appraisal, we summarised the validity, reliability and applicability 
of seven deﬁnitions of hip OA used in epidemiological studies (6). Considering the frequent 
use of the deﬁnitions of hip OA, it is noteworthy that the validity of these deﬁnitions has 
been so poorly investigated. Because of lack of comparability between the different studies 
and because most studies only investigated a single deﬁnition, it was difﬁcult to compare the 
reliability and validity of different deﬁnitions of hip OA. Our appraisal also showed that the 
validity and reliability of Minimal Joint Space (MJS; according to Croft) and Croft’s grade (a 
modiﬁcation of Kellgren & Lawrence) (7) have only been studied in a male population. 
The primary objective of the present study was to compare the reliability and validity of 
three most frequently used radiological deﬁnitions of hip OA, Kellgren & Lawrence grade, 
MJS (according to Croft) and Croft’s grade, in a large open population of elderly people. 
The secondary objective was to investigate whether the validity of the three deﬁnitions of 
hip OA was gender dependent.
Subjects and Methods
The study population consisted of participants of the Rotterdam Study, a prospective cohort 
of men and women aged 55 years and over. The objective of the Rotterdam Study is to 
investigate the incidence of, and risk factors for, chronic disabling diseases. The rationale 
and study design have been described previously (8). The focus is on neurogeriatric, 
cardiovascular, ophthalmologic and locomotor diseases. All 10,275 inhabitants of Ommoord 
(a district in Rotterdam, the Netherlands) were invited to participate. The response rate was 
78%, resulting in 7,983 subjects participating in the study. Written informed consent was 
obtained from each participant. The Medical Ethics Committee of the Erasmus University 
Medical Centre has approved the Rotterdam Study.
For the present study a sample of 3,585 subjects of the Rotterdam study was used. The 
selection was based on the availability of the radiographs of the hip at baseline and follow-
up. The fact that subjects had to be mobile enough to visit the research centre at baseline 
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and follow-up and survive the follow-up period caused a health selection bias in our study 
population. Compared to the total Rotterdam study population, the present study population 
was signiﬁcantly younger (70.6 years versus 66.0 years), had a lower prevalence of lower 
limb disability at baseline (≥ index score of 0.5: 35.5% versus 12.9%) and a somewhat lower 
prevalence of hip pain at baseline (12.7% versus 11.7%). 
Subjects with bilateral Total Hip Replacement (THR) at baseline (N = 24) were excluded from 
analysis, which resulted in a study population of 3561 subjects. The baseline measurements 
were conducted between April 1990 and July 1993, and the follow-up measurements between 
1996 and 1999, with a mean follow-up time of 6.6 years (standard deviation of ± 0.50).
Radiographic assessment 
Weight bearing anteroposterior pelvic radiographs with both feet in 10° internal rotation 
were obtained at 70 KV, a focus of 1.8, and a focus to ﬁlm distance of 120 cm, applying a 
Fuji High Resolution G 35 × 43 cm ﬁlm (9). The X-ray beam was centred on the umbilicus. 
One independent trained reader (MR) evaluated the radiographs according to a standardized 
protocol, unaware of the clinical status of the patients. 
At baseline radiographic osteoarthritis (ROA) of the hip was quantiﬁed by measurements 
of Kellgren & Lawrence grading system (atlas-based) (Appendix) (6, 10–13), Croft grading 
system (a modiﬁcation of Kellgren & Lawrence) (Appendix) and MJS deﬁned by Croft (6, 
7, 12–14). For the Croft grading scale, we assessed the individual radiographic features of 
minimal joint space, presence of osteophytes, subchondral sclerosis and cysts formation. 
The presence of the individual radiographic features (of any grade) was examined, using an 
atlas of individual features (12, 13). Different cut off points to quantify hip ROA were used; 
for Kellgren & Lawrence ≥ grade 2 (moderate) and ≥ grade 3 (severe), for Croft grading 
system ≥ grade 3 (moderate) and ≥ grade 4 (severe), and for MJS ≤ 2.5 mm (moderate), ≤ 
2.0 mm (intermediate) and ≤ 1.5 mm (severe). 
The joint space width (lateral, superior, axial, medial and minimal) measurements were 
standardised using a 0.5-millimetre graduated magnifying glass laid directly over the 
radiograph (15–17). 
The follow-up radiographs were evaluated for the presence of an incident THR (not present 
at baseline). 
For all three grading systems and all measurements, inter-rater reliability (SMABZ and MR) 
was tested in a random set of 148 radiographs (18, 19). 
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Clinical assessment 
At baseline, trained interviewers performed an extensive home interview on demographic 
characteristics, medical history, risk factors for chronic diseases and medication use. 
For the present study we used information on the presence of hip pain (“did you have 
joint complaints of your right/left hip during the last month”), presence of morning stiffness 
and lower limb disability. Lower limb disability was assessed using a modiﬁed version of 
the Stanford Health Assessment Questionnaire (9). A lower limb disability index (LDI) was 
obtained by calculating the mean score of answers to the following six questions: ‘Are you 
able to stand up from a straight chair without using your arms for support?’, ‘Are you able 
to get in and out of bed?’, ‘Are you able to walk outdoors on ﬂat ground?’, ‘Are you able 
to climb up ﬁve steps?’, ‘Are you able to bend down to pick up clothing from the ﬂoor?’ 
and ‘Are you able to get in and out of a car?’. The answers were scored as follows: 0 = yes, 
without difﬁculty, 1 = yes, with some difﬁculty, 2 = yes, with much difﬁculty, 3 = no, unable 
to do (needs help). Moderate disability was deﬁned as a score higher than 0.5 and severe 
disability as a score higher than 1.0 on the lower limb disability index. Moderate disability 
is present whenever there is at least some difﬁculty with three out of six daily activities of 
the LDI (9).
Statistical analysis
For the inter-rater reliability, Kappa and Intraclass Correlation Coefﬁcient (ICC) was assessed 
for the different radiological individual features and the three deﬁnitions of hip ROA.
Because of the absence of a “gold standard” we expressed the validity in the construct validity 
and in the predictive validity. The construct validity is operationalized by the ability to identify 
patients with symptoms (presence of hip pain, morning stiffness or lower limb disability) of 
hip OA (20, 21). The predictive validity is expressed as the ability of the deﬁnition to predict 
important long-term outcomes of disease (21). For the construct validity, the association 
between baseline radiological osteoarthritis of the hip according to the three deﬁnitions 
and the separate baseline clinical symptoms (hip pain, morning stiffness and lower limb 
disability) was tested by means of Generalised Estimating Equations (GEE) (cross-sectional 
design). This is a procedure of repeated measurements. It is used here to take account of 
the correlation between the left and right hip. Additionally, the sensitivity and speciﬁcity 
was assessed using the main symptom of hip OA, hip pain, as “gold standard”. We used 
different cut-off points for the three deﬁnitions of hip ROA and additionally stratiﬁed the 
results for gender and age. A two-sided p-value of 0.05 was considered signiﬁcant. For the 
predictive validity, we assessed the proportion THR, after a clinically meaningful follow-up 
period of 6.6 years, in patients identiﬁed by each deﬁnition as having hip ROA at baseline 
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(longitudinal design). We also calculated the association between the different deﬁnitions of 
hip ROA and THR at follow-up by means of the GEE method (odds ratios). We used SPSS 
version 11.0 (SPSS Inc., Chicago, USA) and SAS software, version 8.0 (SAS Institute, Cary, 
NC) for all analyses. 
Results
Study population
Table 1 shows the demographic characteristics and prevalence data on radiographic hip OA, 
stratiﬁed for gender of the study population of 3,585 participants. Women were older, had a 
higher BMI, and were shorter. The prevalence of lower limb disability and hip pain is twice 
as high in women than in men. Men demonstrated a higher prevalence when deﬁned by 
Kellgren & Lawrence or Croft grade than women. Of the subjects with hip pain, 98.8% had 
longer than 1 month pain, from which 30.2% between 1 and 5 years and 51.1% longer than 
5 years. Radiological hip OA deﬁned by Croft’s grade 3 showed a much higher prevalence 
compared with the other deﬁnitions of a moderate hip OA. The prevalence of moderate 
radiological hip OA deﬁned by Kellgren & Lawrence and MJS is similar. 
Table 1: Demographic characteristics and prevalences of radiographic hip osteoarthritis stratiﬁed for gender
Men 
(N = 1,499)
Women 
(N = 2,086)
Total 
(N = 3,585)
Mean age, years ± SD 65.5 ± 6.5 66.3 ± 7.2 66.0 ± 6.9
Mean BMI, kg/m2 ± SD 25.9 ± 2.8 26.6 ± 4.0 26.3 ± 3.6
Mean height, cm ± SD 175.5 ± 6.6 162.4 ± 6.5 167.9 ± 9.2
Lower limb disability  (≥ 0.5), % 8.2 16.3 12.9
Lower limb disability  (≥ 1.0), % 4.7 9.6 7.6
Morning stiﬀness, % 24.9 36.9 31.9
Hip pain (left and/or right), %
– right
– left
7.1
5.6
4.5
14.9
11.0
9.9
11.7
8.7
7.6
Total Hip Replacements at baseline, 
– unilateral, number (%)
– bilateral, number (%)
20 (1.0)
6 (0.4)
69 (2.6)
18 (0.9)
89 (2.0)
24 (0.7)
Kellgren, %
– ≥ grade 2 
– ≥ grade 3
7.8
1.2
6.4
1.5
7.0
1.4
MJS, %
– ≤ 2.5 mm
– ≤ 2.0 mm
– ≤ 1.5 mm
6.8
2.6
1.2
8.1
3.3
1.5
7.5
3.0
1.4
Croft grade, %
– ≥ grade 3
– ≥ grade 4
39.1
4.5
30.0
4.4
33.9
4.4
BMI = Body Mass Index
MJS = Minimal Joint Space
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Reliability
Table 2 shows the inter-rater reliability for different individual radiological features and three 
deﬁnitions of hip ROA. The inter-rater reliability for the different individual radiological 
features was relatively low, with the exception of the MJS as assessed as a continuous 
variable. Kellgren & Lawrence ≥ grade 2 and MJS ≤ 2.5 mm had a comparable reliability, 
whereas for Croft’s grade ≥ grade 3 the reliability was somewhat lower. 
Construct validity
Table 3 shows the association between the three deﬁnitions of hip ROA for different cut-
off points and clinical symptoms of hip OA; hip pain, morning stiffness and lower limb 
disability (moderate and severe). The percentages of subjects deﬁned by these deﬁnitions 
according to the different cut-off points are shown in Table 1. Table 3 shows that severe 
hip ROA has a stronger association with symptoms than moderate hip ROA. The Kellgren 
& Lawrence grade and MJS demonstrate comparable associations with clinical symptoms of 
hip OA, especially with hip pain and lower limb disability for both moderate and severe hip 
ROA. Croft’s grade shows the weakest associations with clinical symptoms of hip OA. 
Gender as eﬀect modiﬁcator
We found that men had on average a larger joint space width than women (4.2 versus 3.9 
mm, respectively). Furthermore we found that height was positively correlated with the 
joint space width. Additionally, we also found a positive correlation within gender between 
height and the joint space width (respectively a beta of 0.16 for men and 0.14 for women). 
Because in the present study women were shorter than men, we adjusted for height. After 
adjustment for height, the gender effect disappeared.
Table 2: Inter-rater reliability for individual radiological features and three deﬁnitions of radiographic hip osteoarthritis studied 
(N = 148)
Subchondral Sclerosis Osteophytes Cysts Minimal Joint 
Space
(continuous)
Acetabulum Femoral head Acetabulum Femoral head
Inter-rater 
reliability 
0.51
(0.35–0.67)
0.66
(0.22–1.00)
0.23
(0.06–0.40)
0.34
(0.19–0.50)
0.32
(-0.17–0.82)
0.85*
(0.80–0.89)
Kellgren
≥ grade 2
MJS
≤ 2.5 mm
Croft grade
≥ grade 3
Inter-rater 
reliability
0.68
(0.44–0.92)
0.62
(0.43–0.81)
0.51
(0.35–0.67)
Inter-rater reliability is presented by Intraclass Correlation Coeﬃcient (two-way mixed eﬀect model, consistency deﬁnition) for Minimal Joint 
Space (as continuous variable) and by Kappa for other individual radiological features and three deﬁnitions of hip OA studied, with 95% conﬁdence 
interval between parentheses.
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Table 3: Association between diﬀerent deﬁnitions of radiographic hip osteoarthritis and clinical symptoms of hip osteoarthritis 
(N = 3,561)
Hip pain Morning stiﬀness Disability
(LLD ≥ 0.5)
Disability 
(LLD ≥ 1.0)
OR Sensitivity /
Speciﬁcity (%)
OR OR OR
Kellgren
– ≥ grade 2
– ≥ grade 3
2.6
 (1.8–3.6)
6.6 
(3.6–12.1)
20.7 / 92.7
12.5 / 97.9
1.2 
(0.9–1.6)
2.2 
(1.2–3.9)
2.4 
(1.7–3.4)
7.0 
(3.8–12.8)
3.0 
(2.0–4.4)
7.6 
(4.0–14.6)
MJS
– ≤ 2.5 mm
– ≤ 2.0 mm
– ≤ 1.5 mm
2.4 
(1.7–3.4)
4.5 
(2.9–7.0)
6.6 
(3.6–12.2)
14.9 / 93.3
9.3 / 97.8
5.5 / 99.1
1.6 
(1.2–2.1)
1.7 
(1.2–2.6)
2.0 
(1.1–3.7)
2.7 
(2.0–3.7)
3.7 
(2.4–5.9)
5.3 
(2.9–9.8)
3.0 
(2.0–4.4)
4.1 
(2.5–7.0)
6.1 
(3.1–12.1)
Croft grade
– ≥ grade 3
– ≥ grade 4
1.3 
(1.1–1.7)
3.6 
(2.4–5.2)
39.9 / 66.9
11.7 / 96.4
0.9 
(0.7–1.0)
1.6 
(1.1–2.2)
1.0 
(0.8–1.3)
3.3 
(2.3–4.9)
1.1 
(0.8–1.5)
3.7 
(2.3–5.8)
Associations are presented by odds ratios with 95% conﬁdence interval between parentheses. 
LLD: Lower limb disability index, a score of ≥ 0.5 was deﬁned as moderate disabled, and a score of ≥ 1.0 as severe disabled. 
Associations are adjusted for body mass index and radiographic osteoarthritis of the other hip.
Table 4: Association between three diﬀerent deﬁnitions of radiographic hip osteoarthritis studied and clinical symptoms of hip 
OA, stratiﬁed for gender (N = 3,561)
Hip pain Morning stiﬀness LLD ≥ 0.5 LLD ≥ 1.0
men women men women men women men women
Kellgren 
– ≥ grade 2 
– ≥ grade 3
1.6*
(0.8–3.2)
8.7
(3.1–24.5)
3.5
(2.3–5.2)
5.7
(2.7–12.0)
1.1
(0.7–1.7)
2.5
(0.9–6.9)
1.3
(0.9–1.9)
1.9
(0.9–4.1)
1.5*
(0.8–3.0)
4.4
(1.4–13.9)
3.3
(2.2–4.9)
8.7
(4.1–18.6)
1.0*
(0.3–2.7)
3.6
(1.8–16.4)
4.6
(2.9–7.3)
9.6
(4.4–20.7)
MJS
– ≤ 2.5 mm
– ≤ 2.0 mm
– ≤ 1.5 mm
2.7
(1.5–5.0)
4.4
(1.9–10.0)
6.6
(2.2–19.4)
2.3
(1.5–3.4)
4.4
(2.6–7.5)
6.6
(3.1–14.0)
1.6
(1.0–2.5)
1.6
(0.8–3.3)
1.9
(0.7–5.1)
1.5
(1.1–2.2)
1.7
(1.0–2.9)
2.1
(1.0–4.4)
2.5
(1.4–4.6)
2.2
(0.8–5.8)
3.0
(0.9–10.9)
2.7
(1.9–4.0)
4.4
(2.6–7.4)
6.5
(3.1–13.9)
1.2*
(0.4–3.2)
1.6
(0.4–6.6)
3.7
(0.8–16.8)
3.8
(2.4–5.8)
5.1
(2.8–9.2)
7.1
(3.2–15.7)
Croft grade
– ≥ grade 3
– ≥ grade 4
1.3
(0.9–2.0)
2.9
(1.4–6.0)
1.5
(1.1–2.0)
4.1
(2.5–6.5)
0.8
(0.7–1.1)
1.4
(0.8–2.5)
0.9
(0.8–1.1)
1.7
(1.1–2.6)
0.8
(0.5–1.3)
2.7
(1.3–5.5)
1.2
(0.9–1.6)
3.8
(2.4–6.1)
0.8
(0.4–1.4)
1.3*
(0.4–4.4)
1.4
(1.0–2.0)
5.1
(3.0–8.6)
Associations are presented by odds ratios with 95% conﬁdence interval between parentheses.
LLD: Lower limb disability index, a score of ≥ 0.5 was deﬁned as moderate disabled, and a score of ≥ 1.0 as severe disabled.
Associations are adjusted for body mass index and radiographic osteoarthritis of the other hip.
* signiﬁcant diﬀerence between men and women
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Table 4 shows the association between different deﬁnitions of hip ROA and clinical 
symptoms (of hip OA) stratiﬁed for gender. For both deﬁnitions of Croft the results showed 
no signiﬁcant gender difference except for the association between Croft’s grade ≥ grade 4 
and severe lower limb disability. We found, however, that gender was a signiﬁcant effect 
modiﬁer for Kellgren & Lawrence grade (≥ grade 2). For women the associations between 
symptoms (hip pain and lower limb disability) and hip OA deﬁned by Kellgren & Lawrence 
(≥ grade 2) were signiﬁcantly stronger than for men. We also found that for women the 
association between symptoms and hip ROA according to Kellgren & Lawrence (≥ grade 
2) was stronger than according to the MJS (≤ 2.5 mm) or Croft’s grade (≥ grade3). Women 
had a higher body mass index (BMI) than men, but after we adjusted for BMI the assessed 
associations did not change.
Table 5 shows the association between different deﬁnitions of hip ROA (Kellgren ≥ grade 
2 and MJS ≤ 2.5 mm) and hip pain stratiﬁed for gender and age (2 categories). We divided 
men and women in two equal groups, a younger and older group (median of 65.2 years). 
Older persons had a stronger association between hip ROA and hip pain than younger 
persons, especially when deﬁned by Kellgren & Lawrence. The trend was that hip ROA in 
younger men, especially when deﬁned by Kellgren & Lawrence, had a weaker relationship 
with hip pain than in women (both age categories) and older men. These results were 
similar for the association with lower limb disability. 
Predictive validity
Table 6 shows the predictive validity of the three deﬁnitions for THR at follow-up, indicated 
by the association between the different deﬁnitions of hip ROA at baseline and THR at 
Table 5: Association between two deﬁnitions of radiographic hip osteoarthritis and hip pain, stratiﬁed for gender and age 
Men Women Total
Younger Older Younger Older Younger Older
Median age, years
 
60.8
n = 776
70.1
n = 723
60.5 
n = 1,016
71.1
n = 1,070
60.6
n = 1,792
70.6
n = 1,793
Kellgren
≥ grade 2
Proportion with 
hip pain, %
0.3* (0.0–1.9)
2.1
3.7 (1.7–7.9)
16.9
4.0 (2.0–8.2)
36.1
3.2 (1.9–5.3)
31.7
1.7 (1.0–3.2)
16.7
3.2 (2.1–4.9)
25.5
MJS
≤ 2.5 mm
Proportion with
hip pain, %
1.6 (0.5–4.7)
10.8
4.1 (1.9–8.8)
17.9
2.2 (1.1–4.2)
23.6
2.3 (1.4–3.8)
25.5
2.0 (1.2–3.5)
18.5
2.7 (1.8–4.2)
22.7
Associations are presented as odds ratios with 95% conﬁdence interval between parentheses.
Men and women are divided in two equal groups, a younger (1) and older (2) group, divided by median (65.2 years).
Associations are adjusted for body mass index and radiographic osteoarthritis of the other hip.
* 48 cases with radiographic hip osteoarthritis according to Kellgren & Lawrence (5), only 1 of these reported hip pain.
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follow-up. The Kellgren & Lawrence grading system predicted the highest ratio of number 
of incident THR at follow-up divided by the number ROA cases at baseline, and showed the 
strongest association with THR at follow-up, compared to the other deﬁnitions.
Discussion
Based on the results of the present study that Kellgren & Lawrence showed to be the best 
predictor for a THR at follow-up and that MJS is height dependent, we concluded that 
radiological hip OA might be better deﬁned for epidemiological studies by the Kellgren & 
Lawrence grading system than by MJS. 
The inter-rater reliability of Kellgren & Lawrence assessed in this study is similar to that 
described in literature (4, 6, 22, 23). In contrast to more recent studies, the original study of 
Kellgren & Lawrence showed a relatively low inter-rater reliability (ICC of 0.40) (10). In the 
present study we found an inter-rater reliability of the MJS according to Croft, which is similar 
to previous studies (4, 7, 22, 24, 25). The inter-rater reliability for Croft’s grade (≥ grade 3) in 
the present study showed a Kappa-value of 0.51 compared to Kappa statistics of 0.37–0.79 
in earlier studies (4, 7, 25, 26). The wide range of inter-rater reliability between these studies 
is mainly explained by the different cut-off levels used. One study (14) used the same 
cut-off level as the present study, and reported a similar Kappa value of 0.41. However, 
in the original study of Croft the presented Kappa values were based on measurement of 
the size of the individual radiological features and not on atlas-based grades. The inter-
rater reliability reported in the present study was similar for subchondral sclerosis and for 
osteophytes compared with the reliability reported in the study of Croft (14). 
The validity of the different deﬁnitions of hip ROA has been poorly investigated in previous 
studies. In the present study we investigated the construct and predictive validity. Because 
Table 6: Predictive validity of the three deﬁnitions for total hip replacement (THR) at follow-up (N = 3,561)
Total incident
THR at 
follow-up
Number of THR 
predicted by each 
deﬁnition / number 
ROA cases deﬁned 
by each deﬁnition
OR (95% CI)
Kellgren & Lawrence (≥ grade 2) 
right 
left
57
42
33/154 (21.4)
22/110 (20.0)
30.6 (17.5–53.5)
34.3 (18.1–65.2)
MJS (≤ 2.5 mm)
right 
left
57
42
26/151 (17.2) 
19/123 (15.4)
18.6 (10.7–32.3)
22.6 (11.8–43.0)
Croft grade (≥ grade 3)
right
left
57
42
46/673 (6.8)
28/717 (3.9)
16.0 (8.0–31.8)
6.7 (3.4–12.9)
Number of incident THR at follow-up predicted by each deﬁnition / number ROA cases at baseline, as deﬁned by each deﬁnition of hip ROA.
ROA = radiological osteoarthritis 
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of the absence of a “gold standard” we expressed the predictive validity as the ability of each 
deﬁnition to predict a THR at follow-up. The requirement for a THR has been proposed 
as a potential outcome measure based on the assumption that THR is performed only in 
patients with a severe disease from both a symptomatic (painful and disabling disease) 
and a structural point of view (overall severity or advanced JSN) (27, 28). The lower limb 
disability assessed by the HAQ in the Rotterdam Study is not a disease speciﬁc outcome 
measure, but it measures arthritic conditions in general. On the other hand is lower limb 
disability an important symptom of hip OA, and OA is the most important cause of disability 
of elderly people (29). Hence we included lower limb disability, assessed by the HAQ, 
besides the presence of hip pain and morning stiffness as an important symptom of hip OA 
in the analysis. Overall, the Kellgren & Lawrence grading system showed the best predictive 
validity when compared with the other deﬁnitions of hip ROA and similar associations with 
symptoms of hip OA (construct validity), with MJS. MJS came out better concerning the 
construct and predictive validity than Croft’s grade. The weak associations reported in the 
present study between Croft’s grade (≥ grade 3) and symptoms of hip OA, can be explained 
by the high prevalence of moderate hip OA and presumably therefore by the low speciﬁcity 
value, using hip pain as “gold standard” for Croft’s grade (≥ grade 3). Therefore it is difﬁcult 
to compare the deﬁnition of Croft (moderate hip OA, ≥ grade 3) with the other deﬁnitions. 
An earlier study reported similar prevalence of hip OA deﬁned by Croft grade (≥ grade 3) 
and MJS (≤ 2.5 mm) and also similar prevalence of hip pain in “disease positive” hips (14). 
When we excluded those subjects with an incident hip fracture during follow-up time, and 
repeated the analysis for predictive validity, the results did not change essentially.
The second objective of the present study was to investigate whether the relationship 
between the three deﬁnitions and symptoms was gender dependent. Surprisingly, only the 
strength of the association between the Kellgren & Lawrence grading system and symptoms 
of hip OA was gender dependent. These ﬁndings are not reported in previous studies. A 
possible explanation for this gender dependency could be the stronger relationship between 
(femoral) osteophytes and hip pain for women. In women we found a stronger relationship 
between osteophytes and hip pain (OR of 1.7 for women versus 1.2 for men); however, the 
prevalence of osteophytes in women was lower (34.3% for women versus 43.6% for men). 
In contrast to our ﬁndings, we had expected that the strength of the association between 
MJS and symptoms of hip OA would have been gender dependent. 
In older persons a stronger association between hip ROA and hip pain was found compared 
to younger persons. Because of a power problem (due to the smaller sample size for the 
younger men category) the gender difference was not signiﬁcant. A possible explanation 
for this difference might be that younger persons have better muscle strength of the lower 
limb than older persons. Reduced muscle strength is regarded as a risk factor for pain and 
disability in OA (30–32) and exercise therapy, with the aim to improve muscle strength, has 
a beneﬁcial effect on pain in patients with OA of the hip or knee (33, 34).
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The results of the present study may be ﬂawed by the quality of the radiographs. Especially 
measurement of joint space width (MJS) could be ﬂawed because of the quality of the 
radiographs. Important variations in the radiographic procedure are the position of the 
central ray of the X ray beam relative to the centre of the joint, and the distance between the 
centre of the joint and the X ray ﬁlm (focus to ﬁlm distance). Centring the X ray beam on 
the umbilicus instead of on the superior aspect of the symphisis pubis resulted in a average 
increase in joint space width of about 10% (16). The focus to ﬁlm distance may also modify 
the measurement (35). On the other hand in the study of Croft (14) the X ray beam was also 
centred 10 cm higher than a standard anteroposterior view of the pelvis. 
The source of potential bias in this study is a likely health-based selection. The subjects 
in the present study had to be mobile enough to visit the research centre at baseline and 
follow-up and survive the follow-up period (mean 6.6 years). Overall, participants were 
generally healthier than non-participants. In other words, patients with the most severe 
symptoms were most likely not included. It seems probable that, in this younger and 
healthier population with less frequent lower limb disability and hip pain, the prevalence of 
hip ROA as well as the magnitude of the association between the different deﬁnitions of hip 
ROA and symptoms of hip OA is underestimated. Knowing that for older persons a stronger 
relationship was found between hip ROA and hip pain, especially when deﬁned by Kellgren 
& Lawrence, this underestimation may particularly hold for Kellgren & Lawrence. 
When we compared the results of Kellgren & Lawrence and MJS we found the following 
differences. Kellgren & Lawrence was the best predictor for a THR at follow-up. As described 
earlier by Buckland-Wright (36) and Lanyon et al. (37), we also found that men had larger 
joint spaces than women. After adjustment for height these joint space differences between 
men and women disappeared. Considering these results, it is doubtful whether the given 
cut-off point of MJS is valid for people of short stature, for example Asians.
When we stratiﬁed the associations between each deﬁnition and symptoms of hip OA (hip 
pain and lower limb disability) for gender, surprisingly we found for Kellgren & Lawrence 
signiﬁcantly stronger associations for women with hip pain and lower limb disability than 
for men.
Based on these results, we concluded that Kellgren & Lawrence is still a useful deﬁnition for 
hip ROA for epidemiological studies.
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Abstract
Objective: To investigate the association between urinary concentrations of C-telopeptide 
fragments of collagen type II (CTX-II) and the prevalence and progression of ROA of the 
knee and hip.
Methods: The study population consisted of a sample of 514 men and 721 women aged 55 
years and older, of the Rotterdam Study (population-based cohort study), with a mean follow-
up time of 6.6 years. Prevalent ROA was deﬁned by Kellgren ≥ grade 2 and progression of 
ROA as decrease of joint space width.
Results: Subjects with a CTX-II level in the highest quartile had a 4.2 times increased risk 
of having ROA of the knee (95% conﬁdence interval (95% CI) 2.2–7.8) and at the hip (95% 
CI, 2.5–7.0) compared to subjects with a CTX-II level in the lowest quartile. We observed 
a stronger association for subjects with hip pain (17.1 (95% CI) 2.3–185.2) compared with 
those without hip pain (2.3 (95% CI) 1.5–6.0). Subjects with a CTX-II level in the highest 
quartile had a 6.2 times increased risk for progression of ROA at the knee (95% CI 1.2–31.6) 
and an 8.3 times increased risk for progression of ROA at the hip (95% CI 1.0–72.3). All of 
these associations were found to be independent of known risk factors for OA, such as age, 
gender and body mass index.
Conclusion: This study shows that CTX-II is associated with both prevalence and progression 
of ROA at the knee and hip. Importantly, this association is independent from known 
clinical risk factors for OA and seems stronger in subjects with joint pain.
Arthritis Rheum 2004;50(8):2471–8.
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Introduction
Osteoarthritis (OA) is a common age-related disabling locomotor disease characterized by 
degradation of articular cartilage. The most commonly used radiological method to assess 
cartilage damage is measurement of the joint space width. However, a limitation of using plain 
radiographs for detecting cartilage destruction is that signiﬁcant cartilage degradation must 
have occurred in order to be visible on a radiograph (1). Therefore, cartilage degradation 
detectable on radiographs is considered as an already irreversible joint damage. Because 
of its relatively insensitive reﬂection of the disease process, it also takes at least one or two 
years to detect progression of damage that has been visualized on radiographs. 
To overcome this, biochemical markers aiming to detect changes in OA with more reliability 
and sensitivity, preferably in an early stage of OA, have been developed (1–4). Biochemical 
markers are molecules derived from connective tissue matrices, which are released into 
biological ﬂuid during the process of tissue turnover (1, 2). Such a biochemical marker might 
be useful for early identiﬁcation of patients with OA, of patients at high risk for progression, 
for monitoring disease progression, and for assessing therapeutic response in OA all 
because of their improved responsiveness compared with radiographs (2, 4). One approach 
to identify such a marker could involve the analysis of cartilage metabolism. Proteoglycans 
and type II collagen are the major constituents of cartilage (4). Type II collagen is localized 
almost exclusively in cartilage, where it is a major structural component of the tissue. Hence, 
measurements of fragments derived from this protein may potentially represent a speciﬁc 
marker for cartilage degradation (1, 3). Recently, a speciﬁc marker of cartilage degradation, 
measured as the urinary concentration of C-telopeptide fragments of collagen type II (CTX-
II), was developed (2, 3, 5). Mouritzen et al. described slightly increased concentration of 
CTX-II with increasing age, higher CTX-II concentration for women (both after 55 years 
of age) and higher CTX-II concentration in subjects with a higher body mass index (BMI) 
(5). Some evidence supporting the use of CTX-II as a marker has already been obtained. 
Urinary CTX-II levels are elevated in diseases with increased cartilage turnover, such as OA 
(1, 2) and rheumatoid arthritis (6). Garnero et al. reported weak associations of CTX-II with 
prevalent knee radiological OA (ROA) (1), and also modest associations with progression 
of knee ROA (2). However, these studies are small and it remains uncertain to what extent 
CTX-II is an independent marker for ROA and which factors could modify the relation 
between CTX-II and ROA. 
We were therefore interested to explore to what extent the CTX-II marker can be considered 
to be independent from known risk factors for ROA such as age, gender and BMI. Because 
of the limited number of subjects included in the studies on CTX-II up to now there is a clear 
need to examine larger populations to obtain more accurate estimates. Furthermore, it is 
conceivable that in combination with factors that might reﬂect an ongoing OA process, such 
as the presence of joint pain, a dynamic change in cartilage metabolism can be detected. 
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As such, joint pain can be considered as a potential effect modiﬁer of the relation between 
CTX-II and ROA.
Therefore the present study investigated the association between CTX-II and the prevalence 
and progression of ROA of the knee and hip in a large population of men and women aged 
55 years and over. Additionally, we stratiﬁed the baseline associations between CTX-II and 
ROA of the knee or hip for the presence of pain at baseline (knee or hip).
Subjects and Methods
The study population consisted of participants of the Rotterdam Study, a prospective cohort 
of men and women aged 55 years and over. The objective of the Rotterdam Study is to 
investigate the incidence of, and risk factors for, chronic disabling diseases. The rationale 
and study design have been described previously (7). The focus is on neurogeriatric, 
cardiovascular, ophthalmologic and locomotor diseases. All 10,275 inhabitants of Ommoord, 
a district in Rotterdam, were invited to participate. The response rate was 78%, resulting 
in 7,983 subjects participating in the present study. Written informed consent was obtained 
from each participant. The Medical Ethics Committee of the Erasmus University Medical 
Centre has approved the Rotterdam Study.
For the present study a sample of 1,235 subjects of the Rotterdam study was used. The 
selection was based on the availability of the radiographs of the hip and knee both at baseline 
and follow-up, and the availability of urine samples at baseline. The fact that subjects had 
to be mobile enough to visit the research center at baseline and follow-up, and survive 
the follow-up period, led to the selection of a relatively younger and healthier population. 
Compared to the total Rotterdam study population, the present study population was indeed 
younger (66.6 years versus 70.6 years), had a lower prevalence of lower limb disability at 
baseline (≥ index score of 0.5: 11.4% versus 35.5%) and a somewhat lower percentage of 
women (58.4% versus 61.1%). The baseline measurements were conducted between April 
1990 and July 1993, and the follow-up measurements between 1996 and 1999, with a mean 
follow-up time of 6.6 years (range: 5.1–9.4 years). 
Radiographic assessment 
Weight bearing anteroposterior radiographs of the knee and hip were obtained at 70 KV, a 
focus of 1.8, and a focus to ﬁlm distance of 120 cm, applying a Fuji High Resolution G 35 × 
43 cm ﬁlm. Radiographs of the pelvis were obtained with both feet in 10° internal rotation 
and the X-ray beam centred on the umbilicus, and of the knee with the patellae in central 
position. Two trained readers independently evaluated the radiographs of the knee and 
hip at baseline and follow-up, unaware of the clinical status of the patients. All radiographs 
Max Reijman BW.indd   61 10/5/2004   10:29:50 AM
62
Chapter 4
were grouped by patient and read by pairs chronologically ordered, the chronological order 
being known to the reader (chronologically ordered reading procedure) (8). 
At baseline, ROA of the knee and hip was quantiﬁed by measurements following the 
Kellgren & Lawrence grading system (9–12) (atlas-based) in ﬁve grades (from zero to four). 
A person was considered to have ROA of the knee or hip, if the Kellgren & Lawrence score 
of one or both joints was equal to or larger than two. 
At baseline and follow-up the minimal joint space width (JSW) of the knee and hip joints 
were measured using a 0.5 millimetres graduated magnifying glass directly laid over the 
radiograph (13). For the knee the medial and lateral compartment was measured and for 
the hip the lateral, superior and axial compartment, as described previously by Croft et 
al. (13). Joint space narrowing (JSN) was deﬁned as the JSW at baseline minus the JSW 
at follow-up (∆ JSW). Because of the absence of consensus concerning the cut-off point 
for JSN, we used different cut-off points for JSN, namely 1.0, 1.5 and 2.0 mm decrease of 
the JSW between baseline and follow-up. JSN was evaluated per compartment and for the 
knee a JSN of minimally 1 (out of 2; medial and lateral (14)) compartment and for the hip 
a JSN of minimally 1 (out of 3; lateral, superior and axial (13)) was deﬁned as a positive 
progression. Additionally, we also used a JSN of the medial compartment of the knee as 
a deﬁnition of progression. Radiographic progression of JSN can be regarded as the most 
reliable measurement of OA progression (15).
The radiographs of the knee were scored for OA by two independent observers who were 
blinded to all data for the participant, as described previously (14, 16). After each set of 
150 radiographs, the scores of the two readers were evaluated. Whenever the Kellgren 
& Lawrence score differed, the two readers met to read the radiographs together, and a 
consensus score was determined. Two independent readers tested the inter-rater reliability 
of the hip in a random set of 148 radiographs. We determined the inter-rater reliability for 
Kellgren & Lawrence to be 0.68 (Kappa statistics), and for the minimal joint space width we 
obtained an Intraclass Correlation Coefﬁcient (ICC) of 0.85 (12).
Biochemical measurement
Overnight fasting urine samples were obtained from all subjects at baseline and kept frozen 
at –20° C.
Monoclonal antibody mAbF46, speciﬁc for CTX-II C-telopeptide fragments, was used in a 
competitive enzyme-linked immunosorbent assay (ELISA) format developed for measurement 
of urine samples, as described previously (3). In order to ensure the reproducibility and 
performance of the assay, three genuine urine samples were added as controls on each 
microtitre plate to assure performance of
the assay, and the entire plate was re-run if any of the genuine controls were measured with 
a concentration more than 20% of the predetermined value. The concentration CTX-II (ng/l) 
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was standardised to the total urine creatinine (mmol/l), and the unit for corrected CTX-II 
concentration was ng/mmol.
Potential confounders and eﬀect modiﬁers
At baseline, trained interviewers performed an extensive home interview on demographic 
characteristics, medical history, risk factors for chronic diseases and medication use. Lower 
limb disability was assessed using a modiﬁed version of the Stanford Health Assessment 
Questionnaire (HAQ) (16). A lower limb disability index (LDI) was obtained by calculating 
the mean score of answers to six questions, as described previously (12). We used the LDI 
as measurement of mobility of the participant. The presence of knee and hip pain (“did you 
have joint complaints of your right/left knee/hip during the last month”) was asked during 
the home interview at baseline.
Height and weight were measured with participants wearing indoor clothing without shoes. 
BMI was calculated as weight in kilograms divided by height in squared meters (kg/m2). 
Statistical analysis
Differences in baseline characteristics were evaluated by analysis of variance (ANOVA) for 
continuous variables and by Chi-square for categorical variables. Distribution analysis by the 
Shapiro-Wilk test showed that biochemical markers were not normally distributed and, thus, 
were log transformed to obtain normal distribution before statistical analysis. Hereafter CTX-
II concentrations refer to log-transformed CTX-II concentrations. Inﬂuences of age, gender, 
and BMI on baseline CTX-II concentration were tested by independent t-tests.
The cross-sectional associations between CTX-II concentration and ROA of the knee or hip 
were assessed using logistic regression analysis to calculate odds ratios (ORs), by means 
of Generalised Estimating Equations (GEE) (cross-sectional design). This is a procedure of 
repeated measurements, which is used here to take account of the correlation between the 
left and right hip, while using each joint (left or right) as the observation unit (17). The ORs 
were calculated per quartile (with the 1st quartile as reference) and per standard deviation 
CTX-II. For the baseline associations we calculated crude ORs and adjusted the crude ORs 
for age, gender, BMI and LDI. Additionally, we stratiﬁed these associations for the presence 
or absence of pain in knee or hip (during the last month). 
The longitudinal associations between baseline CTX-II concentration and progression 
of ROA of the knee or hip were assessed using logistic regression analysis to calculate 
ORs to estimate the relative risk for progression, by means of GEE (longitudinal design). 
ORs were calculated per quartile and per standard deviation CTX-II. For the associations 
between baseline CTX-II and progression of ROA of the knee or hip we calculated crude 
ORs and adjusted for age, gender, BMI, LDI, baseline Kellgren score and follow-up time. 
The baseline Kellgren score is a known risk factor for radiologic progression (18, 19). 
Additionally, we assessed the longitudinal associations between CTX-II concentration and 
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incident osteophytes at follow-up of the knee or hip. A (two-sided) P-value of 0.05 was 
considered signiﬁcant. 
We estimated the magnitude of confounding by the degree of discrepancy between the 
unadjusted and adjusted estimate (the change-in-estimate-criterion) (20). We choose a cut-
off point of 10% for what constitutes as an important change in the estimate. 
We used SPSS version 11.0 (SPSS Inc., Chicago, USA) and SAS software, version 8.2 (SAS 
Institute, Cary, NC) for all analyses.
Results
Table 1 presents the baseline characteristics of the total study population stratiﬁed for the 
absence or presence of knee or hip ROA. In this study population, with a mean age of 66.6 
years, 19.2% of the subjects had ROA of the knee and 10.0% had ROA of the hip (Kellgren 
& Lawrence ≥ grade 2). During the last month before the baseline interview 12.3% of all 
subjects had knee pain and 18.1% had hip pain. The median CTX-II concentration (not log 
transformed) of the study population, was 177.0 ng / mmol. Participants with knee ROA 
were 3.1 years older, more frequently female (70.5% versus 50.2%), 3.9 kg (2.1 kg/m2) 
heavier and 2.2 cm shorter, compared to those without knee ROA. Subjects with hip ROA 
were 3.8 years older compared to those without hip ROA. Compared with those with ROA 
of the hip, persons with ROA of the knee were more often women (70.5% versus 58.5%) 
and 2.1 kg (1.3 kg/m2) heavier. 
Table 1: Baseline characteristics of the study population, stratiﬁed by the absence / presence of radiological osteoarthritis (ROA) 
of the knee or hip.
Study population Persons without 
Knee ROA
Persons with 
Knee ROA
Persons 
without 
Hip ROA
Persons 
with  
Hip ROA 
Number 1,235 998 237 1,112 123
Gender, % women 58.4 50.2 70.5** 58.1 58.5
Age, years ± SD 66.6 ± 6.8 66.0 ± 6.6 69.1** ± 6.9 66.2 ± 6.7 70.0** ± 6.7
Weight, kg ± SD 73.8 ± 11.5 73.1 ± 11.2 77.0** ±12.0 73.7 ± 11.6 74.9 ± 10.8
Height, cm ± SD 167.5 ± 9.1 167.9 ± 9.2 165.7* ± 8.4 167.5 ± 9.1 167.5 ± 8.8
Body Mass Index, kg/m2 ± SD 26.3 ± 3.6 25.9 ± 3.4 28.0** ± 3.9 26.3 ± 3.6 26.7 ± 3.4
Presence of knee pain, % 12.3 15.1 30.8** 17.6 23.0
Presence of hip pain, % 18.1 11.1 17.1 10.3 29.9**
Lower limb disability, % 11.4 9.0 21.7 8.5 34.6
Concentration CTX-II, ng/mmol 
(median)†
177.0 167.0 228.0** 172.0 231.5**
† Concentration CTX-II, not log transformed
Signiﬁcant diﬀerences between persons with radiological osteoarthritis (ROA) and persons without ROA
* P < 0.01, ** P < 0.001
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The CTX-II concentration was 72.3 ng/mmol higher in women than in men (P-value < 
0.0001), increased 1.1 ng/mmol per year with age (P-value trend = 0.03) (Figure 1) and 
increased 3.3 ng/mmol per kg/m2 with higher BMI (P-value trend < 0.0001). When we 
excluded participants with ROA of the knee or hip at baseline and those with incident 
ROA of the knee or hip at follow-up, only the gender difference in CTX-II concentration 
remained.
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Figure 1: Distribution of CTX-II (median value, ng/mmol) by age and gender.
Concentration of CTX-II not log transformed.
Table 2: Cross-sectional association between baseline CTX-II concentration and baseline radiological osteoarthritis (ROA) of the 
knee and/or hip (Kellgren & Lawrence ≥ grade 2).
Knee ROA Hip ROA
Number of cases 237 123
crude OR adj* OR crude OR adj* OR
CTX-II
1st quartile (1.49–2.10)
2nd quartile (2.11–2.25)
3rd quartile (2.26–2.39)
4th quartile (2.40–3.11)
P-value for trend
1
1.7 (1.0–2.9)
3.2 (2.0–5.2)
5.2 (3.3–8.4)
< 0.0001
1
1.7 (1.0–2.9)
2.8 (1.6–4.6)
4.2 (2.5–7.0)
< 0.0001
1
1.3 (0.7–2.5)
1.7 (0.9–3.1)
3.6 (2.0–6.2)
< 0.0001
1
1.5 (0.8–2.9)
2.1 (1.1–4.0)
4.2 (2.2–7.8)
< 0.0001
CTX-II
Per SD 1.9 (1.6–2.2) 1.7 (1.4–2.0) 1.8 (1.5–2.1) 1.8 (1.4–2.2)
Log-transformed CTX-II concentration is expressed in quartiles and standard deviation (SD)
Associations are presented by odds ratios (OR) with 95% conﬁdence interval between parentheses, for risk of ROA by CTX-II levels.
*Associations are adjusted for age, gender, body mass index and lower limb disability index. 
Knee and hip radiological osteoarthritis is deﬁned as Kellgren & Lawrence ≥ grade 2 in minimally 1 joint.
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Baseline CTX-II concentration (in quartiles and per standard deviation) is higher in subjects 
with baseline ROA of the knee and hip compared to those without baseline ROA of the 
knee and hip (Table 2). The crude data showed a stronger (but not signiﬁcant) association 
between the highest quartile CTX-II and ROA of the knee than for ROA of the hip. After 
adjustment for gender and age, the risk estimate increased for the hip and decreased for 
the knee, resulting in similar ORs for the hip and knee. Additional adjustment for BMI and 
lower LDI did not essentially change the risk estimates for the knee and hip. Overall, we 
observed a clear trend that the higher the CTX-II concentration, the stronger the association 
with prevalent ROA of the knee and hip.
Table 3 shows the associations between baseline CTX-II concentration (in quartiles and per 
standard deviation) and progression of knee ROA using different cut-off points for JSN. We 
found signiﬁcant crude associations between a decrease in joint space of ≥ 1.5 mm or ≥ 
2.0 mm, and the highest quartile of CTX-II. After adjustment for BMI, age, gender, LDI and 
baseline ROA of the knee the risk estimates changed importantly, and only the association 
between JSN ≥ 2.0 mm and the 4th quartile of CTX-II reached signiﬁcance with an OR of 6.2. 
We observed a clear trend, especially for a JSN of ≥ 2.0 mm, but also for a JSN of ≥ 1.5 mm, 
the higher the CTX-II concentration, the stronger the association with progression of knee 
ROA. Additionally, we also assessed the association between CTX-II and progression of the 
medial compartment. These associations did not essentially differ with the abovementioned 
associations (JSN ≥ 1.5 mm and 4th quartile CTX-II: adjusted OR of 2.0 (95% CI) .8–5.1).
Table 4 shows the associations between baseline CTX-II concentration (in quartiles and per 
standard deviation) and progression of hip ROA (for different cut-off points as deﬁned by 
Table 3: Associations between baseline CTX-II concentration and radiological progression of knee osteoarthritis. 
JSN ≥ 1.0 mm JSN ≥ 1.5 mm JSN ≥ 2.0 mm
Number of cases 233 73 26
crude OR adj* OR crude OR adj* OR crude OR adj* OR
CTX-II
1st quartile (1.49–2.10)
2nd quartile (2.11–2.25)
3rd quartile (2.26–2.39)
4th quartile (2.40–3.11)
P-value for trend
1
1.0 (0.7–1.5)
1.2 (0.8–1.8)
1.2 (0.8–1.8)
0.219
1
0.9 (0.6–1.5)
1.1 (0.7–1.7)
1.1 (0.7–1.7)
0.730
1
1.5 (0.7–3.3)
1.9 (0.9–4.1)
2.5 (1.2–5.2)
0.009
1
1.3 (0.6–2.9)
1.5 (0.6–3.3)
1.8 (0.8–4.1)
0.120
1
3.7 (0.8–17.7)
3.6 (0.7–17.5)
5.2 (1.1–23.8)
0.033
1
4.1 (0.8–20.5)
4.5 (0.9–23.0)
6.0 (1.2–30.8)
0.064
CTX-II
Per SD 1.1 (1.0–1.3) 1.1 (.9–1.3) 1.5 (1.1–1.8) 1.4 (1.0–1.8) 1.5 (1.0–2.2) 1.6 (1.0–2.5)
Log-transformed CTX-II concentration is expressed in quartiles and standard deviation (SD).
Associations are presented by odds ratios (OR) with 95% conﬁdence interval between parentheses, for risk of radiological osteoarthritis by CTX-II 
levels.
*Associations are adjusted for age, gender, body mass index, lower limb disability index, baseline radiological osteoarthritis of the knee, baseline 
radiological osteoarthritis of the hip and follow-up time.
JSN (joint space narrowing) is deﬁned as the joint space width at baseline minus the joint space width at follow-up (of the medial and lateral 
compartment), using diﬀerent cut-oﬀ points.
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JSN) are shown. The results for the JSN cut-off point ≥ 2.0 mm are not presented because 
the power is too low (11 cases). At the hip we found a trend similar to prevalent ROA of 
the knee and hip; i.e. the higher the CTX-II concentration, the stronger the association 
with progression of ROA. After adjustment for BMI, age, gender, LDI and baseline ROA of 
the hip only the associations between JSN ≥ 1.5 mm and the 4th quartile of CTX-II reached 
signiﬁcance with an OR of 8.3. When we compared the association between the different 
aspects of ROA as measured by the Kellgren & Lawrence score, i.e. osteophytes and JSN, 
we observed no association with incident osteophytes of the knee and the hip. The ORs 
for the 4th quartile of CTX-II were 0.3 for both knee and hip (P-values of 0.288 and 0.232, 
respectively).
Figure 2 shows the baseline associations between high CTX-II concentrations (4th quartile) 
and ROA of the knee and hip, stratiﬁed for the absence or presence of knee or hip pain. 
For this analyses we compared subjects with a high CTX-II concentration (4th quartile) 
with those with a low concentration (1st quartile), resulting in lower number of subjects as 
reported before. We observed substantially stronger associations between CTX-II levels and 
ROA for subjects with hip pain (OR 20.4) compared to those without hip pain (OR 3.0). 
Adjustment for potential confounders changed the risk estimates importantly (from 17.1 to 
20.4 and from 2.3 to 3.0) for subjects with and without hip pain, respectively. The difference 
between the ORs for subjects with versus without hip pain just failed to reach signiﬁcance 
(P-value 0.105). In case of ROA of the knee the differences in ORs between participants with 
and without knee pain were similar but smaller than found for the hip. After adjustment for 
Table 4: Associations between baseline CTX-II concentration and radiological progression of hip osteoarthritis. 
JSN ≥ 1.0 mm JSN ≥ 1.5 mm
Number of cases 73 24
crude OR adj* OR crude OR adj* OR
CTX-II
1st quartile (1.49–2.10)
2nd quartile (2.11–2.25)
3rd quartile (2.26–2.39)
4th quartile (2.40–3.11)
P-value for trend
1
1.1 (0.5–2.6)
2.3 (1.1–4.7)
2.8 (1.4–5.8)
< 0.0001
1
1.0 (0.4–2.4)
2.1 (0.9–4.6)
1.7 (0.7–4.0)
0.05
1
4.2 (0.5–37.4)
8.5 (1.1–68.5)
12.3 (1.6–95.5)
< 0.0001
1
3.9 (0.4–36.9)
8.3 (1.0–72.2)
8.4 (1.0–72.9)
0.005
CTX-II
Per SD 1.6 (1.3–2.0) 1.3 (1.0–1.8) 2.2 (1.5–3.2) 1.9 (1.2–3.0)
Log-transformed CTX-II concentration is expressed in quartiles and standard deviation (SD)
Associations are presented by odds ratios (OR) with 95% conﬁdence interval between parentheses, for risk of ROA by CTX-II levels.
*Associations are adjusted for age, gender, body mass index, lower limb disability index (LDI), baseline radiological osteoarthritis of the hip, 
baseline radiological osteoarthritis of the knee and follow-up time. 
JSN (joint space narrowing) is deﬁned as the joint space width at baseline minus joint space width at follow-up (of the lateral, superior and axial 
compartment), using the diﬀerent cut oﬀ points.
The associations with the cut-oﬀ point ≥ 2.0 mm were not given because of too low statistical power (N = 11).
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potential confounders the risk estimates changed importantly for participants with (OR from 
7.1 to 6.3) and without (OR from 4.3 to 3.6) knee pain.
Discussion
We report the analysis of CTX-II levels in urine in a large population-based prospective 
cohort study that indicates a strong relation between CTX-II levels and risk of ROA. For 
persons with a CTX-II level in the highest quartile, we observed a more than four times 
increased risk of having prevalent ROA of the knee or hip, and a more than 6 to 8 times 
increased risk for progression of ROA at the knee and the hip, respectively. All these 
associations were found to be independent from known risk factors for ROA, including age, 
gender, BMI and baseline Kellgren score. Furthermore, CTX-II seems to be a speciﬁc marker 
for cartilage degradation, since CTX-II is associated with joint space narrowing but not with 
incident osteophytes.
The baseline associations seemed stronger for those participants with hip pain compared 
with those without hip pain. Because of the low numbers of subjects with hip pain the 
conﬁdence interval of the association for those with hip pain are huge (95% CI 2.3–185.2) 
and overlaps with the CI for those without hip pain. We conﬁrm that women had a higher 
CTX-II concentration than men, and found that this is not explained by prevalent or incident 
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Knee Hip
95% CI P-value Number of 
subjects
95% CI P-value Number of 
subjects
No pain 2.0–6.5 < 0.0001 495 No pain 1.5–6.0 < 0.0001 531
Pain 2.0–20.0 0.002 115 Pain 2.3–185.2 0.007 71
Figure 2: Associations between baseline CTX-II concentration (log transformed, highest quartile) and baseline radiological osteo-
arthritis (ROA) of the knee or hip (Kellgren & Lawrence ≥ grade 2), stratiﬁed for the presence of (knee/hip) pain.
Associations are adjusted for age, gender, body mass index and lower limb disability index.
Max Reijman BW.indd   68 10/5/2004   10:29:51 AM
A new marker for osteoarthritis: cross-sectional and longitudinal approach
69
ROA of the knee or hip. Thus the present study shows that a single degradation marker (CTX-
II) can identify patients who are at high risk for rapid progression of joint destruction.
The distribution of CTX-II concentration by age, gender and BMI in the present study was 
similar to that described by Mouritzen et al (5). We found a slight rise in urinary CTX-II with 
increasing age (after 55 years of age), a signiﬁcantly higher level for women compared to 
men (after 55 years of age), and a signiﬁcantly higher CTX-II concentration in subjects with 
higher BMI. The increased concentration with age seems to reﬂect the increase in prevalence 
of ROA with increasing age. However, the higher concentration found in women remains 
after we excluded participants with prevalent (at baseline) and incident ROA (at follow-up) 
of the knee or hip. In line with this, Mouritzen et al.(5) reported a sudden and marked 
increase in CTX-II concentration after the menopause. This observation may be explained 
by a higher turnover rate for cartilage in women after menopause. Indeed, a recent study 
in cynomolgus monkeys showed that ovariectomy induced OA lesions of articular cartilage 
(21). Furthermore, in a cross-sectional observational study, Wluka et al. (22) reported that 
the use of estrogen replacement therapy (ERT) for more than ﬁve years is associated with 
greater knee cartilage volume. Similarly, a number of retrospective and observational studies 
indicated that ERT is associated with decreased prevalence of OA, but this ﬁnding is not 
universal (23). Finally, polymorphisms in the estrogen receptor α gene have been identiﬁed 
as genetic risk factors for knee OA (14). Altogether these data suggest that estrogen can 
prevent cartilage erosion, and thereby identify the estrogen endocrine system as a signiﬁcant 
regulator of cartilage turnover and structural integrity (21). However, the exact mechanism 
whereby estrogen inﬂuences cartilage metabolism needs further investigation (21, 23–26).
Type II collagen markers are probably a speciﬁc tool for detecting changes in OA (27). Other 
proposed markers of OA, such as collagen crosslinks, proteoglycan, cartilage oligomeric 
matrix protein, matrix metalloproteinases and inﬂammatory markers (27), reﬂect general 
remodeling of the various tissues of the cartilage, bone and synovium. Up to now, increased 
serum or urine levels of the different markers have been obtained from small cross-sectional 
studies (27, 28). This is the ﬁrst large follow-up study that investigated the use of CTX-II as 
biomarker for cartilage degradation and disease progression. 
The strengths of the present study are its size, its population-based prospective design and 
the clinically meaningful follow-up period of 6.6 years. A potential limitation of the present 
study might be that the results are based on a single determination of CTX-II at baseline. 
Because of a possible diurnal variability of the CTX-II level, we obtained overnight fasting 
urine samples of all subjects. However, we found no an indication for the presence of 
a systematic bias due to the inherent variability of the measurements of CTX-II. Another 
limitation is a potential health-based selection bias. The subjects in the present study had 
to be mobile enough to visit the research center at baseline and follow-up, and survive 
the follow-up period (mean 6.6 years). Overall, participants were generally healthier than 
non-participants. In other words, patients with the most severe symptoms were most likely 
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not included. Therefore it seems probable that, in this younger and healthier population 
with less frequent lower limb disability and (knee and hip) pain, the prevalence of knee 
and hip ROA at baseline and the number of cases with progression of ROA at follow-
up is underestimated. This could have resulted in an underestimation of the reported 
associations. Another limitation is the used radiographic procedure of the knee, the serial 
anterior-posterior radiograph. The reliability of radiographic JSW measurements in the knee 
increases when an anterior-posterior radiograph of the knee in 20–30 degrees ﬂexion was 
used (28, 29), and therefore this procedure has been recommended for longitudinal studies 
(30, 31). The procedure used in the present study could have resulted in an under- or 
overestimation of the reported associations of the knee. The reliability of the measurements 
of the joint space width of the knee radiographs of the present study was not assessed. 
As reported by Günther and Sun (32, 33) the lateral joint space width measurement is less 
reliable compared to the medial joint space. Additionally, we repeated the analyses between 
CTX-II and progression of knee ROA with another deﬁnition of progression, namely JSN of 
only the medial compartment. The associations we found did not differ essentially with the 
associations reported in the present study.
Based on the results of the present study, we conclude that CTX-II is markedly associated 
with the prevalence and progression of ROA of the knee and hip, and that these associations 
are independent of known risk factors for ROA. The presence of joint pain seems to augment 
this relationship, which might reﬂect the effects of an ongoing OA process. The increase of 
CTX-II in women after menopause may reﬂect a protective effect of estrogen on cartilage 
loss. Further research is necessary to establish the clinical utility of this novel biomarker for 
OA. 
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Abstract
Objectives: To investigate which variables identify persons at high risk for progression of hip 
osteoarthritis (OA). 
Methods: In 1,920 men and women aged 55 years and older from the Rotterdam Study 
(a population-based cohort study) potential determinants of progression of hip OA were 
collected at baseline. X-rays of the hip at baseline and follow-up (mean follow-up time of 
6.6 years) were evaluated. Radiologic progression of hip OA was deﬁned as a decrease 
of joint space width (≥ 1.0 mm) at follow-up, or an incident total hip replacement. Using 
multi-variate logistic regression models, the association between potential risk factors and 
progression of hip OA was assessed.
Findings: In 13.1% of the study population (mean age of 66.1 years) radiologic progression 
of hip OA was evident. Starting with a simple model of only directly obtainable variables, 
the Kellgren & Lawrence score at baseline, when added to the model, was a strong predictor 
with an odds ratio (OR) of 5.6, increasing in those subjects with hip pain at baseline to 31.7. 
A cartilage degradation marker (CTX-II) had an independent additional association with 
progression (OR of 2.2 and 3.9, respectively).
Conclusion: The Kellgren & Lawrence score at baseline was by far the strongest predictor for 
progression of hip OA, especially in those with existing hip pain at baseline. In patients with 
hip pain, an X-ray has strong additional value to identify those at high risk for progression 
of hip OA.
Submitted
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Introduction
Osteoarthritis (OA) of the hip is one of the main causes of disability among the elderly and 
the prevalence of hip OA will increase with the aging of the Western society (1, 2).
The management of patients with OA focuses on symptom relief and preservation of function 
(3, 4) including, in case of severe symptomatic OA, the consideration of joint replacement 
(3, 4). The attempts to identify potential disease-modifying OA drugs (DMOADs) that may 
halt or retard joint destruction have produced differential results. Hence, identiﬁcation of 
persons at high risk for rapid progression of OA is important for at least two reasons. Firstly, 
well-characterized ‘high risk’ groups may be useful in clinical trials and, secondly, assuming 
that DMOADs do become available in the future, to identify primary target groups in need 
of such therapy. Additionally, the identiﬁed non-progressors can be given some reassurance 
about their disease status. 
There is no consensus on how to deﬁne progression of hip OA (5). International committees 
have suggested to evaluate both structural (joint space narrowing) and symptomatic variables 
of OA (pain, functional impairment, overall assessment by the patient) in clinical studies (6, 
7). A potential composite outcome measure is the need for surgery (total hip replacement; 
THR), based on the assumption that THR is performed only in patients who have a severe 
symptomatic OA together with structural damage of the hip (8, 9). 
Potential factors that may identify persons at risk for progression of hip OA include systemic 
factors (e.g. metabolic, hormonal, genetic, age and gender), local biomechanical factors, 
such as mechanical workload, body mass index (BMI) and acetabular dysplasia, and already 
existing osteoarthritic changes such as radiological signs, clinical symptoms and signs of 
cartilage degradation. In a recent review, Lievense et al. (10) reported that radiological 
features were the main mediators of progression of hip OA; however, all the included 
studies had a small study population, a short follow-up time, and were hospital based.
The present study investigated in a large open population with a long-term follow-up period, 
which easily measurable determinants (clinically relevant risk factors) will best identify 
those persons at high risk for progression of hip OA. 
Subjects and Methods
The study population consisted of participants of the Rotterdam Study, a prospective cohort 
of men and women aged 55 years and over. The objective of the Rotterdam Study is to 
investigate the incidence of, and risk factors for, chronic disabling diseases; the rationale and 
study design have been described previously (11). Written informed consent was obtained 
from each participant. The Medical Ethics Committee of the Erasmus Medical Center has 
approved the Rotterdam Study.
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For the present study a sample of 1,920 subjects from the Rotterdam study was used. The 
selection was based on the availability of radiographs of the hip both at baseline and follow-
up and the presence of radiographic osteoarthritic signs at baseline deﬁned by the Kellgren 
& Lawrence index ≥ grade 1. Of a subset of 754 subjects, CTX-II assessments were available. 
The baseline measurements were conducted between April 1990 and July 1993, and the 
follow-up measurements between 1996 and 1999 with a mean follow-up time of 6.6 years.
Because our study group had to be mobile enough to visit the research center at baseline and 
at follow-up, and survived the follow-up period, implies a healthy cohort effect. Compared 
to the total population of the Rotterdam study, the present study group was younger, had a 
lower prevalence of lower limb disability at baseline, and a lower prevalence of hip pain at 
baseline as reported earlier (12). 
Radiographic assessment 
Weight bearing anteroposterior radiographs of the hip and knee were obtained at 70 KV, a 
focus of 1.8, and a focus to ﬁlm distance of 120 cm, applying a Fuji High Resolution G 35 × 
43 cm ﬁlm. Radiographs of the pelvis were obtained with both feet in 10° internal rotation 
and the X-ray beam centered on the umbilicus, and of the knee with the patellae in central 
position. For the hand, standard anteroposterior radiographs were obtained. One trained 
reader (M.R.) evaluated the radiographs of the hip obtained at baseline and at follow-up, 
unaware of the clinical status of the patients. Three trained readers independently evaluated 
the baseline radiographs of the knee (E.O. and A.P.B.) and the hand (S.D.), also unaware of 
the clinical status of the patients. All radiographs of the hip were grouped per patient and 
read by pairs in chronological order, the order being known to the reader (chronologically 
ordered reading procedure) (13). 
Outcome measure
We deﬁned progression of OA of the hip as a joint space narrowing (JSN) of ≥ 1.0 mm, 
or an incident total hip replacement (THR) at follow-up. At baseline and follow-up the 
minimal joint space width (JSW) of the hip joints was measured using a 0.5 millimeters 
graduated magnifying glass laid directly over the radiograph (14). The lateral, superior and 
axial compartments of the hip were measured, as described previously by Croft et al.(14). 
JSN was deﬁned as the JSW of baseline minus the JSW of follow-up (∆ JSW), and a JSN ≥ 1.0 
mm of minimal 1 (out of 3) compartment was deﬁned as a progression.
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Potential determinants of progression
Radiographic determinants
At baseline, radiographic osteoarthritis (ROA) of the hip, knee and hand was quantiﬁed 
by measurements of the Kellgren & Lawrence grading system (15, 16) (atlas-based) in ﬁve 
grades (from zero to four). A person was considered to have ROA of the hip or knee, if the 
Kellgren & Lawrence score of one or both joints was equal to or larger than two. Hand ROA 
was deﬁned as the presence of a Kellgren & Lawrence score ≥ grade 2 in at least one joint of 
two out of the three groups of hand joints (distal interphalangeal, proximal interphalangeal 
and ﬁrst carpometacarpal joint group) of one or both hands. 
The presence of a superior, axial or medial migration of the femoral head was evaluated to 
be present or absent.
The inter-rater reliability of the hip was 0.68 for Kellgren & Lawrence (Kappa statistics), and 
0.85 (Intraclass Correlation Coefﬁcient) for the minimal JSW, as reported earlier (17). The 
radiographs of the knee were scored for OA by two independent observers, as described 
previously (18, 19). For the hand, an inter-rater reliability was reported for Kellgren & 
Lawrence of 0.68 and 0.77 (Kappa statistics) (20).
Determinants collected by questionnaire
At baseline, trained interviewers conducted an extensive home interview addressing 
demographic characteristics, medical history, risk factors for chronic diseases and medication 
use. Lower limb disability was assessed using a modiﬁed version of the Stanford Health 
Assessment Questionnaire (HAQ). A lower limb disability index (LDI) was obtained by 
calculating the mean score of the answers to six questions, as described previously (range: 
0–3) (17, 19). The presence of hip pain (“Did you have joint pain of your right/left hip 
during the last month”) and morning stiffness (“Did you experience morning stiffness of the 
hips”) was asked. Data on age at and type of menopause (spontaneous or artiﬁcial) were 
collected. Menopause was deﬁned as the cessation of menses for at least one year. For women 
reporting natural menopause, age at menopause was deﬁned as the self-reported age of last 
menstruation (2, 21). The family history of OA in parents and in siblings was asked. The 
current or last occupation was asked including the duration in years of this occupation. The 
jobs were coded according to a job title scheme used at Statistics Netherlands (22). A subject 
was considered to be exposed to heavy mechanical workload if the subject performed 
heavy physically demanding work indoors or outdoors and the exposure time of this job 
was longer than 8 years (3rd and 4th quartile of exposure time). 
Determinants collected by physical examination
At the research center, a clinical examination was performed. Height and weight were 
measured with participants wearing indoor clothing without shoes. Body mass index (BMI) 
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was calculated as weight in kilograms divided by height in squared meters (kg/m2), and BMI 
≥ 30 kg/m2 was deﬁned as obesitas. Blood pressure was measured at the right brachial artery 
using a random-zero sphygmomanometer with the participant in sitting position; the mean 
of two consecutive measurements was used in the analysis. Hypertension was deﬁned as a 
systolic blood pressure of 160 mm Hg or higher or a diastolic blood pressure of 95 mm Hg 
or higher, or current use of antihypertensive drugs for the indication of hypertension (2, 21). 
Diabetes mellitus was considered present when the subject reported the use of antidiabetic 
therapy (code A010 of the Anatomical Therapeutical Chemical Classiﬁcation index, WHO 
1992), or when the pre- or post-load serum glucose level was equal to or higher than 11.0 
mmol/l (2, 21, 23).
In a subset of 525 subjects, the range of motion was tested. In supine position internal and 
external rotation, ﬂexion and extension of the hips were tested. 
Overnight fasting urine samples were obtained from all subjects at baseline and kept frozen 
at –20° C. In these samples a cartilage degradation marker, CTX-II (C-telopeptide fragments) 
was measured by monoclonal antibody mAbF46, and was used in a competitive enzyme-
linked immunosorbent assay (ELISA) format, as described previously (24). The concentration 
of CTX-II (ng/l) was standardized to the total urine creatinine (mmol/l), and the unit for 
corrected CTX-II concentration was ng/mmol. 
Statistical analysis
Of all potential determinants of progression we ﬁrst performed univariate logistic regression 
analyses and those determinants with a P-value < 0.1 were used for the multivariate 
analyses. 
For the multivariate analyses we chose a practical approach and in three different models 
assessed which determinants best identiﬁed persons with progression of hip OA. 
Model 1
In the ﬁrst model only those determinants were included which are easily and directly 
obtainable by the physician such as age, gender, family history of OA, age at menopause, 
hypertension, diabetes, BMI, mechanical work load, lower limb disability, the presence of 
hip pain, and morning stiffness. 
Model 2
In the second model we added the information obtained from additional radiographic 
testing; i.e. using the Wald test (cut-off value of P = 0.05) we assessed whether radiographic 
variables offered additional value to model 1 (with only those variables that are easily and 
directly obtainable by the physician). 
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Model 3
In the third model we added a cartilage degradation marker (CTX-II) to the model. 
To investigate which variables will identify the progressors of hip OA in a clinical situation, 
we repeated the same procedure for those subjects with existing hip pain at baseline. Pain 
was considered as a potential marker for symptomatic OA of the hip. 
The associations between the potential determinants and progression of the hip were 
estimated by calculating ORs, by means of Generalized Estimating Equations (GEE). This 
procedure takes into account the correlation between the left and right hip, using each 
patient as the observation unit and the hips as repeated measurements (25). A (two-sided) 
P-value of 0.05 was considered signiﬁcant. We also calculated Receiver Operating Curves 
(ROC) of the predicted probabilities of each model for progression of hip OA. Additionally, 
a clinically useful cut-off point for CTX-II was estimated by ROC analyses. The cut-off point 
with the best accuracy (i.e. the highest sum of sensitivity and speciﬁcity) was used for the 
development of a prediction rule.
All multivariate analyses were adjusted for follow-up time. 
We used SPSS version 11.0 (SPSS Inc., Chicago, USA) and SAS software, version 8.2 (SAS 
Institute, Cary, NC) for all analyses. 
Results
Table 1 presents baseline characteristics of the study population, and the univariate 
associations with progression of hip OA. In this study population (n = 1,920) with a mean 
age of 66.1 years, 13.1% had progression of ROA of the hip after a mean follow-up time of 
6.6 years. Of these progressors, 38.3% had an incident THR during the follow-up period. 
During the last month before the baseline interview, 12.7% of all subjects had lower limb 
disability, 9.5% had hip pain, and 29.8% had morning stiffness. In the univariate analyses the 
following potential determinants of progression of hip OA had a P-value < 0.1: age, gender, 
BMI ≥ 30 kg/m2, family history of OA, (low) age at menopause, presence of hip pain, lower 
limb disability, presence of morning stiffness, JSW at baseline, ROA of the hip, ROA of the 
hand and CTX-II; these determinants were therefore included in the multi-variate analyses.
Table 2 shows the associations between determinants and progression of hip ROA in the total 
study population for the three models used (see Methods section). In this population-based 
cohort of men and women aged 55 years and over, the ﬁrst model (which included easily 
obtainable variables) showed that age (per year), gender (female), a lower limb disability 
index of ≥ 0.5 and the presence of hip pain were independent determinants of progression 
of hip ROA. When radiographic variables were added to this model we found that especially 
a Kellgren & Lawrence score at baseline of ≥ grade 2 had a strong independent additional 
(P-value of < 0.0001) association with progression of hip OA, with an OR of 5.6. In model 3, 
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Table 1: Baseline characteristics of the study population and univariate associations with progression of hip osteoarthritis.
Study population  OR (95% CI)
Number 1,920
Gender, % women 51.3 2.0* (1.6–2.6)
Age, years ± SD 66.1  ± 6.8 1.1* (1.1–1.1)
Body Mass Index, 
≥ 30 kg/m2, %
12.6 1.6* (1.1–2.2)
Diabetes (type II), % 8.9 .9 (.6–1.3)
Hypertension, % 30.0 0.9 (.7–1.1)
Family history of OA, % 9.9 1.4* (1.0–2.0)
Age at menopause, (reference group > 50 years)
– ≤ 45 years
– 46–50 years
24.6
36.9
1.3* (0.9–1.9)
1.6* (1.1–2.2)
Heavy mechanical workload, % 13.0 .8 (.5–1.1)
Presence of hip pain, % 9.5 3.4* (2.5–4.6)
Lower limb disability, % 12.7 3.2* (2.5–4.3)
Presence of morning stiﬀness, % 29.8 1.7* (1.3–2.2)
Joint space width at baseline ≤ 2.5 mm, % 7.5 7.2* (5.2–9.9)
ROA of the hip, % 12.6 8.9* (6.8–11.6)
ROA of the knee, % 16.6 1.0 (.6–1.4)
ROA of the hand, % 23.3 2.0* (1.5–2.6)
CTX-II, 4th quartile, % – 4.0* (2.4–6.7)
† Progression of the hip was deﬁned as a joint space narrowing ≥ 1.0 mm or an incident total hip replacement at follow-up.
* P-value of < 0.1
Table 2: Association between determinants and progression of hip osteoarthritis of complete study population in three models 
(n = 1,920).
Model 1
(clinical variables)
Model 2
(including radiological variables)
Model 3
(including CTX-II) 
Age
(years)
1.07
(1.05–1.08)
1.06
(1.04–1.08)
1.03
(1.00–1.06)
Gender 1.7
(1.3–2.2)
1.8
(1.3–2.3)
1.6
(1.0–2.5)
Disability
(index score ≥ 0.5)
1.7
(1.2–2.4)
- -
Hip pain
(presence of)
2.7
(1.9–3.8)
2.2
(1.5–3.2)
2.0
(1.1–3.6)
Baseline JSW
(≤ 2.5 mm)
* 1.9
(1.2–2.9)
2.1
(1.1–3.8)
Baseline K & L
(≥ grade 2)
* 5.6
(3.9–8.1)
5.6
(3.3–9.5)
CTX-II
(4th quartile)
* * 2.2
(1.2–4.1)
Explained variance
(R2 Nagelkerke)
.104 .220 †
Associations are presented by odds ratios (OR) with 95% conﬁdence interval between parentheses.
Those determinants were included in a model with a P-value < 0.05.
All odds ratios were adjusted for follow-up time.
Progression of the hip was deﬁned as a joint space narrowing ≥ 1.0 mm or an incident total hip replacement at follow-up.
* not tested in this model.
† CTX-II only available in a subset of this population (n = 754).
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in a subset of the population (n = 754), we added the information of CTX-II level to model 
2 and found that a CTX-II level in the upper quartile also had an independent additional 
(P-value of 0.001) association with progression of hip ROA, with an OR of 2.2. In the ﬁnal 
model, we found that a Kellgren & Lawrence score at baseline of ≥ grade 2 and CTX-II both 
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Area Under the Curve
Model 1 0.703
Model 2 0.895
Model 3 0.926
Figure 1: Receiver operating curves of the predicted probabilities of the three models with progression of hip osteoarthritis for 
participants with hip pain (N = 195).
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Figure 2: Percentage progressors of hip OA by Kellgren & Lawrence grade at baseline.
Progressors are those subjects with a joint space narrowing ≥ 1.0 mm or the presence of an incident total hip replacement at follow-up.
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had an independent association with progression of hip ROA. Furthermore, the lower limb 
disability index disappeared in the ﬁnal model.
We repeated the same procedure for those subjects with prevalent hip pain at baseline (n 
= 411). In this subset of the study population, using by ROC analyses we calculated the 
best accuracy cut-off point for CTX-II to be ≥ 235.5 mmol/l. We found an impressively 
stronger association of a baseline Kellgren & Lawrence score ≥ grade 2 with progression of 
hip ROA in those with initial hip pain with an OR of 35.6 (additional to model 1, P-value 
< 0.0001 and also a higher area under the curve, Figure 1: 0.895 versus 0.703) (Table 3). 
CTX-II also showed an independent additional (P-value of < 0.0001 and also a higher area 
under the curve, Figure 1: 0.926 versus 0.895) association with progression of hip ROA in 
subjects with initial hip pain. Surprisingly age disappeared in the ﬁnal model. In addition we 
repeated all analyses in a subset (n = 525) for whom data on limited range of motion were 
available. In this subset, we found that a restricted ﬂexion of the hip of more than 20% had 
an independent association in the ﬁnal model (OR of 3.1; 95% CI 2.1–4.7) with progression 
of hip OA. However, the strong additional value of radiographic ﬁndings still holds.
Figure 2 shows the percentage progressors and incident THR of the total population and 
of those with probably symptomatic hip OA, stratiﬁed by Kellgren & Lawrence grade at 
baseline. All subjects with a Kellgren & Lawrence grade 4 at baseline had an incident THR at 
follow-up. Of the subjects with hip pain and a Kellgren & Lawrence grade 2 at baseline, 73% 
developed progression during follow-up, compared to 36% in the total study population. 
Table 3: Association between determinants and progression of hip osteoarthritis for participants with hip pain (n = 411) in three 
models.
Model 1
(clinical variables)
Model 2
(inclusive radiological variables)
Model 3
(inclusive CTX-II) 
Age
(years)
1.08 
(1.03–1.13)
– –
Disability
(index score ≥ 0.5)
2.5
(1.4–4.4)
– 4.8
(1.2–19.1)
Baseline K & L 
(≥ grade 2)
* 31.7
(10.2–98.3)
35.6
(11.1–114.2)
CTX-II
(≥ 235.5 mmol/l)
* * 3.9 
(1.3–11.8)
Explained variance 
(R2 Nagelkerke)
.123 .504 †
Associations are presented by odds ratios (OR) with 95% conﬁdence interval between parentheses.
Those determinants were included in a model with a P-value < 0.05.
All odds ratios were adjusted for follow-up time and duration of hip pain (longer than 1 year).
Progression of hip osteoarthritis was deﬁned as a joint space narrowing ≥ 1.0 mm and the presence of hip pain at follow-up or an incident total 
hip replacement at follow-up.
* not tested in this model.
† CTX-II only available in a subset of this population (n = 195).
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Discussion
In this large population-based prospective cohort study with a long-term follow-up we 
found that the presence of a Kellgren & Lawrence score of ≥ grade 2 at baseline was the 
strongest identiﬁer of those persons at high risk for progression of hip OA. This holds 
particularly for in patients with a prevalent hip pain at baseline. In addition, a lower limb 
disability index of ≥ 0.5 and a CTX-II concentration ≥ 235.5 mmol/l were also independent 
identiﬁers of these high-risk persons. 
In the present study we deﬁned progression of hip OA as the presence of a JSN of ≥ 1.0 mm 
or an incident THR. The choice of how to deﬁne progression is arbitrary because there is no 
consensus about the deﬁnition of progression of hip OA. Because JSN is more sensitive to 
change compared to the Kellgren & Lawrence index (7, 9), we used the above-mentioned 
deﬁnition. We also used an incident THR as a deﬁnition of progression of hip OA, based 
on the assumption that THR is performed in patients whit severe symptomatic OA together 
with structural damage of the hip. Although a hip fracture is also a reason for THR and may 
have ﬂawed our results, when we excluded subjects with an incident fracture (n = 16) from 
the analyses we found similar associations between the risk factors and progression of hip 
OA. 
In the total study population the independent identiﬁers of the high-risk group for 
progression of hip OA were age, female gender, the presence of hip pain, JSW at baseline 
≤ 2.5 mm, Kellgren & Lawrence score of ≥ grade 2 at baseline, and a high CTX-II level. Of 
these factors only age and gender are relatively independent factors of the disease, whereas 
the other predictive factors are signs of the presence or severity of OA. These ﬁndings are 
in agreement with those reported by Lievense et al. in a systematic review (10). In subjects 
who consulted a general practitioner for hip pain, Birrell et al. showed that a simple scoring 
system based on both radiographic severity and clinical measures could clearly identify 
groups at high likelihood of being put on a waiting list for THR (26). Based on the results 
of the present study and of the two above-mentioned studies, it is clear that progression of 
hip OA has the strongest associations with signs of the presence or severity of OA, in other 
words with the disease status of the subject. The absence of an association between BMI 
and progression of hip OA in the present study was also reported by Lievense et al (10). 
It is striking that all other potential determinants of progression that are independent of 
the disease, were excluded when signs of the presence or severity of hip OA were added 
to the model. We expected that especially local biomechanical factors (such as mechanical 
workload and sport activity) would have independent associations with progression of hip 
OA. A possible explanation for the lack of association in the present study may that we used 
information about historical workload and not of the workload during the follow-up period. 
Therefore, we may have missed information about important determinants of progression 
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of hip OA in our study, such as mechanical load during follow-up of an already existing 
osteoarthritic joint. 
A possible limitation of the present study is the presence of health-based selection bias; 
overall, participants were generally healthier than non-participants. Therefore, it is likely 
that the generalizability of the reported ﬁndings holds particularly for those subjects who 
are mobile enough to visit a physician. Furthermore, the reported model should ideally be 
tested in another population. 
Based on the results of the present study, we conclude that a Kellgren & Lawrence score of 
≥ grade 2 at baseline is the strongest predictor of progression of hip OA, especially in those 
with prevalent hip pain at baseline. CTX-II seems to be a moderate predictor of progression 
of hip OA compared to the variables collected by history taking, physical examination and 
an X-ray. Overall we conclude that in a clinical situation and for clinical trials an X-ray has 
strong additional value to identify persons who are at high risk for progression of hip OA. 
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Abstract
Objective: To investigate the association between acetabular dysplasia and the incidence 
of radiographic osteoarthritis (ROA) of the hip, in a population-based sample of elderly 
subjects.
Methods: In 835 men and women (aged 55 years and older) from the Rotterdam Study X-rays 
of the hip at baseline and at follow-up (mean follow-up time of 6.6 years) were evaluated. 
Included were subjects with a baseline Kellgren & Lawrence score of grade 0 or 1 in both 
hips. Incident hip ROA was deﬁned as a decrease of joint space width of the hip (≥ 1.0 mm) 
at follow-up. Acetabular dysplasia was assessed using the center-edge angle as deﬁned by 
Wiberg, and the acetabular depth as deﬁned by Murray. The association between acetabular 
dysplasia and incident hip ROA was assessed by calculating odds ratios using multivariate 
regression analysis. 
Results: This study population with a mean age of 65.7 (± 6.6) years, 9.3% developed an 
incident hip ROA. Subjects with acetabular dysplasia had a 4.3 times increased risk for 
incident hip ROA (95% CI; 2.2–8.7) compared to subjects without acetabular dysplasia. These 
associations were independent of known determinants of hip OA such as age, gender, and 
BMI, but tended to be enhanced by female gender, heavy mechanical workload, and low 
body mass index. 
Conclusion: In a study population aged 55 years and over, acetabular dysplasia is still a 
strong independent determinant of incident hip ROA.
Submitted
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Introduction
Hip osteoarthritis (OA) is one of the main causes of disability among the elderly and the 
prevalence will increase with the aging of the Western society (1, 2).
OA is a multifactorial disease involving ﬁrst of all systemic factors such as metabolism, 
hormones, genetics, age and gender and, secondly, local biomechanical factors such as 
mechanical workload, body mass index (BMI) and acetabular dysplasia. Dieppe introduced 
the model that showed that the joint becomes susceptible for OA by systemic factors and 
that local biomechanical factors play the ﬁnal role in determining site and severity of OA 
(1, 3). Marked acetabular dysplasia is a well-known cause of premature hip OA (4, 5), 
whereas the inﬂuence of a mild acetabular dysplasia on the development of hip OA is less 
clear. It has been proposed that in some patients with primary hip OA, the disease occurs 
as a consequence of a mild acetabular dysplasia that persists into adult life. Support for this 
theory comes from radiological observations in patients with OA of the hip (6), and from 
follow-up studies of subjects with dysplastic hips (7). A recent review (8) of the available 
literature on the inﬂuence of hip dysplasia on the development of hip OA, revealed that 
only one study investigated the inﬂuence of this parameter in a prospective cohort design 
with a long follow-up period (9). The authors showed that acetabular dysplasia is associated 
with a modestly increased risk of incident hip OA in elderly white women. Whether the 
inﬂuence of acetabular dysplasia on the development of hip OA is modiﬁed by other known 
determinants (such as gender, BMI or mechanical load) is not yet known. 
Therefore, the present study investigated the association between radiographic evidence 
of acetabular dysplasia in participants without radiological OA of the hip at baseline and 
an incident hip OA, in a large population of men and women aged 55 years and over with 
a long-term follow-up. We also investigated whether the association between acetabular 
dysplasia and incident hip OA could be modiﬁed by other determinants of hip OA.
Subjects and Methods
The study population consisted of participants of the Rotterdam Study, a prospective cohort 
of men and women aged 55 years and over. The Rotterdam Study investigates the incidence 
of, and risk factors for, chronic disabling diseases; the rationale and study design have been 
described previously (10). Written informed consent was obtained from each participant. 
The Medical Ethics Committee of the Erasmus Medical Center has approved the Rotterdam 
Study.
The present study used a selected sample of 875 subjects from the Rotterdam study, based 
on the availability of radiographs of the hip both at baseline and at follow-up. Only those 
participants with a Kellgren & Lawrence score at baseline of grade 0 or 1 in both hips were 
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included. Forty participants were excluded because of a hip fracture during the follow-up 
period, resulting in a ﬁnal study population of 835 subjects. 
Baseline measurements were conducted between April 1990 and July 1993 and the follow-
up measurements between 1996 and 1999, with a mean follow-up time of 6.6 years.
Radiographic assessment 
Weight bearing anteroposterior radiographs of the hip were obtained at 70 KV, a focus of 
1.8, and a focus to ﬁlm distance of 120 cm, applying a Fuji High Resolution G 35 × 43 cm 
ﬁlm. Radiographs of the pelvis were obtained with both feet in 10° internal rotation and 
the X-ray beam centered on the umbilicus. One independent trained reader (MR) evaluated 
the radiographs of the hip made at baseline and at follow-up, unaware of the clinical 
status of the patients. All radiographs of the hip were grouped per patient and read by 
pairs in chronological order, the order being known to the reader (chronologically ordered 
reading procedure) (11). At baseline, radiographic OA (ROA) of the hip was quantiﬁed 
by measurements of the Kellgren & Lawrence grading system (12, 13) (atlas-based) in ﬁve 
grades (from zero to four). A person was considered to have ROA of the hip if the Kellgren 
& Lawrence score of one or both joints was equal to or larger than two. Those persons with 
ROA of the hip at baseline were excluded from this study.
Outcome measure
In the present study two deﬁnitions of an incident hip ROA were used: ﬁrstly, deﬁned by a 
joint space narrowing JSN) ≥ 1.0 mm, and secondly deﬁned as a Kellgren & Lawrence score 
of ≥ grade 2 at follow-up.
The minimal joint space width (JSW) of the hip at baseline and follow-up was measured 
using a 0.5 millimetres graduated magnifying glass laid directly over the radiograph (14). The 
lateral, superior and axial compartments of the hip were measured as described previously 
by Croft et al. (14). JSN was deﬁned as the JSW at baseline minus the JSW at follow-up, and 
a JSN of minimally 1 (out of 3) compartment was deﬁned as a radiological osteoarthritic 
change. 
Acetabular dysplasia
Acetabular dysplasia was assessed using the center-edge (CE) angle as deﬁned by Wiberg 
(15), and the acetabular depth as deﬁned by Murray (16). A period of a few months elapsed 
between the evaluation of the radiographs of the hip and the assessment of the acetabular 
dysplasia. The trained reader assessed the CE angle and the acetabular depth unaware of 
the outcome status of the subjects. The CE angle was deﬁned as the angle formed by a line 
from the center of the femoral head to the lateral margin of the acetabular roof, and a line 
perpendicular to that joining the centers of the two femoral heads (Figure 1). The centers 
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of the femoral heads were located with the aid of a transparent plastic sheet marked with 
concentric circles. The CE angles were measured using a transparent plastic protractor.
Acetabular depth was deﬁned as the greatest perpendicular distance from the acetabular 
roof to a line joining the lateral margin of the acetabular roof and the upper corner of the 
symphysis pubis on the same side (Figure 1).
Two independent readers (MR and SMAB) tested the inter-rater reliability of the measurements 
of the CE angle and the acetabular depth in a random subset of 105 radiographs. The inter-
rater reliability for Kellgren & Lawrence (Kappa statistics of 0.68) and for the JSW (Intraclass 
Correlation Coefﬁcient, ICC of 0.85) has been tested and reported earlier (17). For the CE 
angle the ICC was 0.90 and for the acetabular depth the ICC was 0.89.
Clinical measures 
At baseline, trained interviewers conducted an extensive home interview addressing 
demographic characteristics, medical history, risk factors for chronic diseases and medication 
use. The presence of hip pain (“Did you have joint pain of your right/left hip during the 
last month”) was asked. The current or last occupation was asked including the duration 
in years of this occupation. The jobs were coded according to a job title scheme, used at 
Statistics Netherlands (18). A subject was considered to be exposed to heavy mechanical 
workload if that person performed heavy physically demanding work indoors or outdoors 
and the exposure time of this job was longer than 8 years (3rd and 4th quartile of exposure 
time).
At the research center, a clinical examination was performed. Amongst other measurements, 
height and weight were measured with participants wearing indoor clothing without shoes. 
BMI was calculated as weight in kilograms divided by height in squared meters (kg/m2).  
Statistical analysis
Differences in baseline characteristics were evaluated by analysis of variance (ANOVA) for 
continuous variables and by a Chi-square test for categorical variables. 
�
�
Figure 1: Diagram showing the center edge angle and acetabular depth measurements.
A = center edge angle; B = acetabular depth.
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Associations between baseline measurements of acetabular dysplasia and the two deﬁnitions 
of incident hip ROA were assessed using logistic regression analysis to calculate odds ratios 
(ORs), by means of Generalized Estimating Equations (GEE). This procedure takes into 
account the correlation between the left and right hip, while using each joint (left or right) 
as the observation unit (19).
To assess the association between acetabular dysplasia and incident hip ROA, we calculated 
crude ORs as well as ORs adjusted for age, gender, BMI and follow-up time. To investigate 
whether the associations between baseline measurements of acetabular dysplasia and an 
incident hip ROA were modiﬁed by gender or by mechanical load, we stratiﬁed these 
associations for gender, heavy workload and BMI (≥ 27 kg/m2) at baseline. In addition, we 
stratiﬁed for the presence or absence of hip pain in order to investigate whether acetabular 
dysplasia is associated with incident hip ROA for subjects with hip pain. To establish the 
above-mentioned stratiﬁcations differed signiﬁcantly, formal testing was applied using the 
formula: Z = β1 – β2 / √ (SE β1)2 + (SE β2)2; where β1 and β2 stand for the Beta value of 
strata 1 and 2, and SE β1 and SE β2 for the standard error of Beta 1 and 2.
A (two-sided) P-value of 0.05 was considered signiﬁcant in all analyses. We estimated 
the magnitude of confounding by the degree of discrepancy between the unadjusted and 
adjusted estimate (the change-in-estimate criterion) (20). A cut-off point of 10% was chosen 
to designate an important change in the estimate. SPSS version 11.0 (SPSS Inc., Chicago, 
USA) and SAS software, version 8.2 (SAS Institute, Cary, NC) were used for all analyses. 
Results
Table 1 presents the baseline characteristics of the total study population stratiﬁed for the 
absence or presence of a JSN ≥ 1.0 mm. In this study population (with a mean age of 65.6 
years), 9.3% developed JSN during the follow-up period. Subjects with JSN were 2.9 years 
older and more often female (68.9% versus 55.9%) compared to those without JSN. The 
mean CE angle in this population was 35.1° (± SD 5.6°) and the mean acetabular depth was 
12.2 (± SD 2.8) mm.
Table 2 shows the association between baseline acetabular dysplasia and an incident hip 
ROA, as deﬁned by a JSN ≥ 1.0 mm. The crude data showed a strong association between 
all acetabular dysplasia measurements and JSN of the hip. After adjustment for age, gender, 
BMI and follow-up time the risk estimates did not change substantially.
During the follow-up period, 16.9% developed an incident ROA of the hip as deﬁned by 
Kellgren & Lawrence. For the association between baseline acetabular dysplasia and an 
incident ROA of the hip, as deﬁned by Kellgren & Lawrence, we found lower but signiﬁcant 
ORs (Table 3). After adjustment for age, gender, BMI and follow-up time these risk estimates 
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did not change substantially. This also applies for any deﬁnition of acetabular dysplasia as 
used in the present study. 
The strong associations between acetabular dysplasia and incident hip ROA in the present 
study could be ﬂawed by the pre-existence of a Kellgren & Lawrence grade 1 at baseline. 
Therefore we repeated the analyses separately for subjects with a baseline Kellgren & 
Lawrence score of 0 and for those with a baseline score of 1. Surprisingly, we found 
stronger associations for those with a Kellgren & Lawrence grade 0 at baseline compared to 
those with a Kellgren & Lawrence grade 1: 2.9 (95% CI; 1.4–6.0) and 1.5 (95% CI; .9–2.5), 
respectively. For an incident hip ROA deﬁned by JSN, we found similar associations for both 
these Kellgren & Lawrence grades.
Table 1: Baseline characteristics of the study population, stratiﬁed by the absence or presence of an incident hip osteoarthritis 
(OA) (joint space narrowing ≥ 1.0 mm) at follow-up.
Total
n = 835
Absence of incident hip OA
n = 757
Presence of incident hip OA
n = 78
Age, years ± SD 65.6 ± 6.5 65.3 ± 6.5 *** 68.2 ± 6.6
Gender, % women 57.2 55.9 ** 68.9
BMI, kg/m2 ± SD 26.5 ±3.5 26.4 ± 3.4 26.6 ± 4.0
Heavy mechanical workload, % 12.2 12.5 9.9
CE angle
<30°, %
<25°, %
19.2
4.8
17.9
3.8
31.0
12.6
Acetabular depth 
< 9 mm, %
12.0 10.7 23.0
Signiﬁcant diﬀerences between persons with and without incident hip OA (joint space narrowing ≥ 1.0 mm) at follow-up. 
*P < 0.05, ** P < 0.001, *** P < 0.0001
Table 2: Association between acetabular dysplasia and a joint space narrowing ≥ 1.0 mm of the hip. 
Crude OR Adjusted OR
CE angle < 30° 2.4 (1.6–3.5) 2.8 (1.9–4.2)
CE angle < 25° 4.1 (2.1–7.9) 4.3 (2.2–8.7)
Acetabular depth < 9 mm 2.8 (1.8–4.4) 2.8 (1.8–4.5)
Associations are presented by odds ratios (OR) with 95% conﬁdence interval between parentheses.
Odds ratios were adjusted for age, gender, BMI and follow-up time.
Joint space narrowing ≥ 1.0 mm was used as deﬁnition of an incident hip osteoarthritis. 
Table 3: Association between acetabular dysplasia and incident hip (by Kellgren & Lawrence ≥ grade 2 at follow-up) osteoar-
thritis. 
Crude OR Adjusted OR
CE angle < 30° 1.6 (1.1–2.4) 1.7 (1.2–2.5)
CE angle < 25° 2.3 (1.2–4.5) 2.4 (1.2–4.7)
Acetabular depth < 9 mm 2.3 (1.5–3.5) 2.3 (1.5–3.5)
Associations are presented by odds ratios (OR) with 95% conﬁdence interval between parentheses.
Odds ratios were adjusted for age, gender, BMI and follow-up time.
Incident hip osteoarthritis is deﬁned by baseline Kellgren & Lawrence ≤ grade 1, and follow-up Kellgren & Lawrence ≥ grade 2.
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Table 4 shows the association between baseline acetabular dysplasia and JSN stratiﬁed 
by gender, heavy workload, BMI and the presence of hip pain. Women had a stronger 
association between acetabular dysplasia (as deﬁned by CE angle) and JSN compared to 
men. Those who had performed heavy physically demanding work had stronger associations 
between acetabular dysplasia and JSN, compared to those who had performed low physically 
demanding work. Surprisingly, we found that persons with a low BMI (< 27 kg/m2) at 
baseline had stronger associations between acetabular dysplasia and JSN, compared to those 
with a high BMI (≥ 27 kg/m2) at baseline. Persons with a prevalent hip pain at baseline had 
stronger associations between acetabular dysplasia and JSN, compared to those without a 
prevalent hip pain. The differences in associations did not reach signiﬁcance, except for the 
stratiﬁcation for overweight and non-overweight subjects with acetabular depth < 9 mm, 
and the stratiﬁcation for the absence and presence of hip pain with a CE angle < 30°. Of all 
the subjects with hip pain at baseline, 8.7% developed an incident hip OA during follow-
up period. If these subjects had also a CE angle < 30° or an acetabular depth < 9 mm this 
percentage increased to respectively 40.9% and 47.4%.
Table 4: Association between acetabular dysplasia and joint space narrowing stratiﬁed by gender, heavy mechanical workload, 
BMI, or the presence of hip pain. 
CE angle Acetabular depth
< 9 mm< 25° < 30°
Overall 4.5 (2.4–8.7) 2.6 (1.8–3.9) 2.6 (1.7–4.1)
Gender
– Women
– men
5.9 (2.6–13.5)
2.6 (.8–8.6)
2.8 (1.8–4.4)
2.2 (1.1–4.6)
3.2 (1.9–5.4)
1.8 (.7–4.5)
Workload
– low
– heavy
4.0 (1.9–8.4)
8.0 (1.5–42.4)
2.6 (1.8–3.9)
2.4 (.6–9.9)
2.7 (1.7–4.3)
2.0 (.4–11.2)
BMI
– < 27 kg/m2
– ≥ 27 kg/m2
6.2 (2.8–13.9)
2.5 (.8–8.2)
3.4 (2.1–5.4)
1.8 (.9–3.4)
3.9 (2.2–6.9)*
1.6 (.7–3.3)
Hip pain
– absent
– present
4.1 (2.1–7.8)
†
2.3 (1.5–3.5)*
7.0 (2.0–24.6)
2.2 (1.3–3.7)
5.2 (1.6–16.9)
Associations are presented by odds ratios (OR) with 95% conﬁdence interval between parentheses.
Odds ratios were adjusted for age, gender, BMI and follow-up time.
Joint space narrowing ≥ 1.0 mm was used as deﬁnition of an incident hip osteoarthritis (ﬁrst deﬁnition of incident hip OA).
† The associations between a CE angle < 25° and the occurrence of radiological osteoarthritic changes of the hip stratiﬁed for the presence of hip 
pain, was not estimable because of empty cells (100% of the subjects with hip pain and a CE angle of < 25° developed radiological osteoarthritic 
changes of the hip during follow-up period).
* Signiﬁcant diﬀerence with a P-value < 0.05.
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Discussion
In our study population of men and women aged 55 years and over, with no signs of ROA 
of the hip at baseline, we found that acetabular dysplasia, even in this elderly population, is 
a strong independent determinant of incident hip ROA. The association between acetabular 
dysplasia and incident hip ROA tends to be enhanced by female gender and mechanical 
workload.
In our study, the association in women was similar to that reported by Lane et al. (9) who 
investigated the association between acetabular dysplasia and incident hip ROA in women 
in a setting similar to ours. In the present study the prevalence of acetabular dysplasia 
was similar for men and women, but women more often developed JSN during follow-
up compared to men (12.8% versus 6.8%, respectively). The reason why the association 
between acetabular dysplasia and incident hip ROA seems to be modiﬁed by gender is 
unclear. Different alignment of the lower extremity in women (21) and consequently another 
mechanical loading of the hip joint might be an explanation. To investigate whether high 
mechanical load of the joint is a modiﬁer of the association between acetabular dysplasia and 
incident hip ROA we stratiﬁed for heavy workload, and found an indication for a stronger 
association for persons who had performed heavy physically demanding work compared 
to those who had performed low physically demanding work. A possible mechanism to 
explain the association between acetabular dysplasia and hip OA is that the presence of a 
subtle biomechanical abnormality, secondary to either joint incongruity (smaller acetabular 
depth) or decreased joint surface area (smaller CE angle), may increase joint stresses in the 
superolateral acetabular rim (22, 23). Hence, it seems plausible that a high mechanical load 
can modify this association. In an earlier study we found that heavy workload itself had no 
independent association with progression of hip OA as deﬁned by JSN or an incident total 
hip replacement. However, the results of the present study suggest that high mechanical load 
might be associated with incident hip ROA, but only in subjects with acetabular dysplasia. 
We also investigated whether BMI is a modiﬁer of the association between mild acetabular 
dysplasia and hip OA and surprisingly, found no stronger associations for persons with 
a low BMI (< 27 kg/m2) at baseline compared to those with a high BMI (≥ 27 kg/m2) at 
baseline. A lower activity level in those with a high BMI might explain the lack of association 
between acetabular dysplasia and incident hip ROA in persons with a high BMI. We did 
indeed ﬁnd that persons with a high BMI (≥ 27 kg/m2) were more often disabled at the 
lower limb versus those with a low BMI (15.6% versus 7.6%). In addition, BMI as such may 
not represent a high mechanical overload for the hip joints. Finally, we investigated whether 
acetabular dysplasia is associated with incident hip ROA for those with hip pain. The results 
suggest that for a person with hip pain at baseline but without the radiological evidence of 
hip OA, the presence of mild acetabular dysplasia is associated with an incident hip ROA 
during the follow-up period, even more than in subjects without hip pain.
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Because a prevalent radiological hip ROA may alter hip geometry, such that the true 
prevalence of acetabular dysplasia cannot be assessed, it will always be difﬁcult to 
investigate the association between mild acetabular dysplasia and prevalent hip ROA or the 
progression of ROA. In the present study we included only those subjects with a baseline 
Kellgren & Lawrence score of grade 0 or 1 in both hips. Nevertheless, associations between 
acetabular dysplasia and hip ROA have been suggested to be ﬂawed by the prior existence 
of radiographic osteoarthritic signs at baseline, such as osteophytes at the lateral acetabular 
margin and medial migration of the femoral head (24). However, the results of the present 
study suggest that the reported strong association between acetabular dysplasia and incident 
hip ROA is even slightly stronger in those subjects without radiographic osteoarthritic signs 
of (grade 0) hip ROA at baseline. 
Because there is no consensus on how to deﬁne incident hip ROA, in the present study we 
used two deﬁnitions, namely the presence of a JSN ≥ 1.0 mm and, secondly, the presence of 
a Kellgren & Lawrence ≥ grade 2 at follow-up. Strikingly, the overlap between the incident 
cases deﬁned by both deﬁnitions was low. Of the incident cases deﬁned by Kellgren & 
Lawrence, only 37.7% was deﬁned by a JSN. The problems of using “incident cases” in 
a longitudinal approach were very clear described by Lohmander and Felson (25). “The 
distinction between incident cases of OA and progression of prevalent cases depends on 
where along the continuum patients are considered to have overt OA”. In the present study 
we found that independent of which deﬁnition was used for incident hip ROA, the strong 
associations with acetabular dysplasia holds. The fact that these strong associations were 
independent of the deﬁnition used and even stronger for those with a Kellgren & Lawrence 
grade 0 at baseline makes the results of the present study even more convincing.
Furthermore, the associations between acetabular dysplasia and incident ROA of the hip may 
even be underestimated because of the relatively high mean age of the study population 
(65.7 ± 6.6 years). In other words, we assume that in a younger population the association 
between acetabular dysplasia and OA may be even higher. 
Based on the results of the present study, we conclude that acetabular dysplasia is strongly 
associated with an incident hip ROA even in a population of men and women aged 55 
years and over, and that these associations are independent of known risk factors for ROA 
of the hip. Furthermore, these associations might be enhanced by female gender, heavy 
mechanical workload and low BMI.
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Is there an association between 
the use of diﬀ erent types 
of NSAIDs and radiologic 
progression of osteoarthritis? 
The Rotterdam Study.
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Abstract
Objective: To investigate the inﬂuence of the use of various types of NSAIDs on progression 
of OA of the hip and knee. 
Methods: In 1,695 (for the hip) and 635 (for the knee) men and women aged 55 years 
and older from the Rotterdam Study (a population-based cohort study), X-rays of the hip 
and knee at baseline and follow-up (mean follow-up time of 6.6 years) were evaluated. 
Radiologic progression (ROA) was deﬁned as a decrease of joint space width (hip ≥ 1.0 mm, 
knee ≥ 1.5 mm) or incident joint replacement at follow-up. NSAIDs were divided in those 
(indomethacin, naproxen and ibuprofen) which are supposed to have a deleterious effect on 
joint cartilage, and in a second group of NSAIDs (such as diclofenac and piroxicam) which 
are supposed to have a neutral effect on cartilage metabolism. The associations between the 
different types of NSAIDs and progression of ROA were assessed using multivariate logistic 
regression analysis. 
Results: Those subjects who used NSAIDs supposed to have a neutral effect on cartilage 
metabolism (> 31 days) surprisingly had a 1.7-increased risk (95% CI, 1.0–2.9) for hip ROA, 
compared to the short-term user (1–30 days). This increased risk was mainly due to the 
long-term use (> 180 days) of diclofenac. No clear associations were found between the 
different types of NSAID and progression of knee ROA.
Conclusion: These data suggest that diclofenac may induce accelerated progression of hip 
OA. Whether this occurs due to a real deleterious effect on cartilage or due to excessive 
mechanical loading on an analgesic hip remains to be investigated.
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Introduction
Osteoarthritis (OA) is a common age-related locomotor disease characterized by degradation 
of articular cartilage. OA of the hip and knee can be especially disabling because of the 
related pain and functional impairment, which results from the involvement of a large 
weight-bearing joint (1). Non-steroidal anti-inﬂammatory drugs (NSAIDs) have been widely 
used as a pharmacologic treatment to relieve pain in patients with OA (1–3). However, 
these agents are associated with major and minor side effects, particularly in the elderly 
population (1). Also, the rate of progression of OA might be negatively inﬂuenced by 
NSAIDs (4). Several in-vitro studies of human cartilage (5–7) and also animal studies (8–11) 
suggest that some types of NSAIDs inhibit the synthesis of articular cartilage metabolism. 
Based on the results of these studies, NSAIDs have been divided in those (indomethacin, 
naproxen and ibuprofen) which are supposed to have a deleterious effect on joint cartilage 
by inhibition of glucosaminoglycans (GAG) synthesis, and in a second group of NSAIDs 
(such as diclofenac and piroxicam) which are supposed to have a neutral effect on cartilage 
metabolism (12).
There are also clinical reports of an increased rate of progression of OA in patients receiving 
NSAIDs (13–15). One study concerned patients who used indomethacin and reached earlier 
the end point of OA (total hip replacement), but only in a selected group of patients with end 
stage OA awaiting surgery (14). The study of Huskisson et al. (13), a long-term prospective 
study, demonstrated in 812 patients with knee OA that those who used indomethacin 
had an increased rate of joint space narrowing compared to those who used tiaprofenic 
acid. However, a third patient-based study reported that naproxen had no toxic effect on 
osteoarthritic cartilage; this study, however, included only a small number of patients (15). 
Therefore, the two above-mentioned groups of NSAIDs have not been evaluated for a 
possible deleterious effect in a large population. 
We investigated in the present study the associations between the two above-mentioned 
groups of NSAIDs and progression of OA of the hip and knee in a large open population 
of men and women aged 55 years and over. Additionally, we investigated the associations 
between the individual types of NSAIDs and progression of OA.
Subjects and Methods
The study population consisted of participants of the Rotterdam Study, a prospective cohort 
of men and women aged 55 years and over. The objective of the Rotterdam Study is to 
investigate the incidence of, and risk factors for, chronic disabling diseases. The rationale 
and study design have been described previously (16). The focus is on neurogeriatric, 
cardiovascular, ophthalmologic and locomotor diseases. All 10,275 inhabitants of Ommoord 
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(a district in Rotterdam, the Netherlands) were invited to participate. The response rate 
was 78%, resulting in 7,983 subjects participating in the study. Written informed consent 
was obtained from each participant. The Medical Ethics Committee of the Erasmus Medical 
Center has approved the Rotterdam Study.
For the present study a sample of 3,585 subjects of the Rotterdam study was used. The 
selection was based on the availability of the radiographs of the hip and knee at baseline and 
follow-up. Subjects with bilateral total hip replacement at baseline (n = 24) were excluded 
from analysis. At baseline there were no subjects with bilateral total knee replacement. The 
hypothesis that the rate of progression of OA is inﬂuenced by NSAIDs holds for osteoarthritic 
cartilage and not for normal cartilage (4). For the analyses of the hip we included those 
subjects with at least minimal osteoarthritic signs on the radiograph, deﬁned by a Kellgren 
& Lawrence score of the hip of grade 1 or higher (in at least one joint), resulting in a study 
population of 1,695 subjects. For the analyses of the knee we included 635 subjects, since 
fewer numbers of radiographs of the knee at baseline and at follow-up were available.
The baseline measurements were conducted between April 1990 and July 1993, and the 
follow-up measurements between 1996 and 1999, with a mean follow-up time of 6.6 years.
The fact that subjects had to be mobile enough to visit the research center at baseline 
and follow-up, and survived the follow-up time, caused a healthy cohort effect in our 
study population. Compared to the total Rotterdam study population, the present study 
population was younger, had a lower prevalence of lower limb disability at baseline and a 
lower prevalence of hip pain at baseline as reported earlier (17). 
Radiographic assessment 
Weight bearing anteroposterior radiographs of the hip and knee were obtained at 70 KV, 
a focus of 1.8, and a focus to ﬁlm distance of 120 cm, applying a Fuji High Resolution G 
35 × 43 cm ﬁlm. Radiographs of the pelvis were obtained with both feet in 10° internal 
rotation and the X-ray beam centred on the umbilicus, and of the knee with the patellae in 
central position. Two trained readers independently evaluated the radiographs of the hip 
and knee at baseline and follow-up, unaware of the clinical status of the participants. All 
radiographs were grouped by participant and read by pairs in chronological order, the order 
being known to the reader (chronologically ordered reading procedure) (18). At baseline, 
radiological OA (ROA) of the hip and knee was quantiﬁed by measurements following 
the Kellgren & Lawrence grading system (19, 20) (atlas-based) in ﬁve grades (from zero to 
four). 
We deﬁned progression of the hip as a joint space narrowing (JSN) of ≥ 1.0 mm of minimal 
1 (out of 3) compartment or an incident total hip replacement at follow-up (21). Progression 
of the knee was deﬁned as a JSN of ≥ 1.5 mm of minimal 1 (out of 2) compartment or an 
incident total knee replacement at follow-up (21). 
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At baseline and follow-up the minimal joint space width (JSW) of the hip and knee joints 
were measured using a 0.5 millimetres graduated magnifying glass directly laid over the 
radiograph (22). For the hip the lateral, superior and axial compartment was measured and 
for the knee the medial and lateral compartment, as described previously (22, 23). 
The inter-rater reliability for the Kellgren & Lawrence score of the hip was 0.68 (Kappa 
statistics), and for the minimal JSW 0.85 (Intraclass Correlation Coefﬁcient), as reported 
earlier (17). The radiographs of the knee were scored for ROA by two independent observers, 
as described previously (23, 24). After each set of 150 radiographs, the scores of the two 
readers were evaluated. Whenever the Kellgren & Lawrence score differed, the two readers 
met to read the radiographs together, and a consensus score was determined.
Use of NSAIDs
Data on medication prescription were derived from the pharmacies in Ommoord. These 
pharmacies were fully automated and registered all prescriptions on drug use from January 
1, 1991 through December 31, 1998. Prescriptions included the product name of the drug, 
the generic name, the Anatomical Therapeutic Chemical (ATC) code, the number of tablets, 
capsules or other vehicles in the ﬁlled prescription, the date of delivery of the product, the 
prescribed daily number of tablets to be taken, the daily drug dosage, and the duration 
of the prescription. Thus, for all NSAIDs prescriptions we had data on date of delivery of 
NSAIDs, duration and dosage of NSAID as well as type of NSAID. 
Potential confounders 
At baseline, trained interviewers performed an extensive home interview on demographic 
characteristics, medical history, risk factors for chronic diseases and medication use. Height 
and weight were measured with participants wearing indoor clothing without shoes. Body 
mass index (BMI) was calculated as weight in kilograms divided by height in squared meters 
(kg/m2). 
Statistical analysis
Differences in baseline characteristics were evaluated by analysis of variance (ANOVA) for 
continuous variables and Chi-square for categorical variables. The baseline characteristics 
were stratiﬁed for the presence or absence of progression of hip or knee ROA.
All prescribed NSAIDs were divided in two groups, those (indomethacin, naproxen and 
ibuprofen) that are supposed to have a deleterious effect on joint cartilage, and those 
NSAIDs (such as diclofenac and piroxicam) that are supposed to have a neutral effect on 
cartilage metabolism. 
The associations between NSAIDs and progression of hip and knee OA were investigated 
in a stepwise procedure. Firstly, we assessed the association between the two groups of 
NSAIDs, those that are supposed to have a deleterious effect on joint cartilage and those 
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that are supposed to have a neutral effect on cartilage metabolism, and progression of OA. 
Those subjects who used NSAIDs from both groups were excluded from analysis. The 
duration of NSAID use was categorized in two groups; the short-term user (1–30 days), and 
the long-term user (longer than 31 days). For these analyses we used the 1–30 days users as 
reference group. Additionally, we investigated the associations between the individual types 
of NSAIDs (namely ibuprofen, naproxen, diclofenac and piroxicam) and progression of the 
hip. The numbers of users of indomethacin were too small to allow a subgroup analysis.
The associations between the use of NSAIDs and progression of ROA of the hip or knee 
were assessed using logistic regression analysis to calculate odds ratios (OR) as estimation 
for relative progression risk. All associations were adjusted for age, gender, BMI, baseline 
ROA (Kellgren & Lawrence dichotomized ≥ grade 2), follow-up time, the deﬁned daily 
dosage (actual dosage/recommended dosage for an adult (WHO)), and the duration of use 
(continuous variable). A (two-sided) P-value of 0.05 was considered signiﬁcant. We estimated 
the magnitude of confounding by the degree of discrepancy between the unadjusted and 
adjusted estimate (the change-in-estimate-criterion) (25). We chose a cut-off point of 10% to 
designate an important change in the estimate. SPSS version 11.0 (SPSS Inc., Chicago, USA) 
was used for all analyses.
Results
The baseline characteristics stratiﬁed for baseline Kellgren & Lawrence ≥ grade 1 of the 
hip and knee and for the presence or absence of progression of hip and knee ROA are 
shown in Table 1. Of the subjects with a Kellgren & Lawrence index ≥ grade 1 at baseline, 
11.9% showed progression of ROA of the hip and 8.7% progression of ROA of the knee at 
follow-up. Of the hip progressors, 4.5% (n = 77) had an incident joint replacement during 
the follow-up period and of the knee progressors 1.4 % (n = 9). Those with progression of 
hip ROA were older and were more often women compared to those without progression. 
Furthermore, persons with progression of hip ROA more often had a Kellgren & Lawrence 
index grade ≥ 2 at baseline (53.7% versus 10.2%) compared to those without progression. 
The persons with progression of the knee had a higher BMI and slightly more often a 
Kellgren & Lawrence index grade ≥ 2 at baseline compared to those without progression 
(53.7% versus 48.8%).
Of the NSAIDs supposed to have a deleterious effect on joint cartilage by inhibition of GAG 
synthesis, naproxen was more often prescribed for short-term use (1–30 days) and ibuprofen 
more often for long-term use (> 180 days) (Table 2). The most frequently prescribed NSAID 
of the group supposed to have a neutral effect on cartilage metabolism was diclofenac. 
Similar to naproxen, diclofenac was also prescribed more often for short-term use and less 
Max Reijman BW.indd   107 10/5/2004   10:30:30 AM
108
Chapter 7
often for long-term use. The duration of NSAIDs use of the two groups was dichotomized, 
and short-term use (1–30 days) was used as reference group in the following analyses.
As reported in Table 3, for the hip we unexpectedly found a signiﬁcantly increased risk for 
progression in those subjects who used NSAIDs that were supposed to have a neutral effect 
on cartilage metabolism (group 2) for longer than 31 days with an adjusted OR of 1.7 (95% 
CI, 1.0–2.9), compared to the short-term user (1–30 days). The risk estimate for those who 
used NSAIDs supposed to have a deleterious effect on joint cartilage (group 1) for longer 
than 31 days was only 1.3 (OR) and failed to reach signiﬁcance. The highest percentage 
of persons with progression of the hip was found in the group that used NSAIDs with a 
neutral effect for longer than 180 days (of group 2) (Figure 1). In both groups we found a 
Table 1: Baseline characteristics of the study population, stratiﬁed by the presence or absence of hip or knee progression.
Study population Hip (K & L ≥ grade 1) Knee (K & L ≥ grade 1)
Non progressors Progressors Non progressors Progressors
Number 3,585 1,494 201 580 55
Age, years 
± SD
66.0 ± 6.9 65.6 ± 6.7** 69.0 ± 6.8 67.9 ± 6.8 68.2 ± 6.9
Gender, % women 58.2 50.7** 67.7 64.8 72.7
BMI, kg/m2 
± SD
26.3 ± 3.6 26.2 ± 3.3* 26.8 ± 4.5 27.1 ± 3.7* 28.5 ± 4.2
Kellgren & Lawrence 
≥ grade 2, %
10.2 53.7 48.8 53.7
Presence of pain at 
baseline, %
10.4 28.0 22.5 42.6
K & L = Kellgren & Lawrence index.
BMI = body mass index.
Progression of the hip was deﬁned as the presence of a joint space narrowing ≥ 1.0 mm or an incident total hip replacement at follow-up. 
Progression of the knee was deﬁned as the presence of a joint space narrowing ≥ 1.5 mm or an incident total knee replacement at follow-up.
Signiﬁcant diﬀerences between persons without progression of osteoarthritis (OA) and persons with progression of OA.
* P < 0.05, ** P < 0.001
Table 2: Numbers of patients using the diﬀerent types of (only data of frequently used) NSAIDs of the total study population (n = 
3,585), stratiﬁed by duration of use.
1–30 days 31–90 days 91–180 days > 180 days
Group 1
Ibuprofen
Naproxen
786 (56.1)
320 (37.7)
507 (65.6)
354 (25.3)
301 (35.5)
173 (22.3)
118 (8.4)
92 (10.8)
46 (6.0)
142 (10.2)
136 (16.0)
47 (6.1)
Group 2
Diclofenac
Piroxicam
833 (54.6)
833 (61.0)
117 (49.2)
386 (25.3)
321 (23.5)
75 (31.5)
129 (8.4)
94 (6.9)
14 (5.9)
179 (11.7)
118 (8.6)
32 (13.4)
Group 1: those NSAIDs (ibuprofen and naproxen) that are supposed to have a deleterious eﬀect on joint cartilage.
Group 2: those NSAIDs (such as diclofenac and piroxicam) that are supposed to have a neutral eﬀect on cartilage metabolism.
The relative (%) use of the diﬀerent types of NSAIDs is presented between parentheses. 
Max Reijman BW.indd   108 10/5/2004   10:30:30 AM
Is there an association between diﬀ erent types of NSAIDs and progression of osteoarthritis?
109
clear trend that the longer the duration of use, the higher the percentage of persons with 
progression of hip ROA (Figure 1). For the knee we found no signiﬁcant associations when 
we compared the long-term users with the short-term users of NSAIDs and progression of 
ROA.
To investigate whether individual types of NSAIDs could explain the signiﬁcant increased 
risk for progression of the hip, we also assessed the associations between the use of the 
individual types of NSAIDs and progression of ROA of the hip (Table 4). For these analyses 
we used the four most frequently prescribed types of NSAIDs within the study population, 
namely ibuprofen, naproxen, diclofenac and piroxicam. The duration of the different types 
of NSAIDs use was categorized in four groups, i.e. 1–30 days, 31–90 days, 91–180 days and 
longer than 180 days. The short-term use (1–30 days) was used as reference group in the 
following analyses (Table 4). We found a signiﬁcant crude association between long-term 
Table 3: Associations between use of NSAIDs and progression of hip and knee osteoarthritis. 
Hip
(n = 1,695)
Knee
(n = 635)
crude adjusted* crude adjusted*
Group 1 1.6
(1.0–2.4)
1.3 
(0.8–2.1)
1.5
(0.7–3.0)
0.9
(0.4–2.0)
Group 2 2.4
(1.6–3.7)
1.7
(1.0–2.9)
1.0
(0.5–1.9)
0.9
(0.4–2.0)
Associations are presented by odds ratios (OR) with 95% conﬁdence interval between parentheses.
Reference group is the short time user, between 1–30 days.
* Adjusted for age, gender, BMI, baseline radiological osteoarthritis, follow-up time and Deﬁned Daily Dosage.
Group 1: those NSAIDs (indomethacin, naproxen and ibuprofen) that are supposed to have a deleterious eﬀect on joint cartilage.
Group 2: those NSAIDs (such as diclofenac and piroxicam) that are supposed to have a neutral eﬀect on cartilage metabolism.
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Figure 1: Percentage persons with progression of hip osteoarthritis by duration of use of group 1 and group 2 NSAIDs. 
Group 1: those NSAIDs (indomethacin, naproxen and ibuprofen) that are supposed to have a deleterious eﬀect on joint cartilage.
Group 2: those NSAIDs (such as diclofenac and piroxicam) that are supposed to have a neutral eﬀect on cartilage metabolism.
Numbers of subjects per category:
Group 1: 555 / 193 / 67 / 22 / 22
Group 2: 555 / 232 / 85 / 27 / 32
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use (> 180 days) of diclofenac and progression of hip OA, with an OR of 5.8 (95% CI, 
3.2–10.5). After adjustment for age, gender, BMI, baseline ROA of the hip, follow-up time, 
and deﬁned daily dosage the risk estimate decreased importantly to an OR of 3.6 (95% CI; 
1.7–7.5), but was still signiﬁcantly increased. The association could also be confounded by 
Table 4: Associations between use of diﬀerent types of NSAIDs and progression of hip osteoarthritis.
Hip
(Numbers) crude *adjusted
Ibuprofen
– short (172)
– medium (55)
– long (62)
0.9 (0.5–1.6)
1.1 (0.5–2.5)
1.8 (0.9–3.6)
0.9 (0.4–1.7)
0.6 (0.2–1.7)
1.0 (0.4–2.3)
Naproxen
– short (106)
– medium (33)
– long (26)
1.0 (0.5–1.9)
2.2 (1.0–5.1)
0.2 (0.0–1.9)
1.0 (0.5–2.0)
1.4 (0.5–3.9)
0.1 (0.0–1.2)
Diclofenac
– short (167)
– medium (57)
– long (63)
1.3 (0.8–2.3)
1.4 (0.6–3.2)
5.8 (3.2–10.5)
1.1 (0.6–2.0)
1.4 (0.6–3.6)
3.6 (1.7–7.5)
Piroxicam
– short (45)
– medium (6)
– long (20)
1.3 (0.5–3.5)
1.0 (0.1–9.6)
0.9 (0.2–3.6)
1.5 (0.5–4.5)
0.9 (0.1–10.1)
0.8 (0.2–3.9)
Duration of use; reference group is = 1–30 days, short = 31–90 days, 
medium = 91–180 days, long = > 180 days.
Associations are presented by odds ratios (OR) with 95% conﬁdence interval between parentheses.
* Adjusted for age, gender, BMI, baseline radiological osteoarthritis, follow-up time, and Deﬁned Daily Dosage.
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Figure 2: Percentage of persons with progression of hip osteoarthritis by duration of use of diﬀerent types of NSAIDs.
Numbers of subjects per category:
Ibuprofen: 1461 / 170 / 172 / 55 / 62
Naproxen:  1479 / 276 / 106 / 33 / 26
Diclofenac: 1176 / 457 / 167 / 57 / 63
Piroxicam: 1775 / 74 / 45 / 6 / 20
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the pain severity. Since we had information only on the absence or presence of hip pain, we 
repeated the analysis for those subjects with a prevalent hip pain at baseline. Of the subjects 
with hip pain at baseline (n = 243), 98.8% had pain for longer than 1 month, of which 30.2% 
had pain for 1 to 5 years and 51.1% had pain for longer than 5 years. In those subjects with 
hip pain the risk estimate for the long-term use of diclofenac was similar as reported (OR 
= 3.5), but failed to reach signiﬁcance (95% CI; .9–13.9) due to the small numbers. Finally, 
the association could also be confounded by the “activity” of the OA process. Therefore, 
we additionally adjusted for the baseline erythrocyte sedimentation rate (as inﬂammation 
marker) and for the baseline CTX-II (fragments derived from type II collagen as marker for 
cartilage degradation). Again, the risk estimates (OR = 3.3) did not change importantly after 
adjustment.
In addition, for ibuprofen and diclofenac a trend was found that the longer the duration of 
use, the higher the percentage of persons with progression of hip ROA (Figure 2). This was 
not the case for naproxen and piroxicam.
No signiﬁcant associations were found between the use of the individual types of NSAIDs 
and progression of ROA of the knee (data not reported in Table 4).
Discussion
In a large population-based prospective cohort study the division of NSAIDs into groups 
based on their supposed negative inﬂuence on cartilage metabolism, appears to be 
questionable. If any, the negative effect of NSAIDs on progression of hip ROA was found 
for the long-term use of diclofenac, surprisingly a NSAID considered to be a neutral type for 
cartilage metabolism. No clear associations were found between NSAIDs and progression 
of knee ROA. 
The strengths of the present study are its population-based prospective design, its size, and 
the long follow-up period of 6.6 years, which enabled us to study all these different types 
of NSAIDs together. Because the present study comprised a healthy selection of the total 
population of the Rotterdam study, under-representation of symptoms may have resulted in 
an underestimation of the reported associations. 
An important source of bias in the interpretation of the results concerning the association 
between NSAIDs and progression of OA in observational studies, is confounding by 
indication. The question is if the reported association between long-term use of NSAIDs 
and progression of ROA of the hip has been confounded by the severity of hip ROA or the 
presence of symptoms and/or side effects. After adjustment for radiologic severity at baseline 
and also for potential risk factors of severity (e.g. age, gender and BMI), the risk estimate 
decreased but was still signiﬁcantly increased. Even after adjustment for inﬂammation and 
cartilage degradation markers, as sign of “activity” of the OA process, the risk estimate did 
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not change importantly. Also, in the subgroup of subjects with initial hip pain, the risk 
estimate was similar but failed to reach signiﬁcance, probably because of the small size of 
this subgroup. At least the associations we found did not disappear after adjustment for 
these variables. It appears that the long-term use of NSAIDs is not harmless, with regard to 
their inﬂuence on progression of OA. In the present study, estimation of the use of NSAIDs 
is based on the prescriptions of NSAID and not on the actual NSAID intake in subjects. 
Therefore, it may well be that the actual duration of NSAID use has been overestimated and 
probably resulted in an underestimation of the reported associations.
Diclofenac has a differential effect on progression of hip and knee OA, and this raises the 
question whether diclofenac also has a differential effect on the cartilage metabolism of the 
hip and knee. Until now, only two studies have investigated the inﬂuence of diclofenac on 
the cartilage metabolism of the knee, and both reported that diclofenac did not induce any 
degenerative processes (animal and in vitro study) (9, 26). However, the study of Vignon 
et al. (27) reported a slightly decreased proteoglycanase activity in human osteoarthritic 
cartilage of the hip. One problem is that these studies did not investigate the inﬂuence of 
diclofenac on cartilage metabolism of the hip or the knee joint simultaneously and therefore 
the question whether diclofenac has a differential effect remains unanswered. 
It has been suggested that effective pain relief due to analgesic drugs causes a patients to 
become more active. Because of this (suggested) increased activity, the mechanical loading 
of a less painful joint will increase. This increased mechanical loading may modify the 
supposed deleterious effect of some NSAIDs on cartilage. This would only hold for the 
relation between diclofenac and the hip joint. Consequently, the efﬁcacy of diclofenac in 
pain relief should be considerably better and also result in fewer side-effects compared 
to ibuprofen, naproxen and piroxicam. This was, however, not conﬁrmed by Towheed 
et al. who summarized the literature on the efﬁcacy and side effects of NSAIDs in hip OA 
(1). Moreover, a supposed better efﬁcacy and fewer side effects of diclofenac suggest that 
diclofenac could be used longer than ibuprofen, naproxen and piroxicam. However, our 
ﬁndings (see Table 2) do not support the longer use of diclofenac. 
Our data suggest that diclofenac may not be harmless and may induce accelerated 
progression of hip OA. Whether this occurs due to a real deleterious effect on cartilage or 
due to excessive mechanical loading on an analgesic hip remains to be investigated. In view 
of the effect of diclofenac, it would be interesting to know the effect of cyclooxygenase 
(COX)-II selective inhibitors on cartilage metabolism. We conclude that there is a clear need 
to further investigate the inﬂuence of individual types of NSAIDs on cartilage metabolism 
in a clinical situation.
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In the previous chapters, the main ﬁndings and limitations of each study were discussed. 
In this chapter the main topics addressed in this thesis will be discussed in a broader 
perspective. Finally, suggestions are made for future research. 
Case deﬁnition of prevalent and incident hip OA
The ﬁrst question in this thesis was “How can we deﬁne the presence of hip OA in 
epidemiological studies?” As already mentioned in the Introduction, in most epidemiological 
studies OA was assessed by means of radiologic evaluation. The literature reports a wide 
range of prevalences of hip OA, mainly because of the variation in the deﬁnitions used. 
This would not be a problem if the agreement between the different deﬁnitions were high; 
however, we found that the overlap between three commonly used deﬁnitions of hip OA 
was strikingly low. Only half of the cases deﬁned by the Kellgren & Lawrence index ≥ 
grade 2 were also deﬁned by a minimal joint space of ≤ 2.5 mm, and for the index of Croft 
this was even lower. Because of this problem, the reported estimates of risk factors for hip 
OA may have been underestimated up to now. We argue that international consensus on 
a universal deﬁnition (or deﬁnitions) is needed for epidemiological and clinical studies. 
Therefore the validity (especially the expert or predictive validity) of the commonly used 
deﬁnitions should be studied more thoroughly. 
Chapter 3 presents the results of our study investigating the reliability and validity of the 
Kellgren & Lawrence grade, Minimal Joint Space (MJS), and the Croft grade. Kellgren & 
Lawrence proved to be the best predictor for a total hip replacement at follow-up. We 
also found that the baseline Kellgren & Lawrence grade had an impressively stronger 
independent association with progression of hip OA compared with MJS at baseline. 
Furthermore, we found that MJS is dependent on height. Recently, Lanyon et al. (1) reported 
that women have a signiﬁcantly smaller joint space width than men and that this difference 
remained signiﬁcant after adjusting for height. Goker and colleagues (2, 3) also found 
gender differences in JSW, but these differences were no longer signiﬁcant after adjustment 
for height. Therefore, the somewhat higher prevalence of hip OA in women deﬁned by MJS 
according to Croft, as reported in Chapter 3, might be explained by a smaller JSW in women 
compared with men. 
Based on the above-mentioned ﬁndings and arguments, we conclude that for epidemiological 
studies radiological hip OA should preferably be deﬁned by the Kellgren & Lawrence 
grading system. 
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Incident versus progression
To investigate the prognostic factors for progression of hip OA, we ﬁrst had to deal with 
another issue; namely, how to deﬁne progression of hip OA?
OA is a slow progressive disease, in which the normal joint of the patient degenerates over 
time to end stage OA. During this ongoing process there is a moment at which the patient 
crosses the borderline between what is deﬁned as absence of OA and presence of OA. 
The distinction between incident OA and progression of already existing OA depends on 
at which point along this continuum the cut-off point of present OA is deﬁned (4). If OA is 
diagnosed earlier in the future, because of more sensitive diagnostic tools, cases formerly 
considered to be ‘incident cases’ will then be considered as ‘progressive cases’. 
In case of the Kellgren & Lawrence index, incident hip OA is usually deﬁned as a grade 
0 or 1 at baseline, and greater than or equal to grade 2 at follow-up. However, one can 
question whether the cut-off point of ≥ grade 2 is valid and whether it is correct to classify 
people with grade 1 as a ‘normal’ group? Recently Hart and Spector investigated whether 
the Kellgren & Lawrence grade 1 of the knee was a reliable indicator of knee OA in a 
longitudinal population-based study (5). After 10 years of follow-up, more than 60% of the 
subjects with grade 1 at baseline had developed grade 2 or higher, whereas, 20% of those 
with a Kellgren & Lawrence grade 0 at baseline had developed a grade 2 or higher. In our 
hip study, however, after 6 years of follow-up we found that 7.6% of those subjects with a 
Kellgren & Lawrence hip grade 1 versus 1.4% with grade 0, developed a grade 2 or higher. 
These results suggest that the cut-off point of ≥ grade 2 for the hip seems to be valid, 
whereas for the knee a cut-off point of ≥ grade 1 seems more appropriate. 
In contrast, several international scientiﬁc committees have suggested that assessment of 
joint space narrowing as the most sensitive technique to assess radiographic changes over 
time. The Kellgren & Lawrence index appears to be a valid tool for case deﬁnition; however, 
the index may not be sensitive enough to evaluate osteoarthritic changes over time. In the 
future, the distinction between incident OA and progression of already existing OA may well 
be inﬂuenced by tools that can identify OA in an earlier stage compared to the traditional 
radiograph, such as the MRI or a biomarker. It is important to realize that the chosen 
diagnostic tool and cut-off point determine whether a person is deﬁned as a prevalent OA 
case. For the time being, in case of an incident hip OA the Kellgren & Lawrence index, 
with a cut-off point of ≥ grade 2, appears to be the most useful tool. However, in case of 
progression of hip OA, joint space narrowing appears to be the most useful tool.
Overall we conclude that, from a methodological view, the distinction between incident OA 
and progression of OA is arbitrary and until now this problem remains unanswered.
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Determinants of progression
Why is the distinction between incident hip OA and progression of hip OA so important? This 
would not be the case if the risk factors for developing an incident hip OA or progression 
of an already existing hip OA were similar. However, not all the persons with a present 
hip OA will progress (see Figure 1), indicating that the risk factors for incident hip OA and 
progression of hip OA are different. Within the participants of the Rotterdam Study with a 
radiographic OA of the hip (Kellgren & Lawrence ≥ grade 2), 45.3% showed progression 
during the follow-up period. However, if these subjects also had hip pain at baseline, we 
found that 71.4% showed progression during follow-up. 
In Chapter 5 we reported that age, gender and signs of the presence or severity of OA were 
prognostic factors for progression of hip OA, whereas systemic factors like family history 
of OA, diabetes (type II), hypertension and age at menopause were not. There is growing 
evidence that the development of hip OA is under strong genetic inﬂuence (6, 7), whereas, 
the genetic inﬂuence on progression of hip OA is less clear. Because this suggests that 
the role of systemic factors in progression is less important, we constructed a prognostic 
model of progression of hip OA, i.e. a modiﬁed version of the model of Felson (8). The 
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Figure 1: Relationship between radiographic hip osteoarthritis (OA), the presence of hip pain at baseline and progression of hip 
OA in participants of the Rotterdam Study. 
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model indicates that a person with radiographic OA of the hip will progress depending on 
the interaction with potential prognostic factors (see Figure 2). In Chapter 5 we reported 
that the proportion of progressors was higher in case of the presence of symptoms of 
hip OA and signs of an active OA process. Furthermore, we argue that besides the minor 
role of systemic factors (such as age and gender), local biomechanical factors play an 
important role in progression of hip OA. It is conceivable that local biomechanical factors 
such as workload, sports activity and mechanical load during daily activity interact with 
already existing osteoarthritic signs of the hip joint. Until now, however, all the studies that 
investigated the inﬂuence of mechanical load on hip OA have looked at the historical load 
of the hip joint and not at the load after the occurrence of hip OA. In addition to their direct 
effect, local factors may mediate in the pathway between other factors, such as structure 
modifying therapies and systemic factors, and OA (9). Moreover, we reported in Chapter 6 
that the association between acetabular dysplasia and incident hip radiographic OA might 
be enhanced by female gender and mechanical workload. Whether the same holds for 
progression, however, is not yet clear. In case of the knee there is some evidence that 
malalignment is associated with progression of knee OA (9). Besides these determinants 
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Figure 2: Prognostic factors of hip OA and their interaction on the progression process; modiﬁed from (6).
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of progression, the rate of progression might also be inﬂuenced by potential structure-
modifying therapies, such as glucosamine, chondroitine, NSAIDs, alignment correction, or 
mechanical load reduction. The efﬁcacy of these modifying therapies is currently under 
discussion and several studies are currently exploring this issue.
Overall, we conclude that the distinction between incident OA and progression of OA is 
important from a clinical view, because different determinants play a role in the onset of OA 
than in the progression of an already existing OA. In particular, the role of mechanical load 
and malalignment on progression should be thoroughly investigated.
Biomarkers
As described in Chapter 4, biomarkers aim to detect changes in OA with more reliability and 
sensitivity, preferably in an early stage. The ﬁrst potential use of a biomarker is that a shorter 
follow-up time may be sufﬁcient to observe changes in the joint. In our study we found that 
CTX-II had a strong association with progression of hip and knee OA (with an OR of 8.3 
and 6.2 respectively). These results suggest that CTX-II may be able to identify subjects at 
high risk for progression of OA. However, whether CTX-II is capable to observe OA changes 
during a follow-up period, remains unanswered. As mentioned before, we found that CTX-II 
is associated with progression of OA; however, whether CTX-II has an additional diagnostic 
value is unclear. For such a clinical application it will be more informative to assess the prior 
probability, the posterior probability and the likelihood ratio.
Another potential use of biochemical markers is that the onset of osteoarthritic signs can be 
detected at an earlier stage. This could be useful to identify target groups in need of potential 
disease-modifying OA drugs (DMOADs), assuming that these drugs become available in the 
future. The hypothesis is that these DMOADs modify the synthesis of cartilage. Until now, 
however, the validity of CTX-II as an early detector of OA signs has not been investigated. 
Because of the absence of a gold standard that can detect the onset of OA in an earlier 
stage, another option is to assess the predictive validity of CTX-II. In this case the predictive 
validity is expressed as the ability of CTX-II to predict an incident OA. Because this has not 
yet been investigated, the ability of CTX-II to detect the onset of OA in earlier stage remains 
unanswered. 
In addition, CTX-II seems to be a speciﬁc marker for cartilage degradation, since CTX-II 
is associated with joint space narrowing but not with incident osteophytes. However, the 
main limitation of CTX-II always will be that it is not completely speciﬁc for OA, since it is 
also associated with rheumatoid arthritis (10). Moreover, the CTX-II level express the total 
turnover rate of cartilage and can be modiﬁed by cartilage degradation of another joint next 
to the joint of interest. No studies have investigated the association between, for example, 
CTX-II and OA of the spine. It is conceivable that OA of the spine will inﬂuence the CTX-
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II level as measured in urine. We conclude that besides these remarks concerning the 
speciﬁcity of CTX-II, the ability of CTX-II to detect changes in a shorter period of time and 
the ability of CTX-II to detect the onset of OA in earlier stage need to be investigated.
NSAIDs and progression
In Chapter 7 we discussed that different types of NSAIDs might inﬂuence the rate of 
progression. If any, the negative effect of NSAID was found for the long-term use of 
diclofenac and progression of hip OA. 
Several sources of bias are important when interpreting the results of the association 
between NSAIDs and progression of radiographic OA, as reported in Chapter 7. Bias is 
generally divided into selection bias, information bias and confounding. Selection bias may 
occur when selection of subjects for the drug exposure group and the reference group 
of a cohort study differs between diseased and nondiseased persons. Selection bias may 
also occur if cases and controls are drawn from different source populations. In our study, 
however, it is unlikely that selection bias occurred because the study was a prospective one 
and population based. However, because our study included a healthy selection of the total 
population of the Rotterdam study, under-representation of symptoms may have resulted in 
an underestimation of the reported associations. 
Information bias may occur if classiﬁcation of disease status depends on exposure status, 
or vice versa. In the study reported in Chapter 7, the pharmacy records were used to avoid 
potential misclassiﬁcation. One difﬁculty is that we used the amounts on the prescriptions 
of NSAID, and not the actual use of NSAIDs. Hence, it seems logical that the actual duration 
of use of NSAIDs has been overestimated and probably resulted in an underestimation 
of the reported associations. Overall, we assume that it is unlikely that information bias 
has occurred in this study since the pharmacy data were collected before the follow-up 
measurements. 
Confounding by independent risk factors of progression of hip OA, which may also be 
associated with NSAID use, can usually be dealt with in the analyses of observational 
studies. A more difﬁcult type of confounding is confounding by indication: this term is used 
when a variable is a risk factor for a disease among nonexposed and exposed persons and 
is associated with the exposure of interest in the population from which the cases derive, 
without being an intermediate step in the causal pathway between the exposure and the 
disease (11). This problem is thoroughly discussed in Chapter 7. 
We conclude that at least the associations we reported in Chapter 7 did not disappear after 
adjustment for all the mentioned variables. Hence, there is a clear need to further investigate 
the inﬂuence of individual types of NSAID on cartilage metabolism in a clinical situation.
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Advantages and disadvantages of a large cohort study 
The main advantages of a large cohort study with a prospective design and a long follow-up 
period, such as the Rotterdam Study, are the large database and the possibility to investigate 
interactions between different risk factors. 
Concerning the disadvantages, because of the long follow-up period, the outcome measures 
dependent on the baseline measurements may not have been updated according to the 
latest recommendations of international scientiﬁc committees. Nowadays, the standardization 
of radiographic procedures has become more precise to current opinion. Hence, for the 
radiographic procedure of the hip, especially the focus-to-ﬁlm distance and the location 
of where the X-ray beam should be centered, are more precisely speciﬁed. Another 
disadvantage of using data from an already existing cohort is that the objectives of the 
present study are necessarily deﬁned after the collection of the data. Consequently, for our 
study objectives we missed the optimal data collection of potential risk factors such as the 
exact location of the pain, the severity of the pain, sports activity, speciﬁcity and frequency 
of the components of a job, physical examination, and muscle strength.
In general, however, we were able to adequately answer our research question using the 
data of the Rotterdam Study.
Suggestions for future research
The results of the studies presented in this thesis give rise to new hypotheses for future 
research. Several research questions have already been presented in the Discussion section 
of the various chapters. 
Our hypothesis is, as mentioned before, that the risk factors for incident hip OA are different 
from the prognostic factors for progression of hip OA. The ﬁrst interesting topic is to identify 
persons at high risk for developing incident hip OA or progression of hip OA. More data are 
needed to deﬁne the risk or prognostic factors allowing to identify such a high-risk person. 
Secondly, tools that can detect the onset of OA at an earlier stage, such as biomarkers, need 
to be investigated more thoroughly. Furthermore, in case of progression of hip OA we 
assume that local factors play a more important role, than the systemic factors. Especially 
the inﬂuence of mechanical load on an already existing osteoarthritic joint and the inﬂuence 
of a malalignment on progression should be investigated. Finally, the relationship between 
body mass index and OA is not yet fully elucidated. We suggest that the inﬂuence of body 
mass index on the development and progression of OA of the hip, knee and hand should 
be investigated in the same large open population.
Consequently, the scientiﬁc evidence for therapeutic interventions of patients with OA 
should be expanded. Especially the efﬁcacy of structural modifying interventions (such as 
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disease-modifying OA drugs, alignment correction or reduction of the mechanical load of 
the hip joint) needs to be investigated in clinical trials. Finally, the inﬂuence of different 
types of NSAIDs and the effect of the new COX-II selective inhibiters on progression of hip 
OA are topics for future research. 
Implications for daily practice
Besides suggestions for future research, the reported results also have implications for the 
daily practice of a general practitioner (GP). 
The main implication is the value of an X ray in case of the presence of hip pain. If a patient 
of 55 years or older visits a GP because of the presence of hip pain, an additional X ray can 
be rewarding for two reasons. Firstly, in combination with radiographic acetabular dysplasia 
there is an increased risk of developing an incident hip OA, and secondly, in combination 
with radiographic evidence of hip OA there is an increased risk of progression. 
Based on the results that nearly all patients (of 55 years or older) with a Kellgren & Lawrence 
index ≥ grade 2 and hip pain will develop progression of hip OA, it seems reasonable that 
structure modifying therapies will be more effective in the early stage of OA. Hence, the 
primary target group of such therapies will be those patients with hip pain combined with 
minimal radiographic signs of hip OA. However, as mentioned in the previous paragraph, the 
efﬁcacy of structural modifying interventions needs to be investigated more thoroughly. 
The ACR and Eular guidelines for the medical management of hip OA recommended that 
overweight patients with hip OA should lose weight. However, results of our study and 
also of other epidemiological studies could not conﬁrm that overweight is a risk factor for 
progression of hip OA. So far there has been no study that investigated the inﬂuence of 
mechanical load on an already existing osteoarthritic joint. Hence, the question of what 
should be recommended to a patient with hip OA, concerning mechanical loading of the 
joint, remains unanswered. 
Besides the marginal surplus of NSAIDs in pain relief compared to acetaminophen and the 
known major and minor side effects of NSAIDs, our data suggest that the long-term use of 
diclofenac may not be harmless and may induce accelerated progression of hip OA. Based 
on these results we suggest a GP to be critical in the prescription of long-term use of NSAIDs 
in case of hip OA.
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Summary
Osteoarthritis (OA) is the most frequent disorder of the locomotor system and the prevalence 
of OA will increase with the aging of the Western society. Especially when the hip or knee 
is involved, OA causes considerable difﬁculty in walking, stair climbing and other lower 
extremity tasks. OA of the hip can be especially disabling because of the pain and functional 
impairment. The identiﬁcation of patients at high risk for progression of hip OA is important 
for at least two reasons. Firstly, well-characterized ‘high risk’ groups may be useful in clinical 
trials and, secondly, assuming that disease-modifying OA drugs may become available in the 
future, to identify primary target groups in need of such therapy. Additionally, in a clinical 
situation the identiﬁed non-progressors can be reassured. Until now the prognostic factors 
of progression of hip OA have been investigated in small studies, with a short follow-up 
time, and only in a hospital setting. The overall aim of this thesis was to determine the 
prognostic factors of osteoarthritis of the hip in a large open population with a long-term 
follow-up. 
Nearly all studies presented in this thesis were based on data from the Rotterdam Study, 
a large prospective population-based cohort study in the Netherlands. Participants of this 
study were men and women aged 55 years and over living in Ommoord, a suburb of 
Rotterdam. 
Chapter 2 presents a study in which we systematically summarized the literature addressing 
the validity, reliability and applicability of seven commonly used deﬁnitions of hip OA for 
epidemiological studies, in order to use them primarily as classiﬁcation criteria. Considering 
how frequently the deﬁnitions of hip OA are used for epidemiological studies, it is surprising 
that the validity of these deﬁnitions has been so poorly investigated. Summarizing the 
literature showed that the reliability of the minimal joint space (MJS) according to Croft, 
the Kellgren & Lawrence grade and the index according to Lane was similar, but the MJS 
had the highest relationship with hip pain in a male population. We recommend that the 
validity, especially the expert or predictive validity, of the commonly used deﬁnitions be 
studied more thoroughly. Moreover, the different deﬁnitions should be investigated in the 
same clinical setting.
Therefore, Chapter 3 presents an evaluation of the reliability and validity of three frequently 
used radiological deﬁnitions of hip OA: namely, the Kellgren & Lawrence grade, the Minimal 
Joint Space, and Croft’s grade that were used in the Rotterdam Study. The inter-rater reliability 
was similar for the Kellgren & Lawrence grade and MJS, but slightly lower for Croft’s grade. 
The Kellgren & Lawrence grade and MJS showed the strongest associations with clinical 
symptoms of hip OA. Gender appears to be a signiﬁcant effect modiﬁer for the Kellgren & 
Lawrence grade in that women had a signiﬁcantly stronger association with symptoms than 
men. The gender differences in joint space width, however, were attributed to differences 
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in height between women and men. The Kellgren & Lawrence grade showed the highest 
predictive value for total hip replacement at follow-up compared to the other deﬁnitions.
Chapter 4 focuses on the association between a cartilage degradation marker, urinary 
concentrations of C-telopeptide fragments of collagen type II (CTX-II), and the prevalence 
and progression of radiological OA (ROA) of the hip and knee. Subjects with a CTX-II 
level in the highest quartile had a 4.2 times increased risk of having ROA of the knee and 
at the hip compared to subjects with a CTX-II level in the lowest quartile. We observed a 
stronger association for subjects with hip pain at baseline compared with those without hip 
pain. Subjects with a CTX-II level in the highest quartile had a 6.2 times increased risk for 
progression of ROA at the knee and an 8.3 times increased risk for progression of ROA at the 
hip compared to subjects with a CTX-II level in the lowest quartile. All of these associations 
were found to be independent of known risk factors for OA, such as age, gender and body 
mass index (BMI).
In Chapter 5 we investigated which determinants will best identify those persons at high risk 
for progression of hip OA. Of the study population, 13.1% of the subjects had progression 
of ROA of the hip during follow-up. Starting with a simple model of only directly obtainable 
variables collected by history taking, the Kellgren & Lawrence score at baseline, when 
added to the model, was a strong predictor of progression, especially in those subjects 
with hip pain at baseline. In addition, a lower limb disability index of ≥ 0.5 and a CTX-II 
concentration ≥ 235.5 mmol/l were also independent identiﬁers of these high-risk persons. 
CTX-II is only a moderate predictor of progression of hip OA compared to the variables 
collected by history taking, physical examination and an X-ray. Overall, we conclude that in 
a clinical situation and for clinical trials, an X-ray offers valuable additional information to 
identify persons at high risk for progression of hip OA. 
Chapter 6 explores the association between radiographic evidence of acetabular dysplasia 
in participants without ROA of the hip at baseline, and an incident hip ROA. In this study 
population 9.3% developed an incident ROA of the hip during follow-up. Subjects with 
acetabular dysplasia had a 4.3 times increased risk for incident hip OA compared to subjects 
without acetabular dysplasia. These associations were independent of known determinants 
of OA, such as age, gender, and BMI. Furthermore, these associations seemed to be enhanced 
by female gender, heavy mechanical workload and low BMI. 
Chapter 7 reports on the associations between two groups of NSAIDs, i.e. those 
(indomethacin, naproxen and ibuprofen) that are supposed to have a deleterious effect on 
joint cartilage, and those NSAIDs (such as diclofenac and piroxicam) assumed to have a 
neutral effect on cartilage metabolism, and progression of OA of the hip and knee. Those 
subjects who used NSAIDs supposed to have a neutral effect on cartilage metabolism (> 
31 days) surprisingly had a 1.7 increased risk of hip ROA compared to the short-term user 
(1–30 days). This increased risk could be explained by the long-term use (> 180 days) of 
diclofenac. No clear associations were found between NSAID and progression of knee ROA. 
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Whether the increased risk is due to a real deleterious effect on cartilage or through the 
effect of mechanical loading an analgesic hip remains to be investigated.
In Chapter 8 the main topics addressed in this thesis are discussed in a broader perspective. 
The two main problems of how to deﬁne the presence of hip OA, and how to deﬁne 
progression of hip OA are addressed. The discussion also focuses on the use of a biomarker 
and sources of potential bias in the association between NSAIDs and progression. Finally, 
recommendations are made for future research.
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Artrose is een van de meest voorkomende aandoeningen van het bewegingsapparaat en 
de prevalentie van artrose zal gezien het vergrijzen van de westerse maatschappij alleen 
maar toenemen. Voornamelijk als de heup of de knie is aangedaan, levert artrose veel 
problemen op bij lopen, traplopen en andere functies van de onderste extremiteiten. Door 
de pijn en het verminderd functioneren van de onderste extremiteit kunnen personen met 
heup artrose gehandicapt zijn. Het identiﬁceren van personen met een verhoogd risico 
op progressie van artrose is voor tenminste twee redenen belangrijk. Ten eerste, kunnen 
speciﬁeke ‘hoog risico’ groepen nuttig zijn voor klinische trials en ten tweede, om speciﬁeke 
doelgroepen voor artrose-modiﬁcerende medicijnen te identiﬁceren, ervan uitgaande dat 
deze therapie in de toekomst beschikbaar zijn. Bovendien kunnen in een klinische situatie 
de personen die geïdentiﬁceerd worden waarbij de artrose niet zal verergeren, gerustgesteld 
worden. De prognostische factoren voor progressie van heup artrose zijn tot nu toe alleen 
maar onderzocht in kleine studies, met een korte follow-up tijd en in een ziekenhuis setting. 
De overall doelstelling van dit proefschrift was het bepalen van de prognostische factoren 
van heup artrose in een grote open populatie met een lange follow-up tijd.
Bijna alle studies die in dit proefschrift gepresenteerd worden, zijn gebaseerd op het 
Rotterdamse ERGO-onderzoek (Erasmus Rotterdam Gezondheid en Ouderen), internationaal 
bekend als “the Rotterdam Study”. Dit is een groot prospectief bevolkingsonderzoek onder 
mannen en vrouwen van 55 jaar en ouder uit de Rotterdamse deelgemeente Ommoord. 
In hoofdstuk 2 presenteren we een systematisch overzicht van de literatuur betreffende de 
validiteit, de reproduceerbaarheid en de toepasbaarheid van zeven vaak gebruikte deﬁnities 
(classiﬁcatie criteria) van heup artrose binnen epidemiologische studies. Ervan uitgaande 
hoe frequent deze deﬁnities van heup artrose worden gebruikt binnen epidemiologische 
studies, is het verrassend dat de validiteit van de gebruikte deﬁnities zo weinig is onderzocht. 
De literatuur samenvattend, blijkt dat de reproduceerbaarheid van de “minimal joint space 
(MJS)” volgens Croft, de Kellgren & Lawrence index en de index volgens Lane vergelijkbaar 
is. De MJS vertoonde de sterkste relatie met heuppijn in een mannelijke populatie, echter 
dit is gebaseerd op slechts 1 studie. Onze aanbeveling is dat de validiteit, met name de 
expert of predictieve validiteit, van de gebruikte deﬁnities beter moet worden onderzocht. 
Daarnaast adviseren wij dat zo’n onderzoek gebeurt binnen een zelfde populatie. 
In hoofdstuk 3 evalueren wij de reproduceerbaarheid en validiteit van drie frequent 
gebruikte radiologische deﬁnities van heup artrose, namelijk de Kellgren & Lawrence index, 
de MJS en de index volgens Croft, getoetst binnen één grote open populatie, namelijk 
de Rotterdam studie. De inter-beoordelaar-reproduceerbaarheid was vergelijkbaar voor 
de Kellgren & Lawrence index en de MJS, maar wat lager voor de index volgens Croft. 
De Kellgren & Lawrence index en de MJS lieten beide sterke associaties met klinische 
symptomen van heup artrose zien. Geslacht bleek een signiﬁcante effect modiﬁcator te zijn 
Max Reijman BW.indd   133 10/5/2004   10:30:58 AM
134
Chapter 9
voor de Kellgren & Lawrence index; vrouwen hadden signiﬁcant sterkere associaties met 
klinische symptomen dan mannen. Het verschil in breedte van de gewrichtspleet tussen 
mannen en vrouwen was toe te schrijven aan het verschil in lengte tussen mannen en 
vrouwen. De Kellgren & Lawrence index liet de hoogste predictieve waarde zien voor het 
voorspellen van een “gewricht vervangende operatie” gedurende follow-up vergeleken met 
de andere twee deﬁnities. 
Hoofdstuk 4 richt zich op de associatie tussen een kraakbeen degradatie marker, namelijk 
“C-telopeptide fragmenten van collageen type-II (CTX-II)” en de prevalentie en progressie 
van radiologische artrose van de heup en de knie. Personen met een hoge CTX-II concentratie 
(bovenste kwartiel), gemeten in de urine, hadden een 4.2 keer verhoogd kans op het hebben 
van prevalente radiologische artrose van de heup en de knie vergeleken met personen 
met een lage CTX-II concentratie (laagste kwartiel). Voor personen met heup pijn vonden 
we dat deze associatie sterker was vergeleken met personen zonder heup pijn. Personen 
met een hoge CTX-II concentratie (bovenste kwartiel; baseline meting) hadden een 6.2 
keer verhoogd risico op progressie van knie artrose en een 8.3 keer verhoogd risico op 
progressie van heup artrose vergeleken met personen met een lage CTX-II concentratie. De 
gevonden associaties waren onafhankelijk van bekende risico factoren voor heup artrose, 
zoals leeftijd, geslacht en body mass index. 
In hoofdstuk 5 presenteren we welke determinanten het best die personen kunnen 
identiﬁceren die een groot risico hebben op progressie van heup artrose. Binnen de 
studie populatie ontwikkelde 13.1% progressie van heup artrose gedurende de follow-up 
periode. De Kellgren & Lawrence index (baseline meting) bleek een sterke voorspeller 
te zijn voor progressie, onafhankelijk van variabelen verkregen door een anamnese. Dit 
gold voornamelijk voor die personen met heup pijn tijdens de baseline meting. In het 
uiteindelijke model waren een disability index van de onderste extremiteit ≥ 0.5 en een 
CTX-II concentratie ≥ 235.5 mmol/l ook onafhankelijke voorspellers van progressie. CTX-
II bleek, vergeleken met variabelen verkregen door anamnese, lichamelijk onderzoek en 
röntgenonderzoek, een matige voorspeller te zijn voor progressie van heup artrose. Onze 
overall conclusie is dat in een klinische situatie en voor klinische trials, een röntgenfoto 
sterk toegevoegde waarde heeft om die personen te identiﬁceren die een verhoogd risico 
hebben op progressie van heup artrose.
In hoofdstuk 6 evalueren we de associatie tussen radiologische acetabulaire dysplasie 
en incidente radiologische heup artrose bij de follow-up meting, bij personen die bij de 
baseline meting geen radiologische heup artrose hebben. In deze populatie ontwikkelde 
9.3% een incidente radiologische heup artrose gedurende de follow-up periode. Personen 
met acetabulaire dysplasie hadden een 4.3 verhoogd risico op het ontwikkelen van een 
incidente heup artrose vergeleken met de personen zonder acetabulaire dysplasie. Deze 
associatie was onafhankelijk van bekende determinanten van artrose zoals leeftijd, geslacht 
en body mass index. Verder bleek dat de associatie tussen acetabulaire dysplasie en incidente 
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heup artrose mogelijk wordt gemodiﬁceerd door vrouwelijk geslacht, zwaar lichamelijk 
werk en body mass index. 
De associaties tussen twee groepen NSAIDs; die NSAIDs (indomethacin, naproxen en 
ibuprofen) waarvan wordt verondersteld dat ze een negatief effect hebben op het kraakbeen 
metabolisme en die groep NSAIDs waarvan wordt verondersteld dat ze een neutraal effect 
hebben op het kraakbeen metabolisme; en progressie van heup en knie artrose worden 
gepresenteerd in hoofdstuk 7. De personen die NSAIDs hebben gebruikt waarvan wordt 
verondersteld dat deze een neutraal effect hebben op het kraakbeen metabolisme (> 31 
dagen) hadden verrassend een 1.7 keer verhoogd risico op progressie van heup artrose 
vergeleken met de korte termijn NSAIDs (1–30 dagen) gebruikers uit dezelfde groep. Dit 
verhoogd risico zou mogelijk verklaard kunnen worden door het langdurig gebruik van 
diclofenac (langer dan 180 dagen). Voor de knie vonden we geen duidelijke associaties 
tussen NSAID gebruik en progressie van artrose. Of dit gevonden risico verklaard kan 
worden door een echt negatief effect op kraakbeen metabolisme of door het effect van 
mechanische belasting op een analgetische heup moet nog verder worden onderzocht. 
In de algemene discussie in hoofdstuk 8 worden de belangrijkste bevindingen van dit 
proefschrift besproken in een breder perspectief. Allereerst wordt er besproken hoe de 
aanwezigheid van heup artrose en hoe progressie van heup artrose te deﬁniëren. De 
discussie richt zich daarna op het nut van een biomarker en tevens welke bronnen van 
potentiële bias de associatie tussen NSAIDs gebruik en progressie beïnvloeden. Tenslotte 
worden aanbevelingen gegeven voor toekomstig onderzoek en wat de gevonden resultaten 
betekenen voor de dagelijkse praktijk van een arts.
Max Reijman BW.indd   135 10/5/2004   10:30:58 AM
Max Reijman BW.indd   136 10/5/2004   10:30:58 AM
Dankwoord
137
Dankwoord
Het meest gelezen hoofdstuk van een proefschrift is, helaas voor de desbetreffende 
promovendus, het dankwoord. De promovendus bedankt alle personen die in meer of 
mindere mate een bijdrage hebben geleverd aan het uiteindelijke product, het proefschrift. 
Gedurende de afgelopen drie jaar, heb ik met veel mensen mogen samenwerken die mij 
geholpen hebben bij dit enerverende proces van promoveren. Van mijn eerste analyses met 
SPSS tot aan het voorbereiden van weer een presentatie voor een internationaal congres 
(EULAR), afgelopen juni 2004 in Berlijn.
Allereerst mijn promotor Prof. Dr. J.M.W. Hazes. Beste Mieke, vanaf ons eerste overleg, 
was ik onder de indruk van jouw kwaliteit om anderen enthousiast te maken voor 
wetenschappelijk onderzoek. Je methodologische kennis en klinische blik op analyses 
hebben mij erg gestimuleerd en natuurlijk veel geleerd. Daarnaast wil ik je bedanken voor 
alle tijd (en dat was niet weinig) die je in mij geïnvesteerd hebt; hoe een wetenschappelijk 
artikel te schrijven.
Vervolgens mijn andere promotor Prof. Dr. B.W. Koes. Beste Bart, door onze gedeelde 
interesses in het bewegingsapparaat en voetbalclub klikte het vanaf het begin. Bedankt voor 
je methodologisch begeleiding en vooral voor je positieve feedback. 
Sita, mijn copromotor, wil ik bedanken voor haar altijd openstaande deur. Jouw enthousiasme 
voor nieuwe resultaten, volgende versies van manuscripten, acceptaties van abstracts of 
artikelen is de mooiste feedback die je als promovendus kan krijgen. Ik denk met veel 
plezier terug aan onze uitgebreide discussies over van alles en nog wat en het maken van 
plannen voor toekomstig onderzoek. Daarnaast wil ik je bedanken voor de gezellige Eular 
congressen in Lissabon en Berlijn.
Mijn “derde promotor” Prof. dr. H.A.P. Pols, beste Huib, met name bedankt voor je 
betrokkenheid bij mijn onderzoek. Ik heb veel geleerd van je kritische klinische blik op 
statistische analyses en van je adviezen hoe de resultaten te verkopen op een congres of in 
een artikel. Een “sexy” auteur zal ik waarschijnlijk wel nooit helemaal worden.
Trudie bedankt voor de fraaie voorkant van dit proefschrift, voor de kofﬁe op dinsdag 
ochtend en voor de gezelligheid.
Roos, mijn interesse voor de statistiek is door het samenwerken met jouw alleen maar groter 
geworden (waarschijnlijk statistisch signiﬁcant) en daarnaast natuurlijk bedankt voor de 
gezellige samenwerking.
Mijn kamergenoten; Pepijn, Ton, Leonie, Esther, Arthur en Umit wil ik bedanken voor de 
vele discussies en vooral voor de lol die we samen gehad hebben. Het was goed om leuke 
maar ook frustrerende verhalen te delen. 
Pim, ondanks je soms niet te volgen opmerkingen of redenaties hebben we ook vele 
serieuze en humorvolle gesprekken gehad. Bedankt voor je collegialiteit. 
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Verder natuurlijk alle Westzeedijkers: Marlies, Petra, Marie-Louise, Yvonne, Frieke, Rebecca, 
Hans, Hanneke, Corinne, Robbert, Michiel, Arjan, Diana, Anneke, Liesbeth, Heleen, Herman, 
Sander, Boris en Kees, bedankt voor jullie gezelligheid.
René bedankt voor je hulp ten aanzien van allerlei ondersteunende vragen en natuurlijk 
voor je vriendschap.
Saeede, Janneke, Rianne en Annet, de artrose onderzoekers bij Huisartsgeneeskunde, 
bedankt voor de gezellige samenwerking. Je hield je wel niet bezig met artrose, maar toch 
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